
<html lang="en"     class="pb-page"  data-request-id="9a0739dd-89ac-49e8-8268-e2ea23eb2688"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm901292j;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2010.53.issue-4;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis and Preclinical Evaluations of 2-(2-Fluorophenyl)-6,7-methylenedioxyquinolin-4-one Monosodium Phosphate (CHM-1−P-Na) as a Potent Antitumor Agent" /></meta><meta name="dc.Creator" content="Li-Chen  Chou" /></meta><meta name="dc.Creator" content="Chien-Ting  Chen" /></meta><meta name="dc.Creator" content="Jang-Chang  Lee" /></meta><meta name="dc.Creator" content="Tzong-Der  Way" /></meta><meta name="dc.Creator" content="Chi-Hung  Huang" /></meta><meta name="dc.Creator" content="Shih-Ming  Huang" /></meta><meta name="dc.Creator" content="Che-Ming  Teng" /></meta><meta name="dc.Creator" content="Takao  Yamori" /></meta><meta name="dc.Creator" content="Tian-Shung  Wu" /></meta><meta name="dc.Creator" content="Chung-Ming  Sun" /></meta><meta name="dc.Creator" content="Du-Shieng  Chien" /></meta><meta name="dc.Creator" content="Keduo  Qian" /></meta><meta name="dc.Creator" content="Susan L.  Morris-Natschke" /></meta><meta name="dc.Creator" content="Kuo-Hsiung  Lee" /></meta><meta name="dc.Creator" content="Li-Jiau  Huang" /></meta><meta name="dc.Creator" content="Sheng-Chu  Kuo" /></meta><meta name="dc.Description" content="CHM-1 [2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one] (1) has a unique antitumor mechanism of action. However, because 1 has relatively low hydrophilicity, it was evaluated only via ip admini..." /></meta><meta name="Description" content="CHM-1 [2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one] (1) has a unique antitumor mechanism of action. However, because 1 has relatively low hydrophilicity, it was evaluated only via ip admini..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 26, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm901292j" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm901292j" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm901292j" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm901292j" /></link>
        
    
    

<title>Synthesis and Preclinical Evaluations of 2-(2-Fluorophenyl)-6,7-methylenedioxyquinolin-4-one Monosodium Phosphate (CHM-1−P-Na) as a Potent Antitumor Agent | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm901292j" /></meta><meta property="og:title" content="Synthesis and Preclinical Evaluations of 2-(2-Fluorophenyl)-6,7-methylenedioxyquinolin-4-one Monosodium Phosphate (CHM-1−P-Na) as a Potent Antitumor Agent" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0003.jpeg" /></meta><meta property="og:description" content="CHM-1 [2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one] (1) has a unique antitumor mechanism of action. However, because 1 has relatively low hydrophilicity, it was evaluated only via ip administration, which is not clinically acceptable. In this study, we synthesized the monosodium phosphate salt (CHM-1−P-Na, 4) of 1 as a hydrophilic prodrug. Compound 4 was rapidly converted into 1 following iv and po administration and also possessed excellent antitumor activity in a SKOV-3 xenograft nude mice model. Compound 4 also had clear-cut pharmacological effects on enzymes related with tumor cells. Neither 4 nor 1 significantly affected normal biological function in a safety pharmacology profiling study. Compound 1 caused apoptotic effects in breast carcinoma cells via accumulation of cyclin B1, and importantly, the endogenous levels of the mitotic spindle checkpoint proteins BubR1 directly correlated with cellular response to microtubule disruption. With excellent antitumor activity profiles, 4 is highly promising for development as an anticancer clinical trials candidate." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm901292j"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm901292j">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm901292j&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm901292j&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm901292j&amp;href=/doi/10.1021/jm901292j" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1616-1626</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm901517k" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm901314r" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Preclinical Evaluations of 2-(2-Fluorophenyl)-6,7-methylenedioxyquinolin-4-one Monosodium Phosphate (CHM-1−P-Na) as a Potent Antitumor Agent</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li-Chen++Chou">Li-Chen Chou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chien-Ting++Chen">Chien-Ting Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jang-Chang++Lee">Jang-Chang Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tzong-Der++Way">Tzong-Der Way</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chi-Hung++Huang">Chi-Hung Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shih-Ming++Huang">Shih-Ming Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Che-Ming++Teng">Che-Ming Teng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Takao++Yamori">Takao Yamori</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tian-Shung++Wu">Tian-Shung Wu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>▽</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chung-Ming++Sun">Chung-Ming Sun</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Du-Shieng++Chien">Du-Shieng Chien</a></span><span class="author-xref-symbol author-aff-symbol"><sup>◆</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Keduo++Qian">Keduo Qian</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan+L.++Morris-Natschke">Susan L. Morris-Natschke</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kuo-Hsiung++Lee">Kuo-Hsiung Lee</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li-Jiau++Huang">Li-Jiau Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>¶</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sheng-Chu++Kuo">Sheng-Chu Kuo</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>¶</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Graduate Institute of Pharmaceutical Chemistry, China Medical University, Taichung, Taiwan</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Natural Products Research Laboratories, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599-7568</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">School of Biological Science and Technology, China Medical University, Taichung, Taiwan</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Taiwan Advance Biopharm, Inc., 12F, No. 25, Lane 169, Kangning Street, Xizhi City, Taipei 221, Taiwan</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Pharmacological Institute, College of Medicine, National Taiwan University, Taiwan</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan</span></div><div class="aff-info" id="aff7"><span class="aff-symbol">▽</span> <span class="aff-text">Department of Chemistry, National Cheng Kung University, No. 1, Dasyue Road, Tainan, Taiwan</span></div><div class="aff-info" id="aff8"><span class="aff-symbol">○</span> <span class="aff-text">Department of Applied Chemistry, National Chiao-Tung University, Hsinchu, Taiwan</span></div><div class="aff-info" id="aff9"><span class="aff-symbol">◆</span> <span class="aff-text">SunTen Phytotech Co., Ltd. 4F-1, No. 268, Liancheng Road, Jhonghe City, Taipei County 235, Taiwan</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. For K.-H.L.: phone, 919-962-0066; fax, 1-919-966-3893; E-mail: <a href="/cdn-cgi/l/email-protection#7b1013171e1e3b0e1518551e1f0e"><span class="__cf_email__" data-cfemail="1c77747079795c69727f32797869">[email protected]</span></a>. For S.-C.K.: phone, +886-4-22053366-5608; fax, +886-4-22030760; E-mail: <a href="/cdn-cgi/l/email-protection#5a2939312f351a373b33367439372f743f3e2f742e2d"><span class="__cf_email__" data-cfemail="3142525a445e715c50585d1f525c441f5455441f4546">[email protected]</span></a></div><div class="corresp-fn" id="fn1">¶L.-J. Huang and S.-C. Kuo contributed equally to this work.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm901292j&amp;href=/doi/10.1021%2Fjm901292j" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1616–1626</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 26, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 August 2009</li><li><span class="item_label"><b>Published</b> online</span>26 January 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 February 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm901292j" title="DOI URL">https://doi.org/10.1021/jm901292j</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1616%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLi-Chen%2BChou%252C%2BChien-Ting%2BChen%252C%2BJang-Chang%2BLee%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D4%26contentID%3Djm901292j%26title%3DSynthesis%2Band%2BPreclinical%2BEvaluations%2Bof%2B2-%25282-Fluorophenyl%2529-6%252C7-methylenedioxyquinolin-4-one%2BMonosodium%2BPhosphate%2B%2528CHM-1%25E2%2588%2592P-Na%2529%2Bas%2Ba%2BPotent%2BAntitumor%2BAgent%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1626%26publicationDate%3DFebruary%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm901292j"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2433</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">25</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm901292j" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Preclinical Evaluations of 2-(2-Fluorophenyl)-6,7-methylenedioxyquinolin-4-one Monosodium Phosphate (CHM-1−P-Na) as a Potent Antitumor Agent&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Li-Chen&quot;,&quot;last_name&quot;:&quot;Chou&quot;},{&quot;first_name&quot;:&quot;Chien-Ting&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Jang-Chang&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Tzong-Der&quot;,&quot;last_name&quot;:&quot;Way&quot;},{&quot;first_name&quot;:&quot;Chi-Hung&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Shih-Ming&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Che-Ming&quot;,&quot;last_name&quot;:&quot;Teng&quot;},{&quot;first_name&quot;:&quot;Takao&quot;,&quot;last_name&quot;:&quot;Yamori&quot;},{&quot;first_name&quot;:&quot;Tian-Shung&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Chung-Ming&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Du-Shieng&quot;,&quot;last_name&quot;:&quot;Chien&quot;},{&quot;first_name&quot;:&quot;Keduo&quot;,&quot;last_name&quot;:&quot;Qian&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;L. Morris-Natschke&quot;},{&quot;first_name&quot;:&quot;Kuo-Hsiung&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Li-Jiau&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Sheng-Chu&quot;,&quot;last_name&quot;:&quot;Kuo&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;26&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;1616-1626&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm901292j&quot;},&quot;abstract&quot;:&quot;CHM-1 [2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one] (1) has a unique antitumor mechanism of action. However, because 1 has relatively low hydrophilicity, it was evaluated only via ip administration, which is not clinically acceptable. In this study, we synthesized the monosodium phosphate salt (CHM-1−P-Na, 4) of 1 as a hydrophilic prodrug. Compound 4 was rapidly converted into 1 following iv and po administration and also possessed excellent antitumor activity in a SKOV-3 xenograft nude mice model. Compound 4 also had clear-cut pharmacological effects on enzymes related with tumor cells. Neither 4 nor 1 significantly affected normal biological function in a safety pharmacology profiling study. Compound 1 caused apoptotic effects in breast carcinoma cells via accumulation of cyclin B1, and importantly, the endogenous levels of the mitotic spindle checkpoint proteins BubR1 directly correlated with cellular response to microtubule disruption. With excellent antitumor activity profiles, 4 is highly promis&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901292j&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901292j" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901292j&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901292j" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901292j&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901292j" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm901292j&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901292j&amp;href=/doi/10.1021/jm901292j" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm901292j" /></input><a href="/doi/pdf/10.1021/jm901292j" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm901292j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm901292j%26sid%3Dliteratum%253Aachs%26pmid%3D20102207%26genre%3Darticle%26aulast%3DChou%26date%3D2010%26atitle%3DSynthesis%2Band%2BPreclinical%2BEvaluations%2Bof%2B2-%25282-Fluorophenyl%2529-6%252C7-methylenedioxyquinolin-4-one%2BMonosodium%2BPhosphate%2B%2528CHM-1%25E2%2588%2592P-Na%2529%2Bas%2Ba%2BPotent%2BAntitumor%2BAgent%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D4%26spage%3D1616%26epage%3D1626%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291098" title="Antitumor activity">Antitumor activity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/medium/jm-2009-01292j_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901292j&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">CHM-1 [2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one] (<b>1</b>) has a unique antitumor mechanism of action. However, because <b>1</b> has relatively low hydrophilicity, it was evaluated only via ip administration, which is not clinically acceptable. In this study, we synthesized the monosodium phosphate salt (CHM-1−P-Na, <b>4</b>) of <b>1</b> as a hydrophilic prodrug. Compound <b>4</b> was rapidly converted into <b>1</b> following iv and po administration and also possessed excellent antitumor activity in a SKOV-3 xenograft nude mice model. Compound <b>4</b> also had clear-cut pharmacological effects on enzymes related with tumor cells. Neither <b>4</b> nor <b>1</b> significantly affected normal biological function in a safety pharmacology profiling study. Compound <b>1</b> caused apoptotic effects in breast carcinoma cells via accumulation of cyclin B1, and importantly, the endogenous levels of the mitotic spindle checkpoint proteins BubR1 directly correlated with cellular response to microtubule disruption. With excellent antitumor activity profiles, <b>4</b> is highly promising for development as an anticancer clinical trials candidate.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33851" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33851" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In our prior studies,<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref13 ref14">(1-14)</a> substituted 2-phenylquinolin-4-ones (2-PQs) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A) were identified as novel antimitotic agents, and their structure−activity relationships were established from experimental results of numerous related synthetic analogues. Many of the tested 2-PQ derivatives demonstrated potent cytotoxicity against human cancer cell lines and were selected for in vivo testing in our laboratory. To date, among tested compounds, 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one (CHM-1,<a class="ref internalNav" href="#fn9" aria-label="a">a</a><div class="NLM_fn" id="fn9">a<p class="last">Abbreviations: CHM-1, 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one; CHM-1-P, 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one dihydrogen phosphate; CHM-1-P-Na, 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one monosodium phosphate; ip, intraperitoneal; iv, intravenous; po, oral; SPP, safety pharmacology profiling; MTD, maximum tolerance dose; EMCIT, enzyme-mediated cancer imaging and therapy; JFCR, Japanese Foundation for Cancer Research; AUC, area under curve; ADME, administration, distribution, metabolism, excretion; PQ, phenylquinolone.</p></div><b>1</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B) has been identified as the most active compound in vivo. Namely, when <b>1</b> was evaluated in SCID mice bearing HA-22T xenograft, the tumor growth was remarkably suppressed and the survival life span was significantly extended by <b>1</b> at a dosage of 10 mg/kg injected intraperitoneally (ip) Q4D × 3 when compared with the control group.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Compound <b>1</b> was also evaluated against OVCAR-3 ovarian tumor xenograft in nude mice by the National Cancer Institute (NCI, USA) and was found to exhibit excellent antitumor activity. At dosages of 200, 134, and 79 mg/kg (Q7D × 3, ip), <b>1</b> extended the life span of tumor-bearing mice by 124%, 133%, and 79%, respectively. Notably, even at the highest test dosage (200 mg/kg), <b>1</b> did not reach the maximum tolerance dose (MTD). The preliminary results from the above in vivo studies clearly indicate that <b>1</b> has significant antitumor activity while maintaining low toxicity. Unfortunately, <b>1</b> has relatively low water solubility (13 ng/mL); thus, its animal study could only be done via ip administration, which is not suitable for clinical use. Accordingly, to enhance the developmental value of <b>1</b>, we designed its conversion to a prodrug, which could be administrated through both oral and iv routes.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/medium/jm-2009-01292j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Structures of substituted 2-phenylquinolin-4-ones (2-PQs). (B) Synthesis of sodium 2-(2-fluorophenyl)-6,7-methylenedioxy-quinolin-4-yl hydrogen phosphate (<b>4</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901292j&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the present study, we selected the hydrophilic monosodium phosphate of <b>1</b> (CHM-1−P-Na, <b>4</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B) as the target compound. This prodrug should be converted readily to the parent molecule in the bloodstream or gastrointestinal tract by reaction with nonspecific alkaline or acidic phosphatases.<a onclick="showRef(event, 'ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19 ref20">(16-20)</a> Similar prodrug strategies have successfully improved the clinical usage of estramustine, etoposide, combretastatin A-4, and 2-methoxyestradiol.<a onclick="showRef(event, 'ref21 ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24 ref25">(21-25)</a></div><div class="NLM_p">Recently, enzyme-mediated cancer imaging and therapy (EMCIT)<a onclick="showRef(event, 'ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28 ref29">(26-29)</a> has been developed as a novel method for enzyme-dependent, site-specific in vivo precipitation of water-insoluble radioactive molecules within solid tumors. A radiolabeled prodrug containing a phosphate moiety is dephosphorylated both in vitro and in vivo to its water-insoluble form by alkaline phosphatase overexpressed on the extracellular space of some specific tumor cells, such as ovarian, bladder, and hepatoma cells. On the basis of this methodology, we were encouraged to pursue the synthesis of <b>4</b> as a reasonable target delivery strategy. Our phosphate-bearing prodrug, <b>4</b>, could reasonably be desphosphorylated to its water-insoluble form and precipitated in situ on the extracellular space of SKOV-3 ovarian tumors. In this paper, we report the synthesis of <b>4</b> and the selective toxicity of <b>1</b> against various human cancer cell lines. Also reported are the results of a preliminary pharmacokinetic study and evaluation of the antitumor activity of <b>4</b> following oral and iv administration.</div><div class="NLM_p last">Safety pharmacology profiling (SPP) is a reliable, fast, and cost-effective means for determining potential drug liabilities to aid lead selection and lead optimization. Analysis of profiling data enables us to find off-target interactions for predicting potential side-effects, efficacy, and safety of compounds. SPP concentrates on early hazard identification to guide drug discovery projects and to minimize or abolish deleterious effects through structure−activity relationship considerations. Early compound profiling by in vitro pharmacology profiling can flag for receptor-, enzyme-, transporter-, and channel-related liabilities of compounds and translates these data into conjunction with ADME and toxicity (ADME−Tox) characteristics. Therefore, we can use enzyme and radioligand binding assays to identify targets associated with beneficial effects for treating cancer or with possible side effects. Both <b>1</b> and <b>4</b> were evaluated, and their safety profiling results were recorded. The mechanism of action of <b>4</b>’s antitumor activity was also explored and reported in the current study.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41857" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41857" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Although the synthesis of monosodium phosphate salt of <b>1</b> was challenging due to the ready decomposition of CHM-1-phosphate (<b>3</b>) back to <b>1</b> in MeOH, it was successfully achieved. Although synthetic methods to produce quinolin-4-phosphoric acid dialkyl esters (<b>I</b><sub><b>A</b></sub>) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A) have been reported,<a onclick="showRef(event, 'ref3 ref30'); return false;" href="javascript:void(0);" class="ref ref3 ref30">(3, 30)</a> a literature search revealed no information about the preparation of the hydrolyzed quinolinol-4-phosphoric acids (<b>I</b><sub><b>B</b></sub>) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A). To our knowledge, this is the first time that phosphate has been linked to the 4-<i>O</i> position of a quinoline. The synthesis of 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-yl phosphate monosodium salt (<b>4</b>) is illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B. Initially, <b>1</b> was dissolved in THF, and reacted with tetrabenzyl pyrophosphate in the presence of NaH, to yield dibenzyl 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-yl phosphate (<b>2</b>). Compound <b>2</b> was subjected to Pd/C catalytic hydrogenolysis in MeOH to give <b>3</b> in high yield (97%). The compound precipitated from solution, which prevented the further decomposition of the prodrug. Finally, <b>3</b> was treated with NaHCO<sub>3</sub> to obtain the water-soluble monosodium salt (<b>4</b>).</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Biology</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12204" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12204" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Growth Inhibitory Activity of <b>1</b> against Human Cancer Cell Line Panel</h3><div class="NLM_p">Compound <b>1</b>, the parent compound of <b>4</b>, was evaluated for its growth inhibitory activity against the JFCR-39 human cancer cell panel by the Japanese Foundation for Cancer Research (JFCR).<a onclick="showRef(event, 'ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33">(31-33)</a> The evaluation was carried out to determine the selective responses of <b>1</b> toward various human cancer cell lines so that the results could be used as a guideline for selecting suitable cancer types in the animal study of its prodrug, <b>4</b>.</div><div class="NLM_p">The growth inhibitory activity data of <b>1</b> were analyzed computationally and presented as dose−response curves at five different concentrations between 10<sup>−4</sup> and 10<sup>−8</sup> M. GI<sub>50</sub>, TGI, and LC<sub>50</sub> values were calculated, and the corresponding mean graph or fingerprint (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) was obtained.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/medium/jm-2009-01292j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Differential activity patterns for <b>1</b> against 39 human cancer cell lines. MG-MID: mean of log <i>X</i> values (<i>X</i> = GI<sub>50</sub>, TGI, and LC<sub>50</sub>). Delta: logarithm of the difference between the MG-MID and the log <i>X</i> of the most sensitive cell line. Range: logarithm of the difference between the log <i>X</i> of the most resistant cell line and the log <i>X</i> of the most sensitive cell line. H: High concentration (10<sup>−4</sup> M) (highest concentration of <b>1</b> used during testing); L: Low concentration (10<sup>−8</sup> M) (lowest concentration of <b>1</b> used during testing). H:1 indicates that the number of cell lines tested at the highest concentration is 1. L:0 indicates that the number of cell lines tested at the lowest concentration is 0.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901292j&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Our results showed that <b>1</b> was active against most tested cancer cell lines with a mean log GI<sub>50</sub> (MG-MID) value of −6.65. In particular, <b>1</b> was profoundly cytotoxic (log GI<sub>50</sub> < −7.0) against the following 15 cell lines: U251, KM-12, HCT-15, HCT-116, NCI-H522, DMS-273, DMS-114, OVCAR-4, SKOV-3, RXF-631 L, MKN-1, MKN-7, MKN-45, DU-145, and PC-3.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Unique COMPARE Fingerprint of <b>1</b></h3><div class="NLM_p last">The fingerprint of the preferential responses of <b>1</b> against specific cells in the cell panel was then analyzed by a pattern-recognition computer program (COMPARE), which contains a database covering similar types of fingerprints from over 300 known anticancer agents with various mechanisms of action. The low correlation coefficient (<i>r</i> < 0.4) found in fingerprint-matching for <b>1</b> seemed to imply that its mechanism of action differed widely from those of the anticancer agents covered in the COMPARE database.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Single Dose Pharmacokinetics of <b>4</b> in Male CD-1 (<i>Crl.</i>) Mouse</h3><div class="NLM_p">One objective of this study was to find the dosage of <b>4</b> required to achieve significant antitumor activity via iv and oral administration. As mentioned above, an ip dose of 10 mg/kg of <b>1</b> resulted in significant antitumor activity in our animal study. After the dosing, pharmacokinetic parameters were determined. Similarly, 10 mg/kg of the prodrug <b>4</b> was administered via iv and oral routes, and the pharmacokinetic parameters of <b>3</b> and its metabolite <b>1</b> were determined. The dosage of <b>4</b> required to achieve significant antitumor activity in an animal study could thus be predicted by comparing the pharmacokinetic profiles of <b>1</b> and <b>4</b>.</div><div class="NLM_p">Selected pharmacokinetic parameters are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> for ip, iv, and po administration, respectively. The mean plasma concentration−time curves of <b>1</b> and <b>3</b>, determined after ip, iv, and po dosing, are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A−D.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/medium/jm-2009-01292j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Mean plasma concentration−time profiles of <b>1</b> and <b>4</b> in male CD-1 (<i>Crl.</i>) mice following a single iv dose of <b>4</b> at 10 mg/kg. (B) Mean plasma concentration−time profiles of <b>1</b> in male CD-1(<i>Crl.</i>) mice following a single iv dose of <b>4</b> and single ip dose of <b>1</b> at 10 mg/kg. (C) Mean plasma concentration−time profile of <b>1</b> and <b>3</b> in male CD-1 (<i>Crl.</i>) mice following a single po dose of <b>4</b> at 10 mg/kg. (D) Mean plasma concentration−time profiles of <b>1</b> in male CD-1 (<i>Crl.</i>) mice following a single po dose of <b>4</b> at 10 mg/kg and single ip dose of <b>1</b> at 10 mg/kg.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901292j&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Pharmacokinetic Parameters of <b>1</b> and <b>4</b> in Male CD-1 (<i>Crl.</i>) Mice Following a Single Dose of either <b>1</b> or <b>4</b> at 10 mg/kg by Different Routes</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="center">compd <br /></br>dosed</th><th align="center">compds <br /></br>examined</th><th align="center" char="."><i>C</i><sub>max</sub><br /></br>(ng/mL)</th><th align="center" char=".">AUC(0−inf) <br /></br>(ng·h/mL)</th><th align="center"><i>T</i><sub>max</sub><br /></br>(h)</th><th align="center" char=".">MRT <br /></br>(h)</th><th align="center">CL <br /></br>(mL/(min·kg))</th><th align="center"><i>t</i><sub>1/2</sub><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a><br /></br>(h)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>1</b> (ip)</td><td align="left"><b>1</b></td><td align="char" char=".">155</td><td align="char" char=".">417</td><td align="left">0.3</td><td align="char" char=".">7.3</td><td align="left">nd<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td align="left">7.3</td></tr><tr valign="top"><td align="left"><b>4</b> (iv)</td><td align="left"><b>3</b></td><td align="char" char=".">29810</td><td align="char" char=".">3220</td><td align="left">nd<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td align="char" char=".">0.1</td><td align="left">51.7</td><td align="left">nd<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top"><td align="left"> </td><td align="left"><b>1</b></td><td align="char" char=".">8702</td><td align="char" char=".">1956</td><td align="left">nd<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td align="char" char=".">0.7</td><td align="left">nd<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td align="left">1.0</td></tr><tr valign="top"><td align="left"><b>4</b> (po)</td><td align="left"><b>3</b></td><td align="char" char=".">91</td><td align="char" char=".">28</td><td align="left">0.3</td><td align="char" char=".">0.3</td><td align="left">nd<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td align="left">nd<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top"><td align="left"> </td><td align="left"><b>1</b></td><td align="char" char=".">1312</td><td align="char" char=".">1230</td><td align="left">0.5</td><td align="char" char=".">1.4</td><td align="left">nd<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td align="left">1.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">nd: not determined.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last"><i>t</i><sub>1/2</sub> was determined from 6 to 27 h time points.</p></div></div></div><div class="NLM_p">As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A, a high concentration of active metabolite <b>1</b> appeared almost instantly in the mouse bloodstream after iv dosing of 10 mg/kg of <b>4</b>, while the concentration of prodrug <b>3</b> declined rapidly to a very low level within 1 h. These results indicated that <b>4</b> was quickly converted into its active parent compound <b>1</b> after iv dosing.</div><div class="NLM_p">The plasma levels of <b>1</b> following iv and ip dosing of <b>4</b> and <b>1</b>, respectively, are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B. This comparison indicated that the plasma concentration of <b>1</b> (AUC = 1956 ng·h/mL, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) following iv dosing of <b>4</b> was significantly higher than that of <b>1</b> (AUC = 417 ng·h/mL, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) following ip dosing of <b>1</b>, particularly in the first hour postdosing. Therefore, we expected that the antitumor activity of <b>4</b> at 10 mg/kg iv dosing would be superior to that resulting from <b>1</b> at 10 mg/kg ip dosing.</div><div class="NLM_p">Meanwhile, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>C, after po dosing of 10 mg/kg of <b>4</b>, the plasma concentration−time profiles of <b>3</b> and its metabolite <b>1</b> appeared to follow the same pattern (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A) found with iv dosing of <b>4</b>. Namely, the active metabolite <b>1</b> appeared instantly in the bloodstream, while the concentration of <b>3</b> declined rapidly until it essentially disappeared within an hour. This experiment demonstrated that <b>4</b> was also quickly converted into its active metabolite <b>1</b> following oral dosing.</div><div class="NLM_p last">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>D compares the pharmacokinetic profiles of <b>4</b> and <b>1</b> following po and ip dosing, respectively. The plasma concentration of <b>1</b> (AUC = 1230 ng·h/mL, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), following oral dosing of <b>4</b>, was higher than that of <b>1</b> (AUC = 417 ng·h/mL, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) following ip dosing of <b>1</b>. Likewise, we expected that the antitumor activity for <b>4</b> at 10 mg/kg po dosing of would be superior to that resulting from <b>1</b> at 10 mg/kg ip dosing.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Acute Oral Toxicity of <b>4</b></h3><div class="NLM_p last">The mortality of male mice orally administered <b>4</b> from group 1 to group 5 was 0/5, 0/5, 0/5, 0/5, and 5/5, and of female mice was 0/5, 0/5, 0/5, 2/5, and 5/5, respectively. Dosages of test compound, administered by gavage, were 0, 500, 1500, 2700, and 5000 mg/kg for groups 1−5, respectively. Hunched posture, tremors, and prostration were observed before animals died. Salivation, hypoactivity, soft feces, and feces stain were observed in other surviving animals. All observations were gone within three days. None of the animals had obvious gross lesions. The LD<sub>50</sub> with 95% confidence interval was 2462 mg/kg in females and 2720 mg/kg in males.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Safety Pharmacology Profiling (SPP) of <b>1</b> and <b>4</b></h3><div class="NLM_p">To explore their general pharmacological activities, <b>1</b> and <b>4</b> were further screened in 317 enzyme assays and 167 radioligand binding assays. The results of inhibitory activity screening of <b>1</b> are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. At 10 μM, <b>1</b> showed significant responses (≥50% inhibition) toward glutamate decarboxylase, MAO-A, pepsin, MAPK10, and GABA<sub>A</sub>. The same screening indicated that <b>4</b> exhibited significant inhibitory activity against eight targets at 10 μM, and further assessment was performed to determine IC<sub>50</sub>. The inhibitory activity of <b>4</b> was greatest against protein tyrosine phosphatases PRL-1 and PRL-2 (IC<sub>50</sub> < 10.0 μM) (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Among those enzymes and ligand inhibited by <b>4</b>, PRL-1, -2, and -3 are postulated to promote cell motility, invasion, and metastasis, while cathepsin-D, -E, -S, and GABA<sub>A</sub> are also associated with tumor activity.<a onclick="showRef(event, 'ref34 ref35 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36 ref37 ref38">(34-38)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibitory Effects of <b>1</b> on Enzyme and Radioligand Binding Assays for SPP</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="left">biological assay<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th align="left">species</th><th align="left">% of inhibition</th></tr></thead><tbody><tr valign="top"><td align="left">glutamate decarboxylase<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td align="left"><i>C. perfringens</i></td><td align="left">66</td></tr><tr valign="top"><td align="left">monoamine oxidase MAO-A<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td align="left">human</td><td align="left">52</td></tr><tr valign="top"><td align="left">peptidase, CTSD (cathepsin D)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td align="left">human</td><td align="left">27</td></tr><tr valign="top"><td align="left">peptidase, CTSE (cathepsin E)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td align="left">human</td><td align="left">12</td></tr><tr valign="top"><td align="left">peptidase, CTSS (cathepsin S)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td align="left">human</td><td align="left">1</td></tr><tr valign="top"><td align="left">peptidase, pepsin<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td align="left">pig</td><td align="left">85</td></tr><tr valign="top"><td align="left">CYP450, 2D6<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td align="left">human</td><td align="left">nd<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top"><td align="left">protein serine/threonine kinase [MAPK10 (JNK3)]<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td align="left">human</td><td align="left">55</td></tr><tr valign="top"><td align="left">protein tyrosine phosphatase, PTP4A1(PRL-1)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td align="left">human</td><td align="left">nd<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top"><td align="left">protein tyrosine phosphatase, PTP4A2(PRL-2)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td align="left">human</td><td align="left">nd<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top"><td align="left">protein tyrosine phosphatase, PTP4A3(PRL-3)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td align="left">human</td><td align="left">nd<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top"><td align="left">GABA<sub>A</sub>, benzodiazepine control <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="left">rat</td><td align="left">83</td></tr><tr valign="top"><td align="left">GABA<sub>A</sub>, flunitrazepam, central <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="left">rat</td><td align="left">nd<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Concentration = 10 μM.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Enzyme assay.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Radioligand binding assay.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">nd: no determination.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibitory Effects of <b>4</b> on Enzyme and Radioligand Binding Assays for SPP<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="left">biological assay<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></th><th align="left">species</th><th align="center">inhibition %</th><th align="left">IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top"><td align="left">glutamate decarboxylase <a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></td><td align="left"><i>C. perfringens</i></td><td align="left">nd<a class="ref internalNav" href="#t3fn4" aria-label="e">e</a></td><td align="left">nd<a class="ref internalNav" href="#t3fn4" aria-label="e">e</a></td></tr><tr valign="top"><td align="left">monoamine oxidase MAO-A <a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></td><td align="left">human</td><td align="left">−24</td><td align="left">nd<a class="ref internalNav" href="#t3fn4" aria-label="e">e</a></td></tr><tr valign="top"><td align="left">peptidase, CTSD (cathepsin D) <a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></td><td align="left">human</td><td align="left">50</td><td align="left">9.79</td></tr><tr valign="top"><td align="left">peptidase, CTSE (cathepsin E) <a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></td><td align="left">human</td><td align="left">78</td><td align="left">1.71</td></tr><tr valign="top"><td align="left">peptidase, CTSS (cathepsin S) <a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></td><td align="left">human</td><td align="left">106</td><td align="left">1.62</td></tr><tr valign="top"><td align="left">peptidase, pepsin <a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></td><td align="left">pig</td><td align="left">−19</td><td align="left">nd<a class="ref internalNav" href="#t3fn4" aria-label="e">e</a></td></tr><tr valign="top"><td align="left">CYP450, 2D6 <a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></td><td align="left">human</td><td align="left">73</td><td align="left">3.22</td></tr><tr valign="top"><td align="left">protein serine/threonine kinase [MAPK10 (JNK3)] <a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></td><td align="left">human</td><td align="left">−20</td><td align="left">nd<a class="ref internalNav" href="#t3fn4" aria-label="e">e</a></td></tr><tr valign="top"><td align="left">protein tyrosine phosphatase, PTP4A1(PRL-1) <a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></td><td align="left">human</td><td align="left">98</td><td align="left">0.676</td></tr><tr valign="top"><td align="left">protein tyrosine phosphatase, PTP4A2(PRL-2) <a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></td><td align="left">human</td><td align="left">101</td><td align="left">0.314</td></tr><tr valign="top"><td align="left">protein tyrosine phosphatase, PTP4A3(PRL-3) <a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></td><td align="left">human</td><td align="left">72</td><td align="left">4.93</td></tr><tr valign="top"><td align="left">GABA<sub>A</sub>, benzodiazepine control <a class="ref internalNav" href="#t3fn3" aria-label="d">d</a></td><td align="left">rat</td><td align="left">nd<a class="ref internalNav" href="#t3fn4" aria-label="e">e</a></td><td align="left">nd<a class="ref internalNav" href="#t3fn4" aria-label="e">e</a></td></tr><tr valign="top"><td align="left">GABA<sub>A</sub>, flunitrazepam, central <a class="ref internalNav" href="#t3fn3" aria-label="d">d</a></td><td align="left">rat</td><td align="left">62</td><td align="left">5.57</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">A standard error of the means is presented where results are based on multiple, independent determination.</p></div><div class="footnote" id="t3fn1"><sup>b</sup><p class="last">Concentration = 10 μM.</p></div><div class="footnote" id="t3fn2"><sup>c</sup><p class="last">Enzyme assay.</p></div><div class="footnote" id="t3fn3"><sup>d</sup><p class="last">Radioligand binding assay.</p></div><div class="footnote" id="t3fn4"><sup>e</sup><p class="last">ND: no determination.</p></div></div></div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> In Vivo Antitumor Activity of <b>4</b></h3><div class="NLM_p">On the basis of the above cytotoxicity data of <b>1</b> and the pharmacokinetic parameters of <b>4</b>, we selected the SKOV-3 xenograft model using dosing at 5, 10, and 20 mg/kg (iv and po) to evaluate the in vivo antitumor activity of <b>4</b>.</div><div class="NLM_p">According to the results shown in parts A and B of Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, <b>4</b> induced dose- and time-dependent inhibition of SKOV-3 tumor growth. Significant tumor growth suppression was detected at 5 mg/kg/day, and almost complete tumor suppression was observed at 20 mg/kg/day. During the course of antitumor evaluation, no significant body weight changes were detected in either test or control mice (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C,D).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/medium/jm-2009-01292j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Mean tumor volume−time profiles in SKOV-3 xenograft nude mice (<i>n</i> = 11) following iv dosing of <b>4</b> at 5, 10, and 20 mg/kg five days per week for four consecutive weeks. (B) Mean tumor volume−time profiles in SKOV-3 xenograft nude mice (<i>n</i> = 11) following po dosing of <b>4</b> at 5, 10, and 20 mg/kg five days per week for four consecutive weeks. (C) Mean body weight−time profiles in SKOV-3 xenograft nude mice (<i>n</i> = 11) following iv dosing of <b>4</b> at 5, 10, and 20 mg/kg five days per week for four consecutive weeks. (D) Mean body weight−time profiles in SKOV-3 xenograft nude mice (<i>n</i> = 11) following po dosing of <b>4</b> at 5, 10, and 20 mg/kg five days per week for four consecutive weeks.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901292j&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The above findings indicated that <b>4</b> has excellent antitumor activity when administered either iv or po and that the same dosing led to similar antitumor efficacy, regardless of administration route.</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Compound <b>1</b> Inhibits Cell Growth in Human Ovarian Cancer Cells by Inducing Mitotic Arrest</h3><div class="NLM_p">We first determined the effect of <b>1</b> on the growth of ovarian cancer cell lines using the MTT assay. We chose three clinical trial agents, taxol, colchicine, and doxorubicin, as positive controls, and in comparison, <b>1</b> had a nearly equivalent effect against cancer cells (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A). These data indicate that <b>1</b> induces potent cytotoxicity in human ovarian cancer cells. To clarify the mechanism of <b>1</b>-induced proliferation inhibition, we examined the effect of <b>1</b> on the cell cycle. Compound <b>1</b> caused the accumulation of cells in the G2-M phase with concomitant losses in G0−G1 phase, with a maximum effect observed at 36 h (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B). The accumulation of cells with G2-M DNA content was followed by an increase in hypodiploid cells at the later time points (48 h), as indicated as apoptotic cells. These results indicate that <b>1</b> induced G2-M arrest of the cell cycle followed by apoptosis. To better understand the mechanism of <b>1</b>-induced G2-M arrest, the expression of cell cycle−related proteins was analyzed. Cyclin B1 and securin serve as markers for mitotic arrest induction. Accordingly, we next assessed the effects of <b>1</b> on cyclin B1 and securin protein expression. Treatment of SKOV-3 cells with <b>1</b> resulted in increases in protein expression of cyclin B1 and securing (Figures <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>C,D).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/medium/jm-2009-01292j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of <b>1</b> on cell growth and cell cycle progression in human ovarian cancer cells. (A) SKOV-3 cells were incubated in the absence or presence of the 10 μM of <b>1</b>, colchicine, doxorubicin, and taxol for 24 h. (B) The time effect of <b>1</b> on cell cycle distribution, cells were treated with 10 μM of <b>1</b> for 6, 12, 24, 36, and 48 h and analyzed for propidium iodide-stained DNA content by flow cytometry. (C) SKOV-3 cells were treated with vehicle (DMSO), <b>1</b> (10 μM) for the indicated time. (D) SKOV-3 cells were treated with the indicated dose <b>1</b> for 24 h. Cells were then harvested and lysed for the detection of cyclin B1, securin, and β-actin protein expression. Western blot data presented are representative of those obtained in at least three separate experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901292j&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Upregulation of the Mitotic Spindle Checkpoint Protein BubR1 was Associated with a Sustained G2/M Cell Cycle Arrest after Treatment with <b>1</b></h3><div class="NLM_p">The mitotic spindle checkpoint protein BubR1 has been shown to monitor tension across attached kinetochores and initiate mitotic arrest in response to loss of microtubule tension. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A, upregulation of BubR1 was predominantly found in cells treated with 10 μM of <b>1</b> for the indicated durations. BubR1 upregulation produced microtubule disruption, as indicated by a significant increase in the percentage of cells arrested in the G2/M phase of the cell cycle (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B). Moreover, <b>1</b> caused the accumulation of BuBR1 (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B). Our result suggested that BubR1 contributed to the mitotic checkpoint induced by <b>1</b>.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/medium/jm-2009-01292j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. BubR1 upregulation was associated with <b>1</b>-induced G2/M cell cycle arrest in human ovarian cancer cells. (A) SKOV-3 cells were treated with vehicle (DMSO), <b>1</b> (10 μM) for the indicated time. (B) SKOV-3 cells were treated with the indicated dose <b>1</b> for 24 h. Whole-cell lysates were resolved by SDS-PAGE and probed with anti-BubR1 mouse mAb. Results are representative of three separate experiments. Blots were probed with anti-β-actin mAb as a loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901292j&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63527" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63527" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As we mentioned earlier, although <b>1</b> shows significant antitumor activity with an interesting mechanism of action, its low hydrophilicity limits its development. In this study, we successfully synthesized the monosodium phosphate salt (<b>4</b>) of <b>1</b>, which could be administrated through oral and iv routes instead of the original ip dosing. The single dose pharmacokinetic study of <b>4</b> in male CD-1 mouse proved that <b>4</b> was rapidly converted to its active form of <b>1</b> via iv or oral administration. By comparing the pharmacokinetic parameters, we postulated that the same dosing of <b>4</b> by iv or po routes would result in superior antitumor activity compared with ip dosing of <b>1</b>. This postulate was confirmed in the later in vivo antitumor assay. All of these results demonstrated the success of our prodrug strategy, which may highly improve the clinical usage of our drug candidate <b>1</b>.</div><div class="NLM_p">Because <b>4</b> was rapidly converted to metabolites in mice with both iv and po administration, we presumed that the antitumor activity of <b>4</b> may depend on the overall plasma exposure of <b>3</b> and its metabolites. However, comparison of the data in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> revealed a big difference between the total AUC values (measured as the sum of plasma exposure of <b>1</b> and <b>3</b>) determined after iv and po administration. Nevertheless, the in vivo antitumor activity test results revealed similar antitumor activity between <b>4</b> administered via iv and po routes. The dose-dependency of pharmacokinetics versus pharmacodynamic response appears to be nonlinear. Therefore, the contributions from factors such as protein binding, drug distribution, and the possible presence of additional active metabolites need to be further investigated.</div><div class="NLM_p">The growth inhibition assay of <b>1</b> revealed that this compound was particularly active against breast cancer (U251), lung cancer (NCI-H522, DMS273, DMS114), colon cancer (HCT-15, HCT-116), ovarian cancer (OVCAR-4, SKOV-3), stomach cancer (MKN1, MKN7, MKN45), and prostate cancer (DU-145, PC-3). Compound <b>1</b> displayed a significant growth inhibition and apoptosis in breast carcinoma cells and promising antitumor actions against human ovarian carcinoma cells compared with those of taxol, colchicine, and doxorubicin.</div><div class="NLM_p">In our mechanism of action studies of <b>1</b>, we observed multiple functions, including antimitotic activity, apoptosis-induction, antimetastasis, and antiangiogenesis.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Of particular interest to us is that <b>1</b> causes mitotic arrest through the expression of mitotic kinase BubR-1 and disrupts microtubule organization by enhancing SIRT2-mediated tubulin deacetylation. It has been widely reported that cyclin B1/CDK1 complexes are involved in the regulation of the G2/M phase and the M-phase transition. Many reports have demonstrated that antimicrotubule drug induced M-phase arrest, and inappropriate accumulation of B-type cyclins were associated with the initiation of apoptotic pathways. In this study, <b>1</b> arrested the growth of cancer cells at the G2-M phase and then induced apoptotic cell death via the accumulation of cyclin B1. More importantly, the endogenous levels of the mitotic spindle checkpoint protein BubR1 directly correlated with the cellular response to microtubule disruption. The mitotic spindle checkpoint is a complex pathway conserved across species and monitors the metaphase to anaphase transition. The basic model for the spindle checkpoint defines that tension defects or unattached chromosomes activate the checkpoint, delaying the onset of anaphase until such aberrations are corrected.</div><div class="NLM_p">In this study, our results suggested that absolute levels of BubR1 may determine the length of stay in G2/M. In support of our hypothesis, a recent study demonstrated that knockdown of BubR1 accelerates the normal progression of mitosis.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Furthermore, in our study, the <b>1</b>-induced G2/M block was maintained until endogenous levels of BubR1 protein became undetectable, and at this point, a marked increase in apoptosis was observed. BubR1 cellular levels inversely correlated with the onset of apoptosis. Collectively, these results suggest that endogenous levels of BubR1 may predict the apoptotic efficacy and potential chemotherapeutic benefit of microtubule-targeted drugs in human cancers. Because the current antimitotic anticancer drugs, such as vinca alkaloids and taxoids, are not cost-effective to synthesize due to structural complexity, <b>4</b> represents a promising novel class of mitotic-arresting compounds, which may supplement current cancer chemotherapy.</div><div class="NLM_p last">In conclusion, we have reported the synthesis of the monosodium phosphate prodrug (<b>4</b>) of <b>1</b> in high yield. Prodrug <b>4</b> was readily converted to its parent molecule <b>1</b> during both iv and po administration, and showed excellent antitumor activity when administered via iv and po routes to nude mice bearing SKOV-3 xenograft. Results from SPP using enzyme and radioligand binding assays suggested that <b>4</b> has clear-cut pharmacological effects on several tumor-associated enzymes and ligands. Further mechanism of action study indicated that <b>1</b> arrested the growth of cancer cells at the G2-M phase and then induced apoptotic cell death via the accumulation of cyclin B1. The <b>1</b>-induced G2/M block was maintained until endogenous levels of BubR1 protein became undetectable. On the basis of the above findings, we conclude that <b>4</b> is a promising anticancer clinical trials candidate, which functions as a novel antimitotic agent.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61050" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61050" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Materials</h3><div class="NLM_p last">Compounds <b>1</b> and <b>4</b> were synthesized according to Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B. Melting points were determined with a Yanaco MP-500D melting point apparatus and are uncorrected. IR spectra were recorded on Shimadzu IRPrestige-21 spectrophotometers as KBr pellets. NMR spectra were obtained on a Bruker Avance DPX-300 FT-NMR spectrometer in CDCl<sub>3</sub> or DMSO. The following abbreviations are used: s, singlet; d, doublet; t, triplet; dd, double doublet; and m, multiplet. MS spectra were measured with a Waters Quattro Micro LC/MS/MS instrument. Elemental analyses (C, H, and N) were performed on a Perkin-Elmer 2400 Series II CHNS/O analyzer, and the results were within ±0.4% of the calculated values. HPLC purity analysis of target compound <b>4</b> confirmed purity was 99.77%.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Dibenzyl 2-(2-Fluorophenyl)-6,7-methylenedioxyquinolin-4-yl Phosphate (<b>2</b>)</h3><div class="NLM_p last">Sodium hydride (13.7 mg, 0.57 mmol) was added at 0 °C to a stirred solution of <b>1</b> (64.5 mg, 0.23 mmol) in dry THF (10 mL). After 1 h, tetrabenzyl pyrophosphate (<b>1</b>) (100 mg, 0.19 mmol) was added and stirring was continued for 20 min. The mixture was filtered and washed with CH<sub>2</sub>Cl<sub>2</sub>. Then the filtrate was concentrated under vacuum at a temperature below 35 °C. The residue was purified by column chromatography (silica gel, EtOAc/<i>n</i>-hexane) to give <b>2</b> (69.1 mg, 0.127 mmol). Yield: 67%; mp 101−104 °C. MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 544. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz): δ 5.20 (s, 2H), 5.26 (s, 2H), 6.12 (s, 2H), 7.05 (s, 1H), 7.16−7.43 (m, 14H), 7.77 (s, 1H), 8.01−8.02 (m, 1H). Anal. (C<sub>30</sub>H<sub>23</sub>FNO<sub>6</sub>P) C, H, N.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2-(2-Fluorophenyl)-6,7-methylenedioxyquinolin-4-yl Dihydrogen Phosphate (<b>3</b>)</h3><div class="NLM_p last">A suspension of <b>2</b> (97.7 mg, 0.18 mmol) in anhydrous MeOH (10 mL) was hydrogenated in the presence of 10% Pd/C (50 mg) at rt for 10 min. The catalyst and precipitate were collected and dissolved in 10% NaHCO<sub>3</sub> solution and then filtered. The filtrate was acidified with diluted aq HCl, and the solid was then collected by filtration and washed with acetone to give <b>3</b> (63.5 mg, 0.175 mmol). Yield: 97.2%; mp >300 °C. MS (ESI): <i>m</i>/<i>z</i> 362 (M − H)<sup>−</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz): δ 6.22 (s, 2H), 7.32−7.41 (m, 4H), 7.49−7.54 (m, 1H), 7.74 (s, 1H), 7.93−7.98 (m, 1H). Anal. (C<sub>16</sub>H<sub>11</sub>FNO<sub>6</sub>P) C, H, N.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Sodium 2-(2-Fluorophenyl)-6,7-methylenedioxyquinolin-4-yl Hydrogen Phosphate (<b>4</b>)</h3><div class="NLM_p last">To a flask containing <b>3</b> (3.6 g, 10 mmol), a precooled (ice bath) solution of NaHCO<sub>3</sub> (0.1 M solution in H<sub>2</sub>O, 100 mL) was added dropwise. After the addition was complete, the reaction mixture was removed from the ice bath, stirred at rt for 5 min, and then filtered through celite after no dissolution from the solid was observed. The resulting yellow solution was poured into acetone (400 mL) and kept in an ice bath for 1 h. The precipitate was filtered and washed with ice-cooled acetone (20 mL × 4). The solid was dried under vacuum to yield <b>4</b> (2.9 g, 7.5 mmol). Yield: 75.3%; mp >300 °C. MS(ESI): <i>m</i>/<i>z</i> 384 (M − H)<sup>−</sup>. <sup>1</sup>H NMR (D<sub>2</sub>O, 300 MHz): δ 6.22 (s, 2H), 7.23−7.34 (m, 3H), 7.45−7.49 (m, 1H), 7.61 (s, 1H), 7.64 (s, 1H), 7.70 (t, <i>J</i> = 8.1 Hz, 1H). Anal. (C<sub>16</sub>H<sub>10</sub>FNNaO<sub>6</sub>P) C, H, N. HPLC purity analysis. Column: BEH Shield RP18 1.7 μm. Mobile phase: 0.01 M ammonium formate/CAN = 80/20. Detection wavelength: PDA Ch1 254 nm at 1.2 mm. Retention time: 0.565 min. Flow rate: 0.4 mL/min. Purity: 99.77%.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Growth Inhibitory Activity of <b>1</b> against Human Cancer Cell Line Panel</h3><div class="NLM_p">The system was developed according to the NCI method,<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> modified by the Japanese Foundation for Cancer Research (JFCR).<a onclick="showRef(event, 'ref32 ref43'); return false;" href="javascript:void(0);" class="ref ref32 ref43">(32, 43)</a> The cancer panel experiment for <b>1</b> was carried out by JFCR, and the inhibition profile was compared with those of more than 300 standard compounds, including various anticancer drugs. The precise experimental method and data analyses have been described elsewhere.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><div class="NLM_p last">Briefly, we describe the cell lines used and the method for detecting growth inhibition. The following human cancer cell lines were used in cancer panel experiments: breast cancer HBC-4, BSY-1, HBC-5, MCF-7, and MDA-MB-231; brain cancer U251, SF-268, SF-295, SF-539, SNB-75, and SNB-78; colon cancer HCC2998, KM-12, HT-29, HCT-15, and HCT-116; lung cancer NCI-H23, NCI-H226, NCI-H522, NCI-H460, A549, DMS273, and DMS114; melanoma LOX-IMVI; ovarian cancer OVCAR-3, OVCAR-4, OVCAR-5, OVCAR-8, and SKOV-3; renal cancer RXF-631 L and ACHN; stomach cancer St-4, MKN1, MKN7, MKN28, MKN45, and MKN74; prostate cancer DU-145 and PC-3. The cell lines were cultured in RPMI-1640 (GIBCO/BRL, NY) supplemented with 5% fetal bovine serum (FBS; GIBCO/BRL), penicillin (100 units/mL) (GIBCO/BRL), and streptomycin (100 mg/mL) (GIBCO/BRL) at 37 °C in humidified air containing 5% CO<sub>2</sub>. Dose−response curves at five different concentrations between 10<sup>−4</sup> and 10<sup>−8</sup> M were obtained from computer analysis. The 50% growth inhibition (GI<sub>50</sub>), total growth inhibition (TGI), and 50% lethal concentration (LC<sub>50</sub>) values for these cell lines were determined using the sulforhodamine B (SRB) colorimetric method. Computer processing of these values produced differential activity patterns against the cell lines (mean graphs). The mean graph was compared with those of standard compounds, including various anticancer drugs by using COMPARE analysis.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Single Dose Pharmacokinetics of <b>4</b> in Male CD-1 (<i>Crl.</i>) Mouse</h3><div id="sec5_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23">a Preparation of Dosing Formulations</h4><div class="NLM_p last">Compound <b>1</b> was dissolved in cremophor/DMSO/saline (20/5/75, v/v) to make a dosing solution of 2 mg/mL for ip administration. <b>4</b> was dissolved in 9% NaHCO<sub>3</sub>/water to make a dosing solution of 1 mg/mL for iv and oral administration.</div></div><div id="sec5_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24">b In Vivo Experiment</h4><div class="NLM_p last">Male CD-1 (<i>Crl.</i>) mice (body weight: 22−24 g) were used in this study. Source of animals was BioLasco Taiwan. Water was provided ad libitum, regardless of administration route. The <b>1</b> solutions (2 mg/mL) were injected ip with a bolus dosing volume of 0.11−0.12 mL (5 mL/kg) per animal. For iv administration, <b>4</b> was administered via tail vein with a bolus dosing volume of 0.22−0.24 mL per animal (10 mL/kg). For oral dosing, the drug suspension was given via oral gavages with a dosing volume of 0.22−0.24 mL per animal (10 mL/kg). The animals were fasted for 4 h prior to oral administration and allowed access to standard chow 4 h postdosing.</div></div><div id="sec5_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25">c Sample Collection</h4><div class="NLM_p last">Each blood sample (0.5−0.7 mL) was collected by decapitation and collected in a prechilling 1.5 mL size Eppendorf safe-lock microcentrifuge tube containing sodium fluoride, followed by centrifugation (12000 rpm, 4 °C) for 10 min. The plasma fraction was transferred to a clean microcentrifuge tube and stored at −70 °C for further analysis. The sampling time points were 0, 5, 15, 30 min, 1, 1.5, 2, 4, 6, 9, 24, and 27 h after ip dosing. The sampling time points were 0, 2, 5, 15, 30 min, 1, 1.5, 2, 4, 6, 9, 24, and 27 h after iv dosing. For oral administration, the blood samples were collected at predose, 15, 30 min, 1, 1.5, 2, 4, 6, 9, 24, and 27 h after dosing. Three mice were used per time point.</div></div><div id="sec5_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26">d Analytics and Pharmacokinetic Calculation</h4><div class="NLM_p last">The plasma concentrations of <b>1</b> and <b>3</b> were measured by LC-MS/MS (mass spectrometer: Micromass Quattro Ultima; pump and autosampler: Waters Alliance 2795 LC; data processor: MassLynx version 3.5) method with a reversed-phase Biosil Pro-ODS column. The plasma samples were mixed with acetonitrile, centrifuged, and the supernatant was injected onto an LC column. HPLC conditions were the following. Mobile phase: CHM-1: 35% CH<sub>3</sub>CN + 1.0% HCOOH; CHM-1-P: 30% CH<sub>3</sub>CN + 1.0% CH<sub>3</sub>COOH. Column: Biosil, ODS 4.6 mm × 150 mm, 5 μ. Flow rate: 1.0 mL/min with a post column split 1/10 to mass. Retention time: CHM-1: 2.96 min; CHM-1-P: 3.78 min. Tandem mass spectrometry was performed with electrospray/positive ionization mode, source temperature 80 °C, deesolvation temperature 400 °C. The pharmacokinetic parameters were calculated from mean plasma concentrations by WinNonlin Standard program (version 3.1, Pharsight Corp). The standard curve calculation involved the following: method: simple weighted linear regression with 1 over nominal concentration (1/<i>x</i>) or concentration square (1/<i>x</i><sup>2</sup>) as weighting factor, response: peak area ratio, equation: <i>y</i> = <i>bx</i> + <i>a</i>.</div></div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Acute Oral Toxicity Assay</h3><div class="NLM_p">Acute toxicity of <b>4</b> was evaluated with the lethal dose test, involving single oral administrations to a group of male and female rats at increasing doses in order to determine the dose that would kill 50% of mice (LD50) within a set time frame. The assay was conducted in compliance with the Good Laboratory Practice (GLP) regulations. All procedures were approved by the DCB Institutional Animal Care and Use Committee (IACUC) and conducted in compliance with the Guide for the Care and Use of Laboratory Animals.</div><div class="NLM_p">Fifty SD rats (25 males and 25 females) were obtained from BioLASCO Taiwan Co., Ltd. The rats were approximately 7−8 weeks old at time of dosing. The body weight range was 170−250 g for males and 150−210 g for females.</div><div class="NLM_p last">Rats were randomized into five groups, each consisting of five males and five females. The animals were fasted overnight before dosing. The treated rats were administered test article solution by gavage at dose levels of 500, 1500, 2700, and 5000 mg/kg; the control rats were administered water by gavage with dose volume 20 mL/kg once. Test article solutions were freshly prepared with water for oral injection. Rats were observed once daily for clinical signs of toxicity and twice daily for moribundity/mortality. Body weights were recorded weekly and at necropsy. All animals were euthanized and necropsied for gross lesion examination.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> In Vivo Antitumor Activity Assay</h3><div class="NLM_p">Female BALB/c nude mice (18−20 g; 6−8 weeks of age) were purchased from the National Animal Center and maintained in pressurized ventilated cages according to institutional regulations.</div><div class="NLM_p">SKOV-3, human ovarian cancer cells, were cultured in DMEM/F12 in 10% heat-inactivated bovine serum (FBS) and incubated at 37 °C in humidified atmosphere containing 5% CO<sub>2</sub>.</div><div class="NLM_p">Nude mice were subcutaneously inoculated with SKOV-3 cells at 3 × 10<sup>6</sup> cells per mouse in 0.5 mL PBS via a 24 gauge needle. After appearance of a 100 mm<sup>3</sup> tumor nodule, 88 tumor-bearing mice were randomly divided into eight groups for treatment with vehicle (PBS) or <b>4</b> with different administered methods and doses.</div><div class="NLM_p">Animals were weighed and tumors were measured using calipers twice weekly before, during, and after drug treatments. Tumor volume was calculated with the following formula: <sup>1</sup>/<sub>2</sub>(<i>L</i> + <i>W</i><sup>2</sup>), where <i>L</i> is the length and <i>W</i> is the width.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> At the end of the experiments, animals were euthanized with carbon dioxide followed by cervical dislocation. The tumors were excised, weighed, and sectioned, and the tumor sections were embedded in OCT compound and frozen at −70 °C.</div><div id="sec5_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29">a </h4><div class="NLM_p last">The mice were administered with single intravenous dosing of <b>4</b> via tail vein five days per week for four consecutive weeks at 5, 10, and 20 mg/kg.</div></div><div id="sec5_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30">b </h4><div class="NLM_p last">The mice were administered with single oral dosing of <b>4</b> five days per week for four consecutive weeks at 5, 10, and 20 mg/kg.</div></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Enzyme Assay and Radioligand Binding Assay (Spectrum Screen).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></h3><div class="NLM_p last">MDS PharmaServices performed this testing under standard protocols.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Mechanism of Action Study</h3><div id="sec5_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33">a Antibodies and Reagents</h4><div class="NLM_p last">Antibodies and reagents were purchased from commercial sources: antibodies against cyclin B1 and securing were purchased from Cell Signaling Technology (Beverly, MA); antibody against BuBR1 was from BD Biosciences (Los Angeles, CA); antimouse and antirabbit antibodies conjugated to horseradish peroxidase were obtained from Santa Cruz Biotechnology (Santa Cruz, CA); β-actin antibody and PI were from Sigma Chemical Co. (St. Louis, MO).</div></div><div id="sec5_10_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34">b Cell Lines and Cell Cultures</h4><div class="NLM_p last">The human ovarian cancer cell line SKOV-3 was obtained from The American Type Culture Collection (Rockville, MD) and propagated in 100 mm culture dishes at the desired density in DMEM/F-12 supplemented with 10% fetal calf serum and 1% penicillin−streptomycin. These cells were grown at 37 °C in a humidified atmosphere of 5% CO<sub>2</sub>.</div></div><div id="sec5_10_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35">c Western Blot Analyses</h4><div class="NLM_p last">Cells (1 × 10<sup>6</sup>) were washed twice with PBS, and then the gold lysis buffer (10% glycerol, 1% Triton X-100, 1 mM PMSF, 10 μg/mL leupeptin, 1 mM sodium orthovanadate, 1 mM EGTA, 10 mM NaF, 1 mM sodium pyrophosphate, 100 mM β-glycerophosphate, 20 mM Tris-HCl, 137 mM NaCl, 5 mM EDTA, 0.1% sodium dodecyl sulfate, and 10 μg/mL aprotinin. Adjust pH to 7.9) was added to lyse the cells. After the cells lysed, the suspension solution were centrifuged, and the Bio-Rad protein assay kit (Bio-Red Laboratories) was used to determine the protein contents. Taken were 50 μg proteins to be resolved with SDS-PAGE and transferred to PVDF membrane (polyvinylidene fluoride transfer membrane) (BioTrace, UK.). The membrane was blocked by blocking buffer (nonfat milk 5%), NaN<sub>3</sub> (0.2%), and Tween 20 (0.2%, v/v) in TBS). Then the PVDF membrane was incubated with primary antibodies, followed by incubation with horseradish peroxidase-conjugated goat antimouse antibody (1:2500 dilution, Roche Applied Science, Indianapolis, IN). Reactive bands were visualized with an enhanced chemiluminescence system (Amersham Biosciences, Arlington Heights, IL). The intensity of the bands was scanned and quantified with a Phosphor-Image system.</div></div><div id="sec5_10_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36">d Cell Proliferation Assays</h4><div class="NLM_p last">Cells (1 × 10<sup>4</sup>) were seeded on the 24-well cell culture cluster overnight and then treated with indicated drug and incubated for 24 h. Next, 40 μL of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) (stock conc 2 mg/mL, Sigma Chemical Co.) was added to each well (volume of each well was 500 μL) and then incubated for 2 h at 37 °C. After MTT-formazan crystals were formed, 250 μL of DMSO was added to dissolve the crystals. Finally, absorbance was detected at O.D. 550 nm by an enzyme-linked immunosorbent assay (ELISA) reader.</div></div><div id="sec5_10_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37">e Flow Cytometry</h4><div class="NLM_p last">The cell cycle analysis was determined by flow cytometry. Cells were cultured in 60 mm Petri dishes and incubated for various times. After being trypsinized and washed twice with ice-cold PBS, the cells were fixed with 70% ice-cold EtOH overnight at −20 °C. After centrifugation, the cell pellets were treated with RNAase A and exposed to PI and then analyzed by flow cytometry (FACScan, BD Biosciences, Mountain View, CA). The percentage was analyzed by Cell Quest software (BD Biosciences).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39"><a href="/doi/suppl/10.1021/jm901292j">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62135" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62135" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Literature references for spectrum screen (enzyme and radioligand binding assays); analytical results. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm901292j/suppl_file/jm901292j_si_001.pdf">jm901292j_si_001.pdf (381.67 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm901292j/suppl_file/jm901292j_si_002.pdf">jm901292j_si_002.pdf (13.61 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm901292j" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62268" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62268" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kuo-Hsiung Lee</span> - <span class="hlFld-Affiliation affiliation">Natural Products Research Laboratories, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599-7568</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ea8182868f8faa9f8489c48f8e9fca9989819f85aa878b8386c489879fc48f8e9fc49e9d"><span class="__cf_email__" data-cfemail="0f6467636a6a4f7a616c216a6b7a">[email protected]</span> <span class="__cf_email__" data-cfemail="85f6e6eef0eac5e8e4ece9abe6e8f0abe0e1f0abf1f2">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sheng-Chu Kuo</span> - <span class="hlFld-Affiliation affiliation">Graduate Institute of Pharmaceutical Chemistry, China Medical University, Taichung, Taiwan</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7b1013171e1e3b0e1518551e1f0e5b0818100e143b161a12175518160e551e1f0e550f0c"><span class="__cf_email__" data-cfemail="e48f8c888181a4918a87ca818091">[email protected]</span> <span class="__cf_email__" data-cfemail="7a0919110f153a171b13165419170f541f1e0f540e0d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li-Chen Chou</span> - <span class="hlFld-Affiliation affiliation">Graduate Institute of Pharmaceutical Chemistry, China Medical University, Taichung, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chien-Ting Chen</span> - <span class="hlFld-Affiliation affiliation">Graduate Institute of Pharmaceutical Chemistry, China Medical University, Taichung, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jang-Chang Lee</span> - <span class="hlFld-Affiliation affiliation">Graduate Institute of Pharmaceutical Chemistry, China Medical University, Taichung, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tzong-Der Way</span> - <span class="hlFld-Affiliation affiliation">School of Biological Science and Technology, China Medical University, Taichung, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chi-Hung Huang</span> - <span class="hlFld-Affiliation affiliation">Taiwan Advance Biopharm, Inc., 12F, No. 25, Lane 169, Kangning Street, Xizhi City, Taipei 221, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shih-Ming Huang</span> - <span class="hlFld-Affiliation affiliation">Graduate Institute of Pharmaceutical Chemistry, China Medical University, Taichung, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Che-Ming Teng</span> - <span class="hlFld-Affiliation affiliation">Pharmacological Institute, College of Medicine, National Taiwan University, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Takao Yamori</span> - <span class="hlFld-Affiliation affiliation">Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tian-Shung Wu</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, National Cheng Kung University, No. 1, Dasyue Road, Tainan, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chung-Ming Sun</span> - <span class="hlFld-Affiliation affiliation">Department of Applied Chemistry, National Chiao-Tung University, Hsinchu, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Du-Shieng Chien</span> - <span class="hlFld-Affiliation affiliation">SunTen Phytotech Co., Ltd. 4F-1, No. 268, Liancheng Road, Jhonghe City, Taipei County 235, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keduo Qian</span> - <span class="hlFld-Affiliation affiliation">Natural Products Research Laboratories, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599-7568</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan L. Morris-Natschke</span> - <span class="hlFld-Affiliation affiliation">Natural Products Research Laboratories, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599-7568</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li-Jiau Huang</span> - <span class="hlFld-Affiliation affiliation">Graduate Institute of Pharmaceutical Chemistry, China Medical University, Taichung, Taiwan</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58227" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58227" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The investigation was supported by research grants from the National Science Council of the Republic of China (NSC 96-2323-B-039-001; NSC 97-2323-B-039-001) awarded to S.-C. Kuo. Thanks are also due to partial support from CA17625 awarded to K. H. Lee.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67414" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67414" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 46 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juang, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lednicer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paull, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span> </span><span class="NLM_article-title">Synthesis and cytotoxicity of 1,6,7,8-substituted-2-(4′-substituted phenyl)-4-quinolones and related compounds: identification as antimitotic agents interacting with tubulin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1146</span><span class="NLM_x">–</span> <span class="NLM_lpage">1156</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00061a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=1146-1156&issue=9&author=S.+C.+Kuoauthor=H.+Z.+Leeauthor=J.+P.+Juangauthor=Y.+T.+Linauthor=T.+S.+Wuauthor=J.+J.+Changauthor=D.+Lednicerauthor=K.+D.+Paullauthor=C.+M.+Lin&title=Synthesis+and+cytotoxicity+of+1%2C6%2C7%2C8-substituted-2-%284%E2%80%B2-substituted+phenyl%29-4-quinolones+and+related+compounds%3A+identification+as+antimitotic+agents+interacting+with+tubulin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm00061a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00061a005%26sid%3Dliteratum%253Aachs%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DLee%26aufirst%3DH.%2BZ.%26aulast%3DJuang%26aufirst%3DJ.%2BP.%26aulast%3DLin%26aufirst%3DY.%2BT.%26aulast%3DWu%26aufirst%3DT.%2BS.%26aulast%3DChang%26aufirst%3DJ.%2BJ.%26aulast%3DLednicer%26aufirst%3DD.%26aulast%3DPaull%26aufirst%3DK.%2BD.%26aulast%3DLin%26aufirst%3DC.%2BM.%26atitle%3DSynthesis%2520and%2520cytotoxicity%2520of%25201%252C6%252C7%252C8-substituted-2-%25284%25E2%2580%25B2-substituted%2520phenyl%2529-4-quinolones%2520and%2520related%2520compounds%253A%2520identification%2520as%2520antimitotic%2520agents%2520interacting%2520with%2520tubulin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26issue%3D9%26spage%3D1146%26epage%3D1156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lednicer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents. 150. 2′,3′,4′,5′,5,6,7-Substituted 2-phenyl-4-quinolones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1126</span><span class="NLM_x">–</span> <span class="NLM_lpage">1135</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00034a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1126-1135&issue=8&author=L.+Liauthor=H.+K.+Wangauthor=S.+C.+Kuoauthor=T.+S.+Wuauthor=D.+Lednicerauthor=C.+M.+Linauthor=E.+Hamelauthor=K.+H.+Lee&title=Antitumor+agents.+150.+2%E2%80%B2%2C3%E2%80%B2%2C4%E2%80%B2%2C5%E2%80%B2%2C5%2C6%2C7-Substituted+2-phenyl-4-quinolones+and+related+compounds%3A+their+synthesis%2C+cytotoxicity%2C+and+inhibition+of+tubulin+polymerization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm00034a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00034a010%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%2BK.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DWu%26aufirst%3DT.%2BS.%26aulast%3DLednicer%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents.%2520150.%25202%25E2%2580%25B2%252C3%25E2%2580%25B2%252C4%25E2%2580%25B2%252C5%25E2%2580%25B2%252C5%252C6%252C7-Substituted%25202-phenyl-4-quinolones%2520and%2520related%2520compounds%253A%2520their%2520synthesis%252C%2520cytotoxicity%252C%2520and%2520inhibition%2520of%2520tubulin%2520polymerization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26issue%3D8%26spage%3D1126%26epage%3D1135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents. 155. Synthesis and biological evaluation of 3′,6,7-substituted 2-phenyl-4-quinolones as antimicrotubule agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">3400</span><span class="NLM_x">–</span> <span class="NLM_lpage">3407</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00046a025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=3400-3407&issue=20&author=L.+Liauthor=H.+K.+Wangauthor=S.+C.+Kuoauthor=T.+S.+Wuauthor=A.+Maugerauthor=C.+M.+Linauthor=E.+Hamelauthor=K.+H.+Lee&title=Antitumor+agents.+155.+Synthesis+and+biological+evaluation+of+3%E2%80%B2%2C6%2C7-substituted+2-phenyl-4-quinolones+as+antimicrotubule+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm00046a025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00046a025%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%2BK.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DWu%26aufirst%3DT.%2BS.%26aulast%3DMauger%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents.%2520155.%2520Synthesis%2520and%2520biological%2520evaluation%2520of%25203%25E2%2580%25B2%252C6%252C7-substituted%25202-phenyl-4-quinolones%2520as%2520antimicrotubule%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26issue%3D20%26spage%3D3400%26epage%3D3407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents. 174. 2′,3′,4′,5,6,7-Substituted 2-phenyl-1,8-naphthyridin-4-ones: their synthesis, cytotoxicity, and inhibition of tubulin polymerization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">2266</span><span class="NLM_x">–</span> <span class="NLM_lpage">2275</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm960858s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=2266-2275&issue=14&author=K.+Chenauthor=S.+C.+Kuoauthor=M.+C.+Hsiehauthor=A.+Maugerauthor=C.+M.+Linauthor=E.+Hamelauthor=K.+H.+Lee&title=Antitumor+agents.+174.+2%E2%80%B2%2C3%E2%80%B2%2C4%E2%80%B2%2C5%2C6%2C7-Substituted+2-phenyl-1%2C8-naphthyridin-4-ones%3A+their+synthesis%2C+cytotoxicity%2C+and+inhibition+of+tubulin+polymerization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm960858s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960858s%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DHsieh%26aufirst%3DM.%2BC.%26aulast%3DMauger%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents.%2520174.%25202%25E2%2580%25B2%252C3%25E2%2580%25B2%252C4%25E2%2580%25B2%252C5%252C6%252C7-Substituted%25202-phenyl-1%252C8-naphthyridin-4-ones%253A%2520their%2520synthesis%252C%2520cytotoxicity%252C%2520and%2520inhibition%2520of%2520tubulin%2520polymerization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26issue%3D14%26spage%3D2266%26epage%3D2275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents. 178. Synthesis and biological evaluation of substituted 2-aryl-1,8-naphthyridin-4(1<i>H</i>)-ones as antitumor agents that inhibit tubulin polymerization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">3049</span><span class="NLM_x">–</span> <span class="NLM_lpage">3056</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970146h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=3049-3056&issue=19&author=K.+Chenauthor=S.+C.+Kuoauthor=M.+C.+Hsiehauthor=A.+Maugerauthor=C.+M.+Linauthor=E.+Hamelauthor=K.+H.+Lee&title=Antitumor+agents.+178.+Synthesis+and+biological+evaluation+of+substituted+2-aryl-1%2C8-naphthyridin-4%281H%29-ones+as+antitumor+agents+that+inhibit+tubulin+polymerization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm970146h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970146h%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DHsieh%26aufirst%3DM.%2BC.%26aulast%3DMauger%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents.%2520178.%2520Synthesis%2520and%2520biological%2520evaluation%2520of%2520substituted%25202-aryl-1%252C8-naphthyridin-4%25281H%2529-ones%2520as%2520antitumor%2520agents%2520that%2520inhibit%2520tubulin%2520polymerization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26issue%3D19%26spage%3D3049%26epage%3D3056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tachibana, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents. 181. Synthesis and biological evaluation of 6,7,2′,3′,4′-substituted-1,2,3,4-tetrahydro-2-phenyl-4-quinolones as a new class of antimitotic antitumor agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1155</span><span class="NLM_x">–</span> <span class="NLM_lpage">1162</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9707479" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1155-1162&issue=7&author=Y.+Xiaauthor=Z.+Y.+Yangauthor=P.+Xiaauthor=K.+F.+Bastowauthor=Y.+Tachibanaauthor=S.+C.+Kuoauthor=E.+Hamelauthor=T.+Hacklauthor=K.+H.+Lee&title=Antitumor+agents.+181.+Synthesis+and+biological+evaluation+of+6%2C7%2C2%E2%80%B2%2C3%E2%80%B2%2C4%E2%80%B2-substituted-1%2C2%2C3%2C4-tetrahydro-2-phenyl-4-quinolones+as+a+new+class+of+antimitotic+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm9707479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9707479%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DZ.%2BY.%26aulast%3DXia%26aufirst%3DP.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DTachibana%26aufirst%3DY.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DHackl%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents.%2520181.%2520Synthesis%2520and%2520biological%2520evaluation%2520of%25206%252C7%252C2%25E2%2580%25B2%252C3%25E2%2580%25B2%252C4%25E2%2580%25B2-substituted-1%252C2%252C3%252C4-tetrahydro-2-phenyl-4-quinolones%2520as%2520a%2520new%2520class%2520of%2520antimitotic%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26issue%3D7%26spage%3D1155%26epage%3D1162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Zhang, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tachibana, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents. 196. Substituted 2-thienyl-1,8-naphthyridin-4-ones: their synthesis, cytotoxicity, and inhibition of tubulin polymerization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">4081</span><span class="NLM_x">–</span> <span class="NLM_lpage">4087</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990208z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=4081-4087&issue=20&author=S.+X.+Zhangauthor=K.+F.+Bastowauthor=Y.+Tachibanaauthor=S.+C.+Kuoauthor=E.+Hamelauthor=A.+Maugerauthor=V.+L.+Narayananauthor=K.+H.+Lee&title=Antitumor+agents.+196.+Substituted+2-thienyl-1%2C8-naphthyridin-4-ones%3A+their+synthesis%2C+cytotoxicity%2C+and+inhibition+of+tubulin+polymerization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm990208z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990208z%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%2BX.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DTachibana%26aufirst%3DY.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DMauger%26aufirst%3DA.%26aulast%3DNarayanan%26aufirst%3DV.%2BL.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents.%2520196.%2520Substituted%25202-thienyl-1%252C8-naphthyridin-4-ones%253A%2520their%2520synthesis%252C%2520cytotoxicity%252C%2520and%2520inhibition%2520of%2520tubulin%2520polymerization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26issue%3D20%26spage%3D4081%26epage%3D4087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Zhang, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brossi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tropsha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents. 199. Three-dimensional quantitative structure−activity relationship study of the colchicines binding site ligands using comparative molecular field analysis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990333a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=167-176&issue=2&author=S.+X.+Zhangauthor=J.+Fengauthor=S.+C.+Kuoauthor=A.+Brossiauthor=E.+Hamelauthor=A.+Tropshaauthor=K.+H.+Lee&title=Antitumor+agents.+199.+Three-dimensional+quantitative+structure%E2%88%92activity+relationship+study+of+the+colchicines+binding+site+ligands+using+comparative+molecular+field+analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm990333a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990333a%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%2BX.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DBrossi%26aufirst%3DA.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DTropsha%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents.%2520199.%2520Three-dimensional%2520quantitative%2520structure%25E2%2588%2592activity%2520relationship%2520study%2520of%2520the%2520colchicines%2520binding%2520site%2520ligands%2520using%2520comparative%2520molecular%2520field%2520analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26issue%3D2%26spage%3D167%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Hour, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">6-Alkylamino- and 2,3-dihydro-3′-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicty, and inhibition of tubulin polymerization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">4479</span><span class="NLM_x">–</span> <span class="NLM_lpage">4487</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000151c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4479-4487&issue=23&author=M.+J.+Hourauthor=L.+J.+Huangauthor=S.+C.+Kuoauthor=Y.+Xiaauthor=K.+Bastowauthor=Y.+Nakanishiauthor=E.+Hamelauthor=K.+H.+Lee&title=6-Alkylamino-+and+2%2C3-dihydro-3%E2%80%B2-methoxy-2-phenyl-4-quinazolinones+and+related+compounds%3A+their+synthesis%2C+cytotoxicty%2C+and+inhibition+of+tubulin+polymerization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm000151c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000151c%26sid%3Dliteratum%253Aachs%26aulast%3DHour%26aufirst%3DM.%2BJ.%26aulast%3DHuang%26aufirst%3DL.%2BJ.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DBastow%26aufirst%3DK.%26aulast%3DNakanishi%26aufirst%3DY.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3D6-Alkylamino-%2520and%25202%252C3-dihydro-3%25E2%2580%25B2-methoxy-2-phenyl-4-quinazolinones%2520and%2520related%2520compounds%253A%2520their%2520synthesis%252C%2520cytotoxicty%252C%2520and%2520inhibition%2520of%2520tubulin%2520polymerization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26issue%3D23%26spage%3D4479%26epage%3D4487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents. 211. Fluorinated 2-phenyl-4-quinolone derivatives as antimitotic antitumor agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">3932</span><span class="NLM_x">–</span> <span class="NLM_lpage">3936</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0101085" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3932-3936&issue=23&author=Y.+Xiaauthor=Z.+Y.+Yangauthor=P.+Xiaauthor=T.+Hacklauthor=E.+Hamelauthor=A.+Maugerauthor=J.+H.+Wuauthor=K.+H.+Lee&title=Antitumor+agents.+211.+Fluorinated+2-phenyl-4-quinolone+derivatives+as+antimitotic+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm0101085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0101085%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DZ.%2BY.%26aulast%3DXia%26aufirst%3DP.%26aulast%3DHackl%26aufirst%3DT.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DMauger%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents.%2520211.%2520Fluorinated%25202-phenyl-4-quinolone%2520derivatives%2520as%2520antimitotic%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26issue%3D23%26spage%3D3932%26epage%3D3936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Xia, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hour, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nampoothiri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents. Part 204: Synthesis and biological evaluation of substituted 2-aryl quinazolinones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1193</span><span class="NLM_x">–</span> <span class="NLM_lpage">1196</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=1193-1196&issue=9&author=T.+Xiaauthor=Z.+Y.+Yangauthor=M.+J.+Hourauthor=S.+C.+Kuoauthor=P.+Xiaauthor=K.+F.+Bastowauthor=Y.+Nakanishiauthor=P.+Nampoothiriauthor=T.+Hacklauthor=E.+Hamelauthor=K.+H.+Lee&title=Antitumor+agents.+Part+204%3A+Synthesis+and+biological+evaluation+of+substituted+2-aryl+quinazolinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DZ.%2BY.%26aulast%3DHour%26aufirst%3DM.%2BJ.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DXia%26aufirst%3DP.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DNakanishi%26aufirst%3DY.%26aulast%3DNampoothiri%26aufirst%3DP.%26aulast%3DHackl%26aufirst%3DT.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents.%2520Part%2520204%253A%2520Synthesis%2520and%2520biological%2520evaluation%2520of%2520substituted%25202-aryl%2520quinazolinones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26issue%3D9%26spage%3D1193%26epage%3D1196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Xia, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nampoothiri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brossi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents. Part 226: Synthesis and cytotoxicity of 2-phenyl-4-quinolone acetic acids and their esters</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">2891</span><span class="NLM_x">–</span> <span class="NLM_lpage">2893</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2891-2893&issue=17&author=T.+Xiaauthor=Z.+Y.+Yangauthor=P.+Xiaauthor=K.+F.+Bastowauthor=Y.+Nakanishiauthor=P.+Nampoothiriauthor=E.+Hamelauthor=A.+Brossiauthor=K.+H.+Lee&title=Antitumor+agents.+Part+226%3A+Synthesis+and+cytotoxicity+of+2-phenyl-4-quinolone+acetic+acids+and+their+esters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DZ.%2BY.%26aulast%3DXia%26aufirst%3DP.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DNakanishi%26aufirst%3DY.%26aulast%3DNampoothiri%26aufirst%3DP.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DBrossi%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents.%2520Part%2520226%253A%2520Synthesis%2520and%2520cytotoxicity%2520of%25202-phenyl-4-quinolone%2520acetic%2520acids%2520and%2520their%2520esters%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26issue%3D17%26spage%3D2891%26epage%3D2893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Lai, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span> </span><span class="NLM_article-title">Synthesis and biological relationships of 3′,6-substituted 2-phenyl-4-quinolone-3-carboxylic acid derivatives as antimitotic agents</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=265-275&issue=1&author=Y.+Y.+Laiauthor=L.+J.+Huangauthor=K.+H.+Leeauthor=Z.+Y.+Xiaoauthor=K.+F.+Bastowauthor=T.+Yamoriauthor=S.+C.+Kuo&title=Synthesis+and+biological+relationships+of+3%E2%80%B2%2C6-substituted+2-phenyl-4-quinolone-3-carboxylic+acid+derivatives+as+antimitotic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DY.%2BY.%26aulast%3DHuang%26aufirst%3DL.%2BJ.%26aulast%3DLee%26aufirst%3DK.%2BH.%26aulast%3DXiao%26aufirst%3DZ.%2BY.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DYamori%26aufirst%3DT.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26atitle%3DSynthesis%2520and%2520biological%2520relationships%2520of%25203%25E2%2580%25B2%252C6-substituted%25202-phenyl-4-quinolone-3-carboxylic%2520acid%2520derivatives%2520as%2520antimitotic%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26issue%3D1%26spage%3D265%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Nakamura, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozuka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokuda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuzaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris-Natschke, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Cancer preventive agents, Part 2: Synthesis and evaluation of 2-phenyl-4-quinolone and 9-oxo-9,10-dihydroacridine derivatives as novel antitumor promoters</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">4396</span><span class="NLM_x">–</span> <span class="NLM_lpage">4401</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=4396-4401&issue=14&author=S+Nakamuraauthor=M.+Kozukaauthor=K.+F.+Bastowauthor=H.+Tokudaauthor=H.+Nishinoauthor=M.+Suzukiauthor=J.+Tatsuzakiauthor=S.+L.+Morris-Natschkeauthor=S.+C.+Kuoauthor=K.+H.+Lee&title=Cancer+preventive+agents%2C+Part+2%3A+Synthesis+and+evaluation+of+2-phenyl-4-quinolone+and+9-oxo-9%2C10-dihydroacridine+derivatives+as+novel+antitumor+promoters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DS%26aulast%3DKozuka%26aufirst%3DM.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DTokuda%26aufirst%3DH.%26aulast%3DNishino%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DTatsuzaki%26aufirst%3DJ.%26aulast%3DMorris-Natschke%26aufirst%3DS.%2BL.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DCancer%2520preventive%2520agents%252C%2520Part%25202%253A%2520Synthesis%2520and%2520evaluation%2520of%25202-phenyl-4-quinolone%2520and%25209-oxo-9%252C10-dihydroacridine%2520derivatives%2520as%2520novel%2520antitumor%2520promoters%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26issue%3D14%26spage%3D4396%26epage%3D4401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Wang, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guh, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. Y</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teng, C. M.</span><span> </span><span class="NLM_article-title">CHM-1, a novel synthetic quinolone with potent and selective antimitotic antitumor activity against human hepatocellular carcinoma in vitro and in vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1158%2F1535-7163.MCT-07-2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=18281518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVShsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=350-360&issue=2&author=S.+W.+Wangauthor=S.+L.+Panauthor=Y.+C.+Huangauthor=J.+H.+Guhauthor=P.+C.+Chiangauthor=D.+Y+Huangauthor=S.+C.+Kuoauthor=K.+H.+Leeauthor=C.+M.+Teng&title=CHM-1%2C+a+novel+synthetic+quinolone+with+potent+and+selective+antimitotic+antitumor+activity+against+human+hepatocellular+carcinoma+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">CHM-1, a novel synthetic quinolone with potent and selective antimitotic antitumor activity against human hepatocellular carcinoma in vitro and in vivo</span></div><div class="casAuthors">Wang, Shih-Wei; Pan, Shiow-Lin; Huang, Yu-Chun; Guh, Jih-Hwa; Chiang, Po-Cheng; Huang, Der-Yi; Kuo, Sheng-Chu; Lee, Kuo-Hsiung; Teng, Che-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">350-360</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma is highly chemoresistant to currently available chemotherapeutic agents.  In this study, 2'-fluoro-6,7-methylenedioxy-2-phenyl-4-quinolone (CHM-1), a synthetic 6,7-substituted 2-phenyl-4-quinolone, was identified as a potent and selective antitumor agent in human hepatocellular carcinoma.  CHM-1 induced growth inhibition of HA22T, Hep3B, and HepG2 cells in a concn.-dependent manner but did not obviously impair the viability of normal cells at the IC50 for liver cancer cells.  CHM-1-induced apoptosis was also characterized by immunofluorescence microscopy.  CHM-1 interacted with tubulin at the colchicine-binding site, markedly inhibited tubulin polymn. both in vitro and in vivo, and disrupted microtubule organization.  CHM-1 caused cell cycle arrest at G2-M phase by activating Cdc2/cyclin B1 complex activity.  CHM-1-induced cell death, activation of Cdc2 kinase activity, and elevation of MPM2 phosphoepitopes were profoundly attenuated by roscovitine, a specific cyclin-dependent kinase inhibitor.  CHM-1 did not modulate the caspase cascade, and the pan-caspase-inhibitor z-VAD-fmk did not abolish CHM-1-induced cell death.  However, CHM-1 induced the translocation of apoptosis-inducing factor (AIF) from mitochondria to the nucleus.  Small interfering RNA targeting of AIF substantially attenuated CHM-1-induced AIF translocation.  Importantly, CHM-1 inhibited tumor growth and prolonged the lifespan in mice inoculated with HA22T cells.  In conclusion, we show that CHM-1 exhibits a novel antimitotic antitumor activity against human hepatocellular carcinoma both in vitro and in vivo via a caspase-independent pathway.  CHM-1 is a promising chemotherapeutic agent worthy of further development into a clin. trial candidate for treating cancer, esp. hepatocellular carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorf0i-Lu_cULVg90H21EOLACvtfcHk0liGzpNtfWW9BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVShsr4%253D&md5=e88f1b4fe2236a6ff0a83778b853c504</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-2000%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%2BW.%26aulast%3DPan%26aufirst%3DS.%2BL.%26aulast%3DHuang%26aufirst%3DY.%2BC.%26aulast%3DGuh%26aufirst%3DJ.%2BH.%26aulast%3DChiang%26aufirst%3DP.%2BC.%26aulast%3DHuang%26aufirst%3DD.%2BY%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DLee%26aufirst%3DK.%2BH.%26aulast%3DTeng%26aufirst%3DC.%2BM.%26atitle%3DCHM-1%252C%2520a%2520novel%2520synthetic%2520quinolone%2520with%2520potent%2520and%2520selective%2520antimitotic%2520antitumor%2520activity%2520against%2520human%2520hepatocellular%2520carcinoma%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26issue%3D2%26spage%3D350%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Heimbach, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savolainen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleisher, D.</span><span> </span><span class="NLM_article-title">Absorption rate limit considerations for oral phosphate prodrug</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">848</span><span class="NLM_x">–</span> <span class="NLM_lpage">856</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2003&pages=848-856&issue=6&author=T+Heimbachauthor=D.+M.+Ohauthor=L.+Y.+Liauthor=M.+Forsbergauthor=J.+Savolainenauthor=J.+Lepp%C3%A4nenauthor=Y.+Matsunagaauthor=G.+Flynnauthor=D.+Fleisher&title=Absorption+rate+limit+considerations+for+oral+phosphate+prodrug"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeimbach%26aufirst%3DT%26aulast%3DOh%26aufirst%3DD.%2BM.%26aulast%3DLi%26aufirst%3DL.%2BY.%26aulast%3DForsberg%26aufirst%3DM.%26aulast%3DSavolainen%26aufirst%3DJ.%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DMatsunaga%26aufirst%3DY.%26aulast%3DFlynn%26aufirst%3DG.%26aulast%3DFleisher%26aufirst%3DD.%26atitle%3DAbsorption%2520rate%2520limit%2520considerations%2520for%2520oral%2520phosphate%2520prodrug%26jtitle%3DPharm.%2520Res.%26date%3D2003%26volume%3D20%26issue%3D6%26spage%3D848%26epage%3D856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Jordan, M. A.</span><span> </span><span class="NLM_article-title">Mechanisms of action of antitumor drugs that interact with microtubules and tubulin</span> <span class="citation_source-journal">Curr. Med. Chem. Anticancer Agents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.2174%2F1568011023354290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=12678749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADC%252BD38XislGmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=1-17&author=M.+A.+Jordan&title=Mechanisms+of+action+of+antitumor+drugs+that+interact+with+microtubules+and+tubulin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action of antitumor drugs that interact with microtubules and tubulin</span></div><div class="casAuthors">Jordan, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Anti-Cancer Agents</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-17</span>CODEN:
                <span class="NLM_cas:coden">CMCACI</span>;
        ISSN:<span class="NLM_cas:issn">1568-0118</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Microtubules, major structural components in cells, are the target of a large and diverse group of natural product anticancer drugs.  Given the success of this class of drugs in cancer treatment, it can be argued that microtubules represent the single best cancer target identified to date.  Microtubules are highly dynamic assemblies of the protein tubulin.  They readily polymerize and depolymerize in cells, and they undergo two interesting kinds of dynamics called dynamic instability and treadmilling.  These dynamic behaviors are crucial to mitosis, the process of chromosomal division to form new cells.  Microtubule dynamics are highly regulated during the cell cycle by endogenous cellular regulators.  In addn., many antitumor drugs and natural compds. alter the polymn. dynamics of microtubules, blocking mitosis, and consequently, inducing cell death by apoptosis.  These drugs include several that inhibit microtubule polymn. at high drug concns., namely, the Vinca alkaloids, cryptophycins, halichondrins, estramustine, and colchicine.  Another group of these compds. stimulates microtubule polymn. and stabilizes microtubules at high concns.  These include Taxol, Taxotere, eleutherobins, epothilones, laulimalide, sarcodictyins, and discodermolide.  Importantly, considerable evidence indicates that, at lower concns., these drugs have a common mechanism of action; they suppress the dynamics of microtubules without appreciably changing the mass of microtubules in the cell.  The drugs bind to diverse sites on tubulin and at different positions within the microtubule, and they have diverse effects on microtubule dynamics.  However, by their common mechanism of suppression microtubule dynamics, they all block mitosis at the metaphase/anaphase transition, and induce cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz_AAWMPgVv7Vg90H21EOLACvtfcHk0liGzpNtfWW9BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XislGmurg%253D&md5=02687ec4acc93772995677ebfa998ce9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F1568011023354290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568011023354290%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DM.%2BA.%26atitle%3DMechanisms%2520of%2520action%2520of%2520antitumor%2520drugs%2520that%2520interact%2520with%2520microtubules%2520and%2520tubulin%26jtitle%3DCurr.%2520Med.%2520Chem.%2520Anticancer%2520Agents%26date%3D2002%26volume%3D2%26spage%3D1%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Casagrande, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miragoli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semeraro, C.</span><span> </span><span class="NLM_article-title">Cardiovascular and renal action of dopaminergic prodrugs</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">S40</span><span class="NLM_x">–</span> <span class="NLM_lpage">S59</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1989&pages=S40-S59&author=C.+Casagrandeauthor=L.+Merloauthor=R.+Ferriniauthor=G.+Miragoliauthor=C.+Semeraro&title=Cardiovascular+and+renal+action+of+dopaminergic+prodrugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCasagrande%26aufirst%3DC.%26aulast%3DMerlo%26aufirst%3DL.%26aulast%3DFerrini%26aufirst%3DR.%26aulast%3DMiragoli%26aufirst%3DG.%26aulast%3DSemeraro%26aufirst%3DC.%26atitle%3DCardiovascular%2520and%2520renal%2520action%2520of%2520dopaminergic%2520prodrugs%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D1989%26volume%3D14%26spage%3DS40%26epage%3DS59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Juntunen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huuskonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laine, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niemi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taipale, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pate, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Järvinen, T.</span><span> </span><span class="NLM_article-title">Anandamide prodrugs 1. Water-soluble phosphate esters of arachidonylethanolamide and R-methanandamide</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1016%2FS0928-0987%2803%2900044-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=12729860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1Ogsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2003&pages=37-43&issue=1&author=J.+Juntunenauthor=J.+Huuskonenauthor=K.+Laineauthor=R.+Niemiauthor=H.+Taipaleauthor=T.+Nevalainenauthor=D.+W.+Pateauthor=T.+J%C3%A4rvinen&title=Anandamide+prodrugs+1.+Water-soluble+phosphate+esters+of+arachidonylethanolamide+and+R-methanandamide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Anandamide prodrugs 1. Water-soluble phosphate esters of arachidonylethanolamide and R-methanandamide</span></div><div class="casAuthors">Juntunen, Juha; Huuskonen, Juhani; Laine, Krista; Niemi, Riku; Taipale, Hannu; Nevalainen, Tapio; Pate, David W.; Jarvinen, Tomi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-43</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Phosphate esters of arachidonylethanolamide (AEA) and R-methanandamide were synthesized and evaluated as water-sol. prodrugs.  Various physicochem. properties (pKa, partition coeff., aq. soly.) were detd. for the synthesized phosphate esters.  The chem. stability of phosphate esters was detd. at pH 7.4.  In vitro enzymic hydrolysis rates were detd. in 10% liver homogenate, and in a pure enzyme-contg. (alk. phosphatase) soln. at pH 7.4.  The intraocular pressure (IOP) lowering properties of R-methanandamide phosphate ester were tested on normotensive rabbits.  The phosphate promoiety increased the aq. soly. of the parent compds. by more than 16 500-fold at pH 7.4.  Phosphate esters were stable in buffer solns., but rapidly hydrolyzed to their parent compds. in alk. phosphatase soln. (t1/2<<15 s) and liver homogenate (t1/2=8-9 min).  The phosphate ester of R-methanandamide reduced IOP in rabbits.  These results indicate that the phosphate esters of AEA and R-methanandamide are useful water-sol. prodrugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorXS1smzJO-LVg90H21EOLACvtfcHk0lgdpVr0IOMZlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1Ogsrg%253D&md5=14dd387434e738be4b43bf083f7a6588</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0928-0987%2803%2900044-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0928-0987%252803%252900044-7%26sid%3Dliteratum%253Aachs%26aulast%3DJuntunen%26aufirst%3DJ.%26aulast%3DHuuskonen%26aufirst%3DJ.%26aulast%3DLaine%26aufirst%3DK.%26aulast%3DNiemi%26aufirst%3DR.%26aulast%3DTaipale%26aufirst%3DH.%26aulast%3DNevalainen%26aufirst%3DT.%26aulast%3DPate%26aufirst%3DD.%2BW.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26atitle%3DAnandamide%2520prodrugs%25201.%2520Water-soluble%2520phosphate%2520esters%2520of%2520arachidonylethanolamide%2520and%2520R-methanandamide%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2003%26volume%3D19%26issue%3D1%26spage%3D37%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Pettit, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grealish, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettit, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapuis, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, J. M.</span><span> </span><span class="NLM_article-title">Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">2534</span><span class="NLM_x">–</span> <span class="NLM_lpage">2542</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010119y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2534-2542&issue=12&author=G.+R.+Pettitauthor=M.+P.+Grealishauthor=M.+K.+Jungauthor=E.+Hamelauthor=R.+K.+Pettitauthor=J.+C.+Chapuisauthor=J.+M.+Schmidt&title=Antineoplastic+agents.+465.+Structural+modification+of+resveratrol%3A+sodium+resverastatin+phosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm010119y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010119y%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DGrealish%26aufirst%3DM.%2BP.%26aulast%3DJung%26aufirst%3DM.%2BK.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DPettit%26aufirst%3DR.%2BK.%26aulast%3DChapuis%26aufirst%3DJ.%2BC.%26aulast%3DSchmidt%26aufirst%3DJ.%2BM.%26atitle%3DAntineoplastic%2520agents.%2520465.%2520Structural%2520modification%2520of%2520resveratrol%253A%2520sodium%2520resverastatin%2520phosphate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26issue%3D12%26spage%3D2534%26epage%3D2542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Perry, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTavish, D.</span><span> </span><span class="NLM_article-title">Estramustine phosphate sodium. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.2165%2F00002512-199507010-00006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=7579781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A280%3ADyaK28%252FovF2guw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1995&pages=49-74&issue=1&author=C.+M.+Perryauthor=D.+McTavish&title=Estramustine+phosphate+sodium.+A+review+of+its+pharmacodynamic+and+pharmacokinetic+properties%2C+and+therapeutic+efficacy+in+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Estramustine phosphate sodium. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer</span></div><div class="casAuthors">Perry C M; McTavish D</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & aging</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-74</span>
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    </div><div class="casAbstract">Estramustine phosphate sodium (estramustine phosphate), a unique antitumour agent, is selectively taken up by prostate cells and exerts antineoplastic effects by interfering with microtubule of dynamics and by reducing plasma levels of testosterone.  In noncomparative studies of estramustine phosphate in patients with hormone-refractory disease, objective response rates ranging from 19 to 69% have been reported.  Preliminary clinical investigations indicate that combining estramustine phosphate with vinblastine, etoposide or paclitaxel improves objective response rates over single-agent treatment, although no survival benefit over single-agent treatment has been demonstrated to date.  In comparative studies, estramustine phosphate produces similar objective response rates to conventional antineoplastic agents in patients with hormone-refractory prostate cancer.  In previously untreated patients with advanced metastatic hormone-responsive prostate cancer, objective responses are achieved in approximately 80% of patients.  Estramustine phosphate appears to be at least as effective as estrogen or flutamide therapy in these patients.  Nausea and vomiting are the most frequently observed adverse effects of treatment with estramustine phosphate.  While these symptoms are usually mild to moderate in nature, they may occasionally be more troublesome to the patient and necessitate withdrawal of treatment.  Cardiovascular complications are a more serious, though less frequently encountered, adverse effect of the drug.  However, these complications may be avoided by careful patient selection and prophylactic treatment measures.  Unlike some other antineoplastic agents, estramustine phosphate is rarely associated with myelosuppression.  In addition to producing similar objective response rates to other established agents, estramustine phosphate improves the subjective status of many patients and has been shown to reduce the intensity of pain and improve the performance status of patients.(ABSTRACT TRUNCATED AT 250 WORDS)</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQwyuB6-rl7DzDnmmyUf5qOfW6udTcc2eYQrcuIk5YAqbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28%252FovF2guw%253D%253D&md5=fbe9637c735c85a6a96e178e99a93a44</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2165%2F00002512-199507010-00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002512-199507010-00006%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DC.%2BM.%26aulast%3DMcTavish%26aufirst%3DD.%26atitle%3DEstramustine%2520phosphate%2520sodium.%2520A%2520review%2520of%2520its%2520pharmacodynamic%2520and%2520pharmacokinetic%2520properties%252C%2520and%2520therapeutic%2520efficacy%2520in%2520prostate%2520cancer%26jtitle%3DDrugs%2520Aging%26date%3D1995%26volume%3D7%26issue%3D1%26spage%3D49%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Witterland, A. H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koks, C. H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beijnen, J. H.</span><span> </span><span class="NLM_article-title">Etoposide phosphate, the water soluble prodrug of etoposide</span> <span class="citation_source-journal">Pharm. World Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1007%2FBF00820727" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=8933576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADyaK28Xnt1KgsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1996&pages=163-170&author=A.+H.+I.+Witterlandauthor=C.+H.+W.+Koksauthor=J.+H.+Beijnen&title=Etoposide+phosphate%2C+the+water+soluble+prodrug+of+etoposide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Etoposide phosphate, the water soluble prodrug of etoposide</span></div><div class="casAuthors">Witterland, A. H. I.; Koks, C. H. W.; Beijnen, J. H.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacy World & Science</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">163-170</span>CODEN:
                <span class="NLM_cas:coden">PWSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-1231</span>.
    
            (<span class="NLM_cas:orgname">Kluwer</span>)
        </div><div class="casAbstract">A review with 38 refs. on the pharmaceutical properties and the current status of etoposide phosphate in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX_cYka0CTw7Vg90H21EOLACvtfcHk0lhP__E2dtZU6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xnt1KgsLo%253D&md5=e53300ce695ea93d67d664c06153dbc8</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2FBF00820727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00820727%26sid%3Dliteratum%253Aachs%26aulast%3DWitterland%26aufirst%3DA.%2BH.%2BI.%26aulast%3DKoks%26aufirst%3DC.%2BH.%2BW.%26aulast%3DBeijnen%26aufirst%3DJ.%2BH.%26atitle%3DEtoposide%2520phosphate%252C%2520the%2520water%2520soluble%2520prodrug%2520of%2520etoposide%26jtitle%3DPharm.%2520World%2520Sci.%26date%3D1996%26volume%3D18%26spage%3D163%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Vincent, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kermani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shido, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bompais-Vincent, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicklin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohlen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafii, S.</span><span> </span><span class="NLM_article-title">Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2992</span><span class="NLM_x">–</span> <span class="NLM_lpage">3006</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2005&pages=2992-3006&issue=11&author=L.+Vincentauthor=P.+Kermaniauthor=L.+M.+Youngauthor=J.+Chengauthor=Z.+Fanauthor=K.+Shidoauthor=G.+Lamauthor=H.+Bompais-Vincentauthor=Z.+Zhuauthor=D.+J.+Hicklinauthor=P.+Bohlenauthor=D.+J.+Chaplinauthor=C.+Mayauthor=S.+Rafii&title=Combretastatin+A4+phosphate+induces+rapid+regression+of+tumor+neovessels+and+growth+through+interference+with+vascular+endothelial-cadherin+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVincent%26aufirst%3DL.%26aulast%3DKermani%26aufirst%3DP.%26aulast%3DYoung%26aufirst%3DL.%2BM.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DZ.%26aulast%3DShido%26aufirst%3DK.%26aulast%3DLam%26aufirst%3DG.%26aulast%3DBompais-Vincent%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DHicklin%26aufirst%3DD.%2BJ.%26aulast%3DBohlen%26aufirst%3DP.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DMay%26aufirst%3DC.%26aulast%3DRafii%26aufirst%3DS.%26atitle%3DCombretastatin%2520A4%2520phosphate%2520induces%2520rapid%2520regression%2520of%2520tumor%2520neovessels%2520and%2520growth%2520through%2520interference%2520with%2520vascular%2520endothelial-cadherin%2520signaling%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2005%26volume%3D115%26issue%3D11%26spage%3D2992%26epage%3D3006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Pettit, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temple, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rener, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansal, N.</span><span> </span><span class="NLM_article-title">Antineoplastic agents 322. Synthesis of combretastatin A-4 prodrugs</span> <span class="citation_source-journal">Anti-Cancer Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=7786396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADyaK2MXms1Wktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1995&pages=299-309&issue=4&author=G.+R.+Pettitauthor=C.+Templeauthor=V.+L.+Narayananauthor=R.+Varmaauthor=M.+J.+Simpsonauthor=M.+R.+Boydauthor=G.+A.+Renerauthor=N.+Bansal&title=Antineoplastic+agents+322.+Synthesis+of+combretastatin+A-4+prodrugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Antineoplastic agents. 322. Synthesis of combretastatin A-4 prodrugs</span></div><div class="casAuthors">Pettit, George R.; Temple, Carroll, Jr.; Narayanan, Ven L.; Varma, Ravi; Simpson, Michael J.; Boyd, Michael R.; Rener, Gregory A.; Bansal, Namita</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drug Design</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">299-309</span>CODEN:
                <span class="NLM_cas:coden">ACDDEA</span>;
        ISSN:<span class="NLM_cas:issn">0266-9536</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Combretastatin A-4 (I, R = H), the principal cancer cell growth-inhibitory constituent of the Zulu medicinal plant (Combretum caffrum, has been undergoing preclin. development.  However, the very limited water soly. of this phenol has complicated drug formation.  Hence, derivs. of the combretastatin A-4 3'-phenol group were prepd. for evaluation as possible water-sol. prodrugs.  As obsd. for combretastatin A-4, the sodium salt (I, R = Na), potassium salt (I, R = K), and hemisuccinic acid ester (I, R = COCH2CH2CO2H) derivs. were essentially insol. in water.  Indeed, these substances regenerated combretastatin A-4 upon reaction with water.  A series of other simple derivs., e.g. I [R = COCH(NH2)CH2CH2CO2H], proved unsatisfactory in terms of water soly. or stability, or both.  The most sol. derivs. evaluated included the ammonium [I, R = P(O)(OH)ONH4], and potassium [I, R = P(O)(OK)2] and sodium [I, R = P(O)(ONa)2] phosphate salts, where the latter two proved most stable and suitable.  Both the potassium and sodium phosphate derivs. of combretastatin A-4 were also found to exhibit the requisite biol. properties necessary for a useful prodrug.  The sodium phosphate salt was selected for drug formulation and further pre-clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCWV9UApN5crVg90H21EOLACvtfcHk0lhP__E2dtZU6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXms1Wktbs%253D&md5=0a16b2b4db491916a9a742c7af69669a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DTemple%26aufirst%3DC.%26aulast%3DNarayanan%26aufirst%3DV.%2BL.%26aulast%3DVarma%26aufirst%3DR.%26aulast%3DSimpson%26aufirst%3DM.%2BJ.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26aulast%3DRener%26aufirst%3DG.%2BA.%26aulast%3DBansal%26aufirst%3DN.%26atitle%3DAntineoplastic%2520agents%2520322.%2520Synthesis%2520of%2520combretastatin%2520A-4%2520prodrugs%26jtitle%3DAnti-Cancer%2520Drug%2520Des.%26date%3D1995%26volume%3D10%26issue%3D4%26spage%3D299%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Edsall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agoston, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClanahan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, M.</span><span> </span><span class="NLM_article-title">Synthesis and in vivo antitumor evaluation of 2-methoxyestradiol 3-phosphate, 17-phosphate, and 3,17-diphosphate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">6700</span><span class="NLM_x">–</span> <span class="NLM_lpage">6705</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070639e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6700-6705&issue=26&author=A.+Edsallauthor=G.+Agostonauthor=A.+Trestonauthor=S.+Plumauthor=R.+McClanahanauthor=T.+Luauthor=W.+Songauthor=M.+Cushman&title=Synthesis+and+in+vivo+antitumor+evaluation+of+2-methoxyestradiol+3-phosphate%2C+17-phosphate%2C+and+3%2C17-diphosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm070639e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070639e%26sid%3Dliteratum%253Aachs%26aulast%3DEdsall%26aufirst%3DA.%26aulast%3DAgoston%26aufirst%3DG.%26aulast%3DTreston%26aufirst%3DA.%26aulast%3DPlum%26aufirst%3DS.%26aulast%3DMcClanahan%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DT.%26aulast%3DSong%26aufirst%3DW.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520in%2520vivo%2520antitumor%2520evaluation%2520of%25202-methoxyestradiol%25203-phosphate%252C%252017-phosphate%252C%2520and%25203%252C17-diphosphate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D26%26spage%3D6700%26epage%3D6705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Ho, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harapanhalli, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahman, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelstein, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassis, A. I.</span><span> </span><span class="NLM_article-title">Synthesis and biologic evaluation of a radioiodinated quinazolinone derivative for enzyme-mediated insolubilization therapy</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc010093p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsV2hs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=357-364&issue=2&author=N.+H.+Hoauthor=R.+S.+Harapanhalliauthor=B.+A.+Dahmanauthor=K.+Chenauthor=K.+Wangauthor=S.+J.+Adelsteinauthor=A.+I.+Kassis&title=Synthesis+and+biologic+evaluation+of+a+radioiodinated+quinazolinone+derivative+for+enzyme-mediated+insolubilization+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biologic Evaluation of a Radioiodinated Quinazolinone Derivative for Enzyme-Mediated Insolubilization Therapy</span></div><div class="casAuthors">Ho, Nanhui; Harapanhalli, Ravi S.; Dahman, Bassam A.; Chen, Kai; Wang, Ketai; Adelstein, S. James; Kassis, Amin I.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">357-364</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have developed a new strategy that aims to conc. therapeutic radionuclides within solid tumors.  This approach, which we have named EMIT (enzyme-mediated insolubilization therapy), is a method for enzyme-dependent, site-specific, in vivo pptn. of a radioactive mol. (from a water-sol. precursor) within the extracellular space of solid tumors.  The prodrug, ammonium 2-(2'-phosphoryloxyphenyl)-6-iodo-4-(3H)-quinazolinone, labeled with iodine-125 (125IPD) and its authentic compd. labeled with iodine-127 (IPD) have been synthesized, purified, and characterized.  The alk. phosphatase (ALP)-mediated conversion of these water-sol. nonfluorescent prodrugs to the water-insol. fluorescent species, iodine-125-labeled 2-(2'-hydroxyphenyl)-6-iodo-4-(3H)-quinazolinone (125ID) and its iodine-127-labeled deriv. (ID), has been demonstrated in vitro.  Biodistribution studies in mice indicate that both 125IPD and 125ID are minimally retained by most tissues and organs.  In addn., following its i.v. injection in mice, 125IPD is localized in ALP-rich regions and converted to 125ID, which remains indefinitely within the tissues where it is produced.  We believe that EMIT is a strategy that will lead to the active and specific concn. and entrapment of therapeutic radionuclides within solid tumors, the consequent protracted irradn. of tumor cells within the range of the emitted particles, and the effective therapy of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs2mEbUpKNQLVg90H21EOLACvtfcHk0ljI1WqawK8ROg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsV2hs7k%253D&md5=4f28d555a5752708f79cd2c6013c8a73</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fbc010093p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc010093p%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DN.%2BH.%26aulast%3DHarapanhalli%26aufirst%3DR.%2BS.%26aulast%3DDahman%26aufirst%3DB.%2BA.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DAdelstein%26aufirst%3DS.%2BJ.%26aulast%3DKassis%26aufirst%3DA.%2BI.%26atitle%3DSynthesis%2520and%2520biologic%2520evaluation%2520of%2520a%2520radioiodinated%2520quinazolinone%2520derivative%2520for%2520enzyme-mediated%2520insolubilization%2520therapy%26jtitle%3DBioconjugate%2520Chem.%26date%3D2002%26volume%3D13%26issue%3D2%26spage%3D357%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Chen, K</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirichian, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al Aowad, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelstein, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassis, A. I.</span><span> </span><span class="NLM_article-title">In silico design, synthesis, and biological evaluation of radioiodinated quinazolinone derivatives for alkaline phosphatase-mediated cancer diagnosis and therapy</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3001</span><span class="NLM_x">–</span> <span class="NLM_lpage">3013</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1158%2F1535-7163.MCT-06-0465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=17172404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlagsb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=3001-3013&issue=12&author=K+Chenauthor=K+Wangauthor=A.+M.+Kirichianauthor=A.+F.+Al+Aowadauthor=L.+K.+Iyerauthor=S.+J.+Adelsteinauthor=A.+I.+Kassis&title=In+silico+design%2C+synthesis%2C+and+biological+evaluation+of+radioiodinated+quinazolinone+derivatives+for+alkaline+phosphatase-mediated+cancer+diagnosis+and+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">In silico design, synthesis, and biological evaluation of radioiodinated quinazolinone derivatives for alkaline phosphatase-mediated cancer diagnosis and therapy</span></div><div class="casAuthors">Chen, Kai; Wang, Ketai; Kirichian, Agop M.; Al Aowad, Ayman F.; Iyer, Lakshmanan K.; Adelstein, S. James; Kassis, Amin I.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3001-3013</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">As part of the development of enzyme-mediated cancer imaging and therapy, a novel technol. to entrap water-insol. radioactive mols. within solid tumors, we show that a water-sol., radioactive quinazolinone prodrug, ammonium 2-(2'-phosphoryloxyphenyl)-6-[125I]iodo-4-(3H)-quinazolinone (125IQ2-P), is hydrolyzed by alk. phosphatase to a water-insol., radiolabeled drug, 2-(2'-hydroxyphenyl)-6-[125I]iodo-4-(3H)-quinazolinone (125IQ2-OH).  Biodistribution data suggest the existence of two isoforms of the prodrug (IQ2-P(I) and IQ2-P), and this has been confirmed by their synthesis and characterization.  Structural differences of the two isoforms have been examd. using in silico mol. modeling techniques and docking methods to describe the interaction/binding between the isoforms and human placental alk. phosphatase (PLAP), a tumor cell, membrane-assocd., hydrolytic enzyme whose structure is known by X-ray crystallog. detn.  Docking data show that IQ2-P, but not IQ2-P(I), fits the active binding site of PLAP favorably and interacts with the catalytic amino acid Ser92, which plays an important role in the hydrolytic process.  The binding free energies (ΔGbinding) of the isoforms to PLAP predict that IQ2-P will be the better substrate for PLAP.  The in vitro incubation of the isoforms with PLAP leads to the rapid hydrolysis of IQ2-P only and confirms the in silico expectations.  Fluorescence microscopy shows that in vitro incubation of IQ2-P with mouse and human tumor cells causes the extracellular, alk. phosphatase-mediated hydrolysis of the mol. and pptn. of fluorescent crystals of IQ2-OH.  No hydrolysis is seen in the presence of normal mouse and human cells.  Furthermore, the intratumoral injection of 125IQ2-P into alk. phosphatase-expressing solid human tumors grown s.c. in nude rats results in efficient hydrolysis of the compd. and retention of ∼70% of the injected radioactivity, whereas similar injection into normal tissues (e.g., muscle) does not produce any measurable hydrolysis (∼1%) or retention of radioactivity at the injected site.  These studies support the enzyme-mediated cancer imaging and therapy technol. and show the potential of such quinazolinone derivs. in the in vivo radio-detection (123I/124I) and therapy (131I) of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF8VRRpStf1bVg90H21EOLACvtfcHk0ljI1WqawK8ROg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlagsb3K&md5=1940df50c83ae3c3cdb933101495ce15</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0465%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK%26aulast%3DWang%26aufirst%3DK%26aulast%3DKirichian%26aufirst%3DA.%2BM.%26aulast%3DAl%2BAowad%26aufirst%3DA.%2BF.%26aulast%3DIyer%26aufirst%3DL.%2BK.%26aulast%3DAdelstein%26aufirst%3DS.%2BJ.%26aulast%3DKassis%26aufirst%3DA.%2BI.%26atitle%3DIn%2520silico%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520radioiodinated%2520quinazolinone%2520derivatives%2520for%2520alkaline%2520phosphatase-mediated%2520cancer%2520diagnosis%2520and%2520therapy%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26issue%3D12%26spage%3D3001%26epage%3D3013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Posoisil, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al Aowad, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelstein, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassis, A. I.</span><span> </span><span class="NLM_article-title">Computational modeling and experimental evaluation of a novel prodrug for targeting the extracellular space of prostate tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">2197</span><span class="NLM_x">–</span> <span class="NLM_lpage">2205</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=2197-2205&author=P.+Posoisilauthor=K.+Wangauthor=A.+F.+Al+Aowadauthor=L.+K.+Iyerauthor=S.+J.+Adelsteinauthor=A.+I.+Kassis&title=Computational+modeling+and+experimental+evaluation+of+a+novel+prodrug+for+targeting+the+extracellular+space+of+prostate+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPosoisil%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DAl%2BAowad%26aufirst%3DA.%2BF.%26aulast%3DIyer%26aufirst%3DL.%2BK.%26aulast%3DAdelstein%26aufirst%3DS.%2BJ.%26aulast%3DKassis%26aufirst%3DA.%2BI.%26atitle%3DComputational%2520modeling%2520and%2520experimental%2520evaluation%2520of%2520a%2520novel%2520prodrug%2520for%2520targeting%2520the%2520extracellular%2520space%2520of%2520prostate%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D2197%26epage%3D2205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirichian, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al Aowad, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelstein, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassis, A. I.</span><span> </span><span class="NLM_article-title">Evaluation of chemical, physical, and biologic properties of tumor-targeting radioiodinated quinazolinone derivative</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">754</span><span class="NLM_x">–</span> <span class="NLM_lpage">764</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc0602937" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVaju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=754-764&author=K.+Wangauthor=A.+M.+Kirichianauthor=A.+F.+Al+Aowadauthor=S.+J.+Adelsteinauthor=A.+I.+Kassis&title=Evaluation+of+chemical%2C+physical%2C+and+biologic+properties+of+tumor-targeting+radioiodinated+quinazolinone+derivative"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of chemical, physical, and biologic properties of tumor-targeting radioiodinated quinazolinone derivative</span></div><div class="casAuthors">Wang, Ketai; Kirichian, Agop M.; Al Aowad, Ayman F.; Adelstein, S. James; Kassis, Amin I.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">754-764</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Our group is developing a novel technol., enzyme-mediated cancer imaging and therapy (EMCIT), that aims to entrap radioiodinated compds. within solid tumors for noninvasive tumor detection and therapy.  In this approach, a water-sol., radioiodinated prodrug is hydrolyzed in vivo to a highly water-insol. compd. by an enzyme overexpressed extracellularly by tumor cells.  We have synthesized and characterized the water-sol. prodrug, 2-(2'-phosphoryloxyphenyl)-6-[125I]iodo-4-(3H)-quinazolinone [125I]5, which is readily hydrolyzed by alk. phosphatase, an enzyme expressed by many tumor cell lines, to a water-insol. drug, 2-(2'-hydroxyphenyl)-6-[125I]iodo-4-(3H)-quinazolinone [125I]1.  In the course of our study, we discovered that ammonium 2-(2'-phosphoryloxyphenyl)-6-tributylstannyl-4-(3H)-quinazolinone, an intermediate in the radioiodination of the prodrug, exists as two isomers (3 and 4) whose radioiodination leads, resp., to [125I]6 and [125I]5.  These prodrugs have different in vitro and in vivo biol. activities.  Compd. 6 is not hydrolyzed by alk. phosphatase (ALP), whereas 5 is highly sol. (mg/mL) in aq. soln. and is rapidly dephosphorylated in the presence of ALP to 1, a water-insol. mol. (ng/mL).  Mouse biodistribution studies indicate that [125I]6 has high uptake in kidney and liver and [125I]5 has very low uptake in all normal organs.  Compds. 3 and 6 are converted, resp., to 4 and 5 after incubation in DMSO.  The stability of 5 in human serum is high.  The min. ALP concn. needed to hydrolyze 5 is much greater than the ALP level in the blood of patients with cancer, and the latter should not affect the pharmacokinetics of the compd.  Incubation of 5 with viable human and mouse tumor-cell lines-but not with normal human cells and mouse tissues-leads to its hydrolysis and the formation of large crystals of 1.  We expect that 5 will also be hydrolyzed in vivo by tumor cells that express phosphatase activity extracellularly and anticipate the specific pptn. of radioiodinated 1 within tumor cell clusters.  This should lead to high tumor-to-normal-tissue ratios and enable imaging (SPECT/PET) and radionuclide therapy of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXYGdIwzwmMrVg90H21EOLACvtfcHk0ljI1WqawK8ROg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVaju7s%253D&md5=faf7c8cb5a12c01f126a97ad47aa8988</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fbc0602937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc0602937%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DK.%26aulast%3DKirichian%26aufirst%3DA.%2BM.%26aulast%3DAl%2BAowad%26aufirst%3DA.%2BF.%26aulast%3DAdelstein%26aufirst%3DS.%2BJ.%26aulast%3DKassis%26aufirst%3DA.%2BI.%26atitle%3DEvaluation%2520of%2520chemical%252C%2520physical%252C%2520and%2520biologic%2520properties%2520of%2520tumor-targeting%2520radioiodinated%2520quinazolinone%2520derivative%26jtitle%3DBioconjugate%2520Chem.%26date%3D2007%26volume%3D18%26spage%3D754%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Andrews, K. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atherton, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, A. L.</span><span> </span><span class="NLM_article-title">Hydroxypyridine and hydroxyquinoline phosphates as anti-cholinesterases</span> <span class="citation_source-journal">J. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1954</span><span class="NLM_x">, </span> <span class="NLM_fpage">1638</span><span class="NLM_x">–</span> <span class="NLM_lpage">1640</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1954&pages=1638-1640&author=K.+J.+M.+Andrewsauthor=F.+R.+Athertonauthor=F.+Bergelauthor=A.+L.+Morrison&title=Hydroxypyridine+and+hydroxyquinoline+phosphates+as+anti-cholinesterases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndrews%26aufirst%3DK.%2BJ.%2BM.%26aulast%3DAtherton%26aufirst%3DF.%2BR.%26aulast%3DBergel%26aufirst%3DF.%26aulast%3DMorrison%26aufirst%3DA.%2BL.%26atitle%3DHydroxypyridine%2520and%2520hydroxyquinoline%2520phosphates%2520as%2520anti-cholinesterases%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1954%26spage%3D1638%26epage%3D1640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Horst, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harald, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilmar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhard, S.</span><span> </span><span class="NLM_article-title">New 4-quinolinol- and 5,6,7,8-tetrahydro-4-quinolinol derivatives with biocidal effect</span> <span class="citation_source-journal">Liebigs Ann. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_fpage">1656</span><span class="NLM_x">–</span> <span class="NLM_lpage">1676</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1982&pages=1656-1676&author=G.+Horstauthor=K.+Haraldauthor=M.+Hilmarauthor=S.+Gerhard&title=New+4-quinolinol-+and+5%2C6%2C7%2C8-tetrahydro-4-quinolinol+derivatives+with+biocidal+effect"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHorst%26aufirst%3DG.%26aulast%3DHarald%26aufirst%3DK.%26aulast%3DHilmar%26aufirst%3DM.%26aulast%3DGerhard%26aufirst%3DS.%26atitle%3DNew%25204-quinolinol-%2520and%25205%252C6%252C7%252C8-tetrahydro-4-quinolinol%2520derivatives%2520with%2520biocidal%2520effect%26jtitle%3DLiebigs%2520Ann.%2520Chem.%26date%3D1982%26spage%3D1656%26epage%3D1676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Yamori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishizu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mita, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edatsugi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuba, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takezawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruo, T.</span><span> </span><span class="NLM_article-title">Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">4042</span><span class="NLM_x">–</span> <span class="NLM_lpage">4049</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=4042-4049&author=T.+Yamoriauthor=A.+Matsunagaauthor=S.+Satoauthor=K.+Yamazakiauthor=A.+Komiauthor=K.+Ishizuauthor=I.+Mitaauthor=H.+Edatsugiauthor=Y.+Matsubaauthor=K.+Takezawaauthor=O.+Nakanishiauthor=H.+Kohnoauthor=Y.+Nakajimaauthor=H.+Komatsuauthor=T.+Andohauthor=T.+Tsuruo&title=Potent+antitumor+activity+of+MS-247%2C+a+novel+DNA+minor+groove+binder%2C+evaluated+by+an+in+vitro+and+in+vivo+human+cancer+cell+line+panel"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamori%26aufirst%3DT.%26aulast%3DMatsunaga%26aufirst%3DA.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DK.%26aulast%3DKomi%26aufirst%3DA.%26aulast%3DIshizu%26aufirst%3DK.%26aulast%3DMita%26aufirst%3DI.%26aulast%3DEdatsugi%26aufirst%3DH.%26aulast%3DMatsuba%26aufirst%3DY.%26aulast%3DTakezawa%26aufirst%3DK.%26aulast%3DNakanishi%26aufirst%3DO.%26aulast%3DKohno%26aufirst%3DH.%26aulast%3DNakajima%26aufirst%3DY.%26aulast%3DKomatsu%26aufirst%3DH.%26aulast%3DAndoh%26aufirst%3DT.%26aulast%3DTsuruo%26aufirst%3DT.%26atitle%3DPotent%2520antitumor%2520activity%2520of%2520MS-247%252C%2520a%2520novel%2520DNA%2520minor%2520groove%2520binder%252C%2520evaluated%2520by%2520an%2520in%2520vitro%2520and%2520in%2520vivo%2520human%2520cancer%2520cell%2520line%2520panel%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D4042%26epage%3D4049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Yaguchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koshimizu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirono, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamori, T.</span><span> </span><span class="NLM_article-title">Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1093%2Fjnci%2Fdjj133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=16622124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADC%252BD28XjslOjsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2006&pages=545-556&issue=8&author=S.+Yaguchiauthor=Y.+Fukuiauthor=I.+Koshimizuauthor=H.+Yoshimiauthor=T.+Matsunoauthor=H.+Goudaauthor=S.+Hironoauthor=K.+Yamazakiauthor=T.+Yamori&title=Antitumor+activity+of+ZSTK474%2C+a+new+phosphatidylinositol+3-kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of ZSTK474, a New Phosphatidylinositol 3-Kinase Inhibitor</span></div><div class="casAuthors">Yaguchi, Shin-ichi; Fukui, Yasuhisa; Koshimizu, Ichiro; Yoshimi, Hisashi; Matsuno, Toshiyuki; Gouda, Hiroaki; Hirono, Shuichi; Yamazaki, Kanami; Yamori, Takao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">545-556</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: We previously synthesized a novel s-triazine deriv., ZSTK474 [2-(2-difluoromethylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine], that strongly inhibited the growth of tumor cells.  We identified its mol. target, investigated its effects on cellular signaling pathways, and examd. its antitumor efficacy and toxicity in vivo.  Methods: We used COMPARE anal. of chemosensitivity measurements from 39 human cancer cell lines and identified phosphatidylinositol 3-kinase (PI3K) as a mol. target for ZSTK474.  PI3K was immunopptd. from A549 cell lysates, and its activity was measured by assessing the incorporation of 32P into phosphatidylinositol.  We used the crystal structure of the PI3K-LY294002 complex to model the binding of ZSTK474 to PI3K (where LY294002 is a known PI3K inhibitor).  PI3K downstream activity was analyzed by immunoblotting.  Antitumor activity of ZSTK474 was examd. against A549, PC-3, and WiDr xenografts in nude mice.  Phosphorylation of Akt, a serine/threonine protein kinase and a major signaling component downstream of PI3K, was assessed in vivo by immunohistochem.  Results: PI3K was identified as a mol. target for ZSTK474 by COMPARE anal.  We confirmed that ZSTK474 directly inhibited PI3K activity more efficiently than the PI3K inhibitor LY294002.  At concns. of 1 μM, ZSTK474 and LY2194002 reduced PI3K activity to 4.7% (95% confidence interval [CI] = 3.2% to 6.1%) and 44.6% (95% CI = 38.9% to 50.3%), resp., of the untreated control level.  Mol. modeling of the PI3K-ZSTK474 complex indicated that ZSTK474 could bind to the ATP-binding pocket of PI3K.  ZSTK474 inhibited phosphorylation of signaling components downstream from PI3K, such as Akt and glycogen synthase kinase 3β, and mediated a decrease in cyclin D1 levels.  ZSTK474 administered orally to mice had strong antitumor activity against human cancer xenografts without toxic effects in crit. organs.  Akt phosphorylation was reduced in xenograft tumors after oral administration of ZSTK474.  Conclusion: ZSTK474 is a new PI3K inhibitor with strong antitumor activity against human cancer xenografts without toxic effects in crit. organs.  ZSTK474 merits further investigation as an anticancer drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG0v8LFKdruLVg90H21EOLACvtfcHk0liVUfj3NYHDHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjslOjsLw%253D&md5=a2593024975536089ab2ee7e53234ebc</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjj133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjj133%26sid%3Dliteratum%253Aachs%26aulast%3DYaguchi%26aufirst%3DS.%26aulast%3DFukui%26aufirst%3DY.%26aulast%3DKoshimizu%26aufirst%3DI.%26aulast%3DYoshimi%26aufirst%3DH.%26aulast%3DMatsuno%26aufirst%3DT.%26aulast%3DGouda%26aufirst%3DH.%26aulast%3DHirono%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DK.%26aulast%3DYamori%26aufirst%3DT.%26atitle%3DAntitumor%2520activity%2520of%2520ZSTK474%252C%2520a%2520new%2520phosphatidylinositol%25203-kinase%2520inhibitor%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2006%26volume%3D98%26issue%3D8%26spage%3D545%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Radke, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kersting, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiesel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wulfing, P.</span><span> </span><span class="NLM_article-title">Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1038%2Fsj.bjc.6603261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=16832410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnsl2hsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2006&pages=347-354&issue=3&author=I.+Radkeauthor=M.+Gotteauthor=C.+Kerstingauthor=B.+Mattssonauthor=L.+Kieselauthor=P.+Wulfing&title=Expression+and+prognostic+impact+of+the+protein+tyrosine+phosphatases+PRL-1%2C+PRL-2%2C+and+PRL-3+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer</span></div><div class="casAuthors">Radke, I.; Goette, M.; Kersting, C.; Mattsson, B.; Kiesel, L.; Wuelfing, P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-354</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The aim of this study was to investigate the expression of the protein tyrosine phosphatases (PTP) PRL-1, PRL-2, and PRL-3 in human breast cancer and to evaluate its clin. and prognostic significance.  PRL-PTP mRNA expression was examd. in malignant (n=7) and nonmalignant (n=7) cryoconserved breast tissue samples as well as in eight breast cancer cell lines by RT-PCR.  Furthermore, protein expression of PRL-3 was analyzed semiquant. by immunohistochem. in ductal breast carcinoma in situ (n=135) and invasive breast cancer (n=147) by use of tissue microarray technol. (TMA).  In 24 lymph node-pos. patients we selected the corresponding lymph node metastases for anal. of PRL-3 expression, and a validation set (n=99) of invasive breast cancer samples was examd.  Staining results were correlated with clinicopathol. parameters and long-term follow-up.  PRL-3 mRNA expression was significantly higher in malignant compared to benign breast tissue.  For PRL-1 and PRL-2 expression no significant differences were obsd.  Staining of TMAs showed PRL-3 expression in 85.9% ductal carcinoma in situ and 75.5% invasive breast carcinomas.  Anal. of survival parameters revealed a shorter disease-free survival (DFS) in patients with PRL-3-pos. carcinomas, and in particular a significantly shorter DFS in nodal-pos. patients with PRL-3 overexpressing tumors as compared to PRL-3-neg. breast carcinomas (66±7 mo (95% CI, 52-80) vs 97±9 mo (95% CI, 79-115); P=0.032).  Moreover, we found a more frequent expression of PRL-3 in lymph node metastases as compared to the primary tumors (91.7 vs 66.7%; P=0.033).  Our results suggest that PRL-3 might serve as a novel prognostic factor in breast cancer, which may help to predict an adverse disease outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6at4syLymzbVg90H21EOLACvtfcHk0liVUfj3NYHDHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnsl2hsrs%253D&md5=04b8400f8b03e01a10c2d4121529a74b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6603261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6603261%26sid%3Dliteratum%253Aachs%26aulast%3DRadke%26aufirst%3DI.%26aulast%3DGotte%26aufirst%3DM.%26aulast%3DKersting%26aufirst%3DC.%26aulast%3DMattsson%26aufirst%3DB.%26aulast%3DKiesel%26aufirst%3DL.%26aulast%3DWulfing%26aufirst%3DP.%26atitle%3DExpression%2520and%2520prognostic%2520impact%2520of%2520the%2520protein%2520tyrosine%2520phosphatases%2520PRL-1%252C%2520PRL-2%252C%2520and%2520PRL-3%2520in%2520breast%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2006%26volume%3D95%26issue%3D3%26spage%3D347%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Rochefort, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glondu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurent, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liaudet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roger, P.</span><span> </span><span class="NLM_article-title">Cathepsin D in breast cancer: mechanisms and clinical application, a 1999 overview</span> <span class="citation_source-journal">Clin. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1016%2FS0009-8981%2899%2900226-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=10675721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtFagurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2000&pages=157-170&issue=2&author=H.+Rochefortauthor=M.+Garciaauthor=M.+Glonduauthor=V.+Laurentauthor=E.+Liaudetauthor=J.-M.+Reyauthor=P.+Roger&title=Cathepsin+D+in+breast+cancer%3A+mechanisms+and+clinical+application%2C+a+1999+overview"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview</span></div><div class="casAuthors">Rochefort, H.; Garcia, M.; Glondu, M.; Laurent, V.; Liaudet, E.; Rey, J.-M.; Roger, P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinica Chimica Acta</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-170</span>CODEN:
                <span class="NLM_cas:coden">CCATAR</span>;
        ISSN:<span class="NLM_cas:issn">0009-8981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 59 refs.  A short review of the literature first confirms the clin. value of cathepsin D as a prognostic marker in breast cancer, when using well standardized assays.  The authors then summarize results of studies, mostly performed in the authors' lab., aimed at understanding the effect of cathepsin D overexpression on metastasis and the mol. mechanisms involved.  Cathepsin D-cDNA transfection increases tumor cell proliferation in vitro and the metastatic potential of 3Y1-Ad12 embryonic rat tumorigenic cells when injected in vivo into nude mice.  The mechanism by which cathepsin D increases the incidence of clin. metastasis involves increased cell growth and decreased contact inhibition rather than escape of cancer cells through the basement membrane.  Different mechanisms are considered to explain this mitogenic activity.  Cathepsin D could act as a protease following its activation at an acidic pH, or as a ligand of different membrane receptors at a more neutral pH.  In this case cathepsin D can displace IGFII from the mannose-6-phosphate/IGFII receptor to the IGFI receptor or activate another membrane receptor to be identified.  The nature of the mechanisms involved in vivo may depend on the micro environment of the tumor cells.  These studies should guide in the development of new therapies aimed at inhibiting the deleterious effect of overexpressed cathepsin D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjO_2Rcg8E3LVg90H21EOLACvtfcHk0lhNyYvkfF01Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtFagurw%253D&md5=2f6925755152e3b7f72b08966b4fec77</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FS0009-8981%2899%2900226-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-8981%252899%252900226-0%26sid%3Dliteratum%253Aachs%26aulast%3DRochefort%26aufirst%3DH.%26aulast%3DGarcia%26aufirst%3DM.%26aulast%3DGlondu%26aufirst%3DM.%26aulast%3DLaurent%26aufirst%3DV.%26aulast%3DLiaudet%26aufirst%3DE.%26aulast%3DRey%26aufirst%3DJ.-M.%26aulast%3DRoger%26aufirst%3DP.%26atitle%3DCathepsin%2520D%2520in%2520breast%2520cancer%253A%2520mechanisms%2520and%2520clinical%2520application%252C%2520a%25201999%2520overview%26jtitle%3DClin.%2520Chim.%2520Acta%26date%3D2000%26volume%3D291%26issue%3D2%26spage%3D157%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Liaudet-Coopman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaujouin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derocq, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glondu-Lassis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurent-Matha, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prébois, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochefort, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vignon, F.</span><span> </span><span class="NLM_article-title">Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">237</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1016%2Fj.canlet.2005.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=16046058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADC%252BD28XltF2qsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=2006&pages=167-179&issue=2&author=E.+Liaudet-Coopmanauthor=M.+Beaujouinauthor=D.+Derocqauthor=M.+Garciaauthor=M.+Glondu-Lassisauthor=V.+Laurent-Mathaauthor=C.+Pr%C3%A9boisauthor=H.+Rochefortauthor=F.+Vignon&title=Cathepsin+D%3A+newly+discovered+functions+of+a+long-standing+aspartic+protease+in+cancer+and+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin D: Newly discovered functions of a long-standing aspartic protease in cancer and apoptosis</span></div><div class="casAuthors">Liaudet-Coopman, Emmanuelle; Beaujouin, Melanie; Derocq, Danielle; Garcia, Marcel; Glondu-Lassis, Murielle; Laurent-Matha, Valerie; Prebois, Christine; Rochefort, Henri; Vignon, Francoise</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">237</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-179</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The lysosomal aspartic protease cathepsin D (cath-D) is over-expressed and hyper-secreted by epithelial breast cancer cells.  This protease is an independent marker of poor prognosis in breast cancer being correlated with the incidence of clin. metastasis.  Cath-D over-expression stimulates tumorigenicity and metastasis.  Indeed it plays an essential role in the multiple steps of tumor progression, in stimulating cancer cell proliferation, fibroblast outgrowth and angiogenesis, as well as in inhibiting tumor apoptosis.  A mutated cath-D devoid of catalytic activity still proved mitogenic for cancer, endothelial and fibroblastic cells, suggesting an extra-cellular mode of action of cath-D involving a triggering, either directly or indirectly, of an as yet unidentified cell surface receptor.  Cath-D is also a key mediator of induced-apoptosis and its proteolytic activity has been involved generally in this event.  During apoptosis, mature lysosomal cath-D is translocated to the cytosol.  Since cath-D is one of the lysosomal enzymes which requires a more acidic pH to be proteolytically-active relative to the cysteine lysosomal enzymes, such as cath-B and -L, it is open to question whether cytosolic cath-D might be able to cleave substrate(s) implicated in the apoptotic cascade.  This review summarises our current knowledge on cath-D action in cancer progression and metastasis, as well as its dual function in apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFJdjUCIwta7Vg90H21EOLACvtfcHk0lhNyYvkfF01Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltF2qsbc%253D&md5=eb7be2df7685a6574ca0b161a6c9716d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2005.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2005.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DLiaudet-Coopman%26aufirst%3DE.%26aulast%3DBeaujouin%26aufirst%3DM.%26aulast%3DDerocq%26aufirst%3DD.%26aulast%3DGarcia%26aufirst%3DM.%26aulast%3DGlondu-Lassis%26aufirst%3DM.%26aulast%3DLaurent-Matha%26aufirst%3DV.%26aulast%3DPr%25C3%25A9bois%26aufirst%3DC.%26aulast%3DRochefort%26aufirst%3DH.%26aulast%3DVignon%26aufirst%3DF.%26atitle%3DCathepsin%2520D%253A%2520newly%2520discovered%2520functions%2520of%2520a%2520long-standing%2520aspartic%2520protease%2520in%2520cancer%2520and%2520apoptosis%26jtitle%3DCancer%2520Lett.%26date%3D2006%26volume%3D237%26issue%3D2%26spage%3D167%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Chang, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. Y.</span><span> </span><span class="NLM_article-title">Lysosomal cysteine proteinase cathepsin S as a potential target for anti-cancer therapy</span> <span class="citation_source-journal">J. Cancer Mol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXislyis7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=5-14&author=W.+S.+Changauthor=H.+R.+Wuauthor=C.+T.+Yehauthor=C.+W.+Wuauthor=J.+Y.+Chang&title=Lysosomal+cysteine+proteinase+cathepsin+S+as+a+potential+target+for+anti-cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomal cysteine proteinase cathepsin S as a potential target for anti-cancer therapy</span></div><div class="casAuthors">Chang, Wun-Shaing W.; Wu, Hsin-Ru; Yeh, Chi-Tai; Wu, Cheng-Wen; Chang, Jang-Yang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cancer Molecules</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-14</span>CODEN:
                <span class="NLM_cas:coden">JCMOCF</span>;
        ISSN:<span class="NLM_cas:issn">1816-0735</span>.
    
            (<span class="NLM_cas:orgname">MedUnion Press</span>)
        </div><div class="casAbstract">A review.  In mammalian cells, cysteine proteinases are localized mainly in the cytoplasm and lysosomal compartments.  For lysosomal cysteine proteinases, they are synthesized as inactive zymogens and converted to active forms occurred in the acidic and reducing conditions of late endosomes or lysosomes.  Here we review the roles of active lysosomal cysteine proteinases in particular cathepsin S and its importance to many physiol. or pathol. processes including tumor growth, angiogenesis, and metastasis.  Biochem. and clin. studies have shown significant changes in the levels of mRNA expression and enzyme activity of cathepsin S in various cancer tissues and cell lines.  Immunol., mol. and pharmaceutical approaches to alter the expression and proteolytic activity of cathepsin S all provided strong evidence for a causal role of this proteolytic enzyme in tumor progression and invasion.  Detn. of the x-ray structures of either cathepsin S alone or complexed with inhibitors further offered insights of the active site pocket of cathepsin S, thereby making the rational design of low-mol. wt. synthetic inhibitors feasible for anti-cancer drug development and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKIeGD-mx08LVg90H21EOLACvtfcHk0lhNyYvkfF01Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXislyis7w%253D&md5=2572a030bed10ec8e31fa72fddb466c4</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DW.%2BS.%26aulast%3DWu%26aufirst%3DH.%2BR.%26aulast%3DYeh%26aufirst%3DC.%2BT.%26aulast%3DWu%26aufirst%3DC.%2BW.%26aulast%3DChang%26aufirst%3DJ.%2BY.%26atitle%3DLysosomal%2520cysteine%2520proteinase%2520cathepsin%2520S%2520as%2520a%2520potential%2520target%2520for%2520anti-cancer%2520therapy%26jtitle%3DJ.%2520Cancer%2520Mol.%26date%3D2007%26volume%3D3%26spage%3D5%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Takehara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosokawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohigashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span> </span><span class="NLM_article-title">γ-Aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABA<sub>A</sub> receptor π subunit</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">9704</span><span class="NLM_x">–</span> <span class="NLM_lpage">9712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=9704-9712&author=A.+Takeharaauthor=M.+Hosokawaauthor=H.+Eguchiauthor=H.+Ohigashiauthor=O.+Ishikawaauthor=Y.+Nakamuraauthor=H.+Nakagawa&title=%CE%B3-Aminobutyric+acid+%28GABA%29+stimulates+pancreatic+cancer+growth+through+overexpressing+GABAA+receptor+%CF%80+subunit"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakehara%26aufirst%3DA.%26aulast%3DHosokawa%26aufirst%3DM.%26aulast%3DEguchi%26aufirst%3DH.%26aulast%3DOhigashi%26aufirst%3DH.%26aulast%3DIshikawa%26aufirst%3DO.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DNakagawa%26aufirst%3DH.%26atitle%3D%25CE%25B3-Aminobutyric%2520acid%2520%2528GABA%2529%2520stimulates%2520pancreatic%2520cancer%2520growth%2520through%2520overexpressing%2520GABAA%2520receptor%2520%25CF%2580%2520subunit%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D9704%26epage%3D9712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Wang, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guh, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teng, C. M.</span><span> </span><span class="NLM_article-title">CHM-1 inhibits hepatocyte growth factor-induced invasion of SK-Hep-1 human hepatocellular carcinoma cells by suppressing matrix metalloproteinase-9 expression</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1016%2Fj.canlet.2007.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=17689859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSnt7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=2007&pages=87-96&author=S.+W.+Wangauthor=S.+L.+Panauthor=C.+Y.+Pengauthor=D.+Y.+Huangauthor=A.+C.+Tsaiauthor=Y.+L.+Changauthor=J.+H.+Guhauthor=S.+C.+Kuoauthor=K.+H.+Leeauthor=C.+M.+Teng&title=CHM-1+inhibits+hepatocyte+growth+factor-induced+invasion+of+SK-Hep-1+human+hepatocellular+carcinoma+cells+by+suppressing+matrix+metalloproteinase-9+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">CHM-1 inhibits hepatocyte growth factor-induced invasion of SK-Hep-1 human hepatocellular carcinoma cells by suppressing matrix metalloproteinase-9 expression</span></div><div class="casAuthors">Wang, Shih-Wei; Pan, Shiow-Lin; Peng, Chieh-Yu; Huang, Der-Yi; Tsai, An-Chi; Chang, Ya-Ling; Guh, Jih-Hwa; Kuo, Sheng-Chu; Lee, Kuo-Hsiung; Teng, Che-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">257</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-96</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Clin. observations suggest that hepatocyte growth factor (HGF) can promote invasion and metastasis in hepatocellular carcinoma.  In this study, we found that HGF-stimulated invasion of SK-Hep-1 cells, together with increased expression of matrix metalloproteinase (MMP)-9.  CHM-1 was identified from 2-phenyl-4-quinolone derivs. to potently inhibit HGF-induced cell invasion, proteolytic activity, and expression of MMP-9.  CHM-1 significantly inhibited tyrosine autophosphorylation of c-Met induced by HGF.  CHM-1 also suppressed HGF-induced Akt phosphorylation, and NF-κB activation, the downstream regulators of HGF/c-Met signaling, resulting in the inhibition of MMP-9.  Thus, we suggest that CHM-1 is a potential therapeutic agent against tumor invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtlJme6dRgS7Vg90H21EOLACvtfcHk0lj-ogqYk7iw8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSnt7jM&md5=cf714b78ba65bdfffb8d594df27f354c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2007.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2007.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%2BW.%26aulast%3DPan%26aufirst%3DS.%2BL.%26aulast%3DPeng%26aufirst%3DC.%2BY.%26aulast%3DHuang%26aufirst%3DD.%2BY.%26aulast%3DTsai%26aufirst%3DA.%2BC.%26aulast%3DChang%26aufirst%3DY.%2BL.%26aulast%3DGuh%26aufirst%3DJ.%2BH.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DLee%26aufirst%3DK.%2BH.%26aulast%3DTeng%26aufirst%3DC.%2BM.%26atitle%3DCHM-1%2520inhibits%2520hepatocyte%2520growth%2520factor-induced%2520invasion%2520of%2520SK-Hep-1%2520human%2520hepatocellular%2520carcinoma%2520cells%2520by%2520suppressing%2520matrix%2520metalloproteinase-9%2520expression%26jtitle%3DCancer%2520Lett.%26date%3D2007%26volume%3D257%26spage%3D87%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Meraldi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draviam, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorger, P. K.</span><span> </span><span class="NLM_article-title">Timing and checkpoints in the regulation of mitotic progression</span> <span class="citation_source-journal">Dev. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=45-60&author=P.+Meraldiauthor=V.+M.+Draviamauthor=P.+K.+Sorger&title=Timing+and+checkpoints+in+the+regulation+of+mitotic+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeraldi%26aufirst%3DP.%26aulast%3DDraviam%26aufirst%3DV.%2BM.%26aulast%3DSorger%26aufirst%3DP.%2BK.%26atitle%3DTiming%2520and%2520checkpoints%2520in%2520the%2520regulation%2520of%2520mitotic%2520progression%26jtitle%3DDev.%2520Cell%26date%3D2004%26volume%3D7%26spage%3D45%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Paull, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubinstein, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plowman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span> </span><span class="NLM_article-title">Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">1088</span><span class="NLM_x">–</span> <span class="NLM_lpage">1092</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1093%2Fjnci%2F81.14.1088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=2738938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A280%3ADyaL1M3ptlyrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1989&pages=1088-1092&issue=14&author=K.+D.+Paullauthor=R.+H.+Shoemakerauthor=L.+Hodesauthor=A.+Monksauthor=D.+A.+Scudieroauthor=L.+Rubinsteinauthor=J.+Plowmanauthor=M.+R.+Boyd&title=Display+and+analysis+of+patterns+of+differential+activity+of+drugs+against+human+tumor+cell+lines%3A+development+of+mean+graph+and+COMPARE+algorithm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm</span></div><div class="casAuthors">Paull K D; Shoemaker R H; Hodes L; Monks A; Scudiero D A; Rubinstein L; Plowman J; Boyd M R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1088-92</span>
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">The objective of this study was to develop and investigate an approach to optimally detect, rank, display, and analyze patterns of differential growth inhibition among cultured cell lines.  Such patterns of cellular responsiveness are produced by substances tested in vitro against disease-oriented panels of human tumor cell lines in a new anticancer screening model under development by the National Cancer Institute.  In the first phase of the study, we developed a key methodological tool, the mean graph, which allowed the transformation of the numerical cell line response data into graphic patterns.  These patterns were particularly expressive of differential cell growth inhibition and were conveniently amenable to further analyses by an algorithm we devised and implemented in the COMPARE computer program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQUJX57ADL8cwpJitSxOdIlfW6udTcc2ebjoaayduvgSbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M3ptlyrsw%253D%253D&md5=6612f9f2a7793d1296dfa24224f09545</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F81.14.1088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F81.14.1088%26sid%3Dliteratum%253Aachs%26aulast%3DPaull%26aufirst%3DK.%2BD.%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26aulast%3DHodes%26aufirst%3DL.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DScudiero%26aufirst%3DD.%2BA.%26aulast%3DRubinstein%26aufirst%3DL.%26aulast%3DPlowman%26aufirst%3DJ.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DDisplay%2520and%2520analysis%2520of%2520patterns%2520of%2520differential%2520activity%2520of%2520drugs%2520against%2520human%2520tumor%2520cell%2520lines%253A%2520development%2520of%2520mean%2520graph%2520and%2520COMPARE%2520algorithm%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1989%26volume%3D81%26issue%3D14%26spage%3D1088%26epage%3D1092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skehan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paull, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vistica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hose, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cronise, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaigro-Wolff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray-Goodrich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M.</span><span> </span><span class="NLM_article-title">Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">757</span><span class="NLM_x">–</span> <span class="NLM_lpage">766</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1093%2Fjnci%2F83.11.757" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=2041050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADyaK3MXksVWiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1991&pages=757-766&author=A.+Monksauthor=D.+Scudieroauthor=P.+Skehanauthor=R.+Shoemakerauthor=K.+Paullauthor=D.+Visticaauthor=C.+Hoseauthor=J.+Langleyauthor=P.+Croniseauthor=A.+Vaigro-Wolffauthor=M.+Gray-Goodrichauthor=H.+Campbellauthor=J.+Mayoauthor=M.+Boyd&title=Feasibility+of+a+high-flux+anticancer+drug+screen+using+a+diverse+panel+of+cultured+human+tumor+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines</span></div><div class="casAuthors">Monks, Anne; Scudiero, Dominic; Skehan, Philip; Shoemaker, Robert; Paull, Kenneth; Vistica, David; Hose, Curtis; Langley, John; Cronise, Paul; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">757-66</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">The development and implementation of a pilot-scale, in vitro, anticancer drug screen utilizing a panel of 60 human tumor cell lines organized into subpanels representing leukemia, melanoma, and cancers of the lung, colon, kidney, ovary, and central nervous system is described.  The ultimate goal of this disease-oriented screen is to facilitate the discovery of new compds. with potential cell line-specific and/or subpanel-specific antitumor activity.  In the current screening protocol, each cell line is inoculated onto microtiter plates, then preincubated for 24-28 h.  Subsequently, test agents are added in five 10-fold dilns. and the culture is incubated for an addnl. 48 h.  For each test agent, a dose-response profile is generated.  End-point detns. of the cell viability or cell growth are performed by in situ fixation of cells, followed by staining with a protein-binding dye, sulforhodamine B (SRB).  The SRB binds to the basic amino acids of cellular macromols.; the solubilized stain is measured spectrophotometrically to det. relative cell growth or viability in treated and untreated cells.  Following the pilot screening studies, a screening rate of 400 compds. per wk has been consistently achieved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs2v5P80YUP7Vg90H21EOLACvtfcHk0libWxvTqGB9Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXksVWiuro%253D&md5=cee33642400d34b01d8f962cb16a9386</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F83.11.757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F83.11.757%26sid%3Dliteratum%253Aachs%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DScudiero%26aufirst%3DD.%26aulast%3DSkehan%26aufirst%3DP.%26aulast%3DShoemaker%26aufirst%3DR.%26aulast%3DPaull%26aufirst%3DK.%26aulast%3DVistica%26aufirst%3DD.%26aulast%3DHose%26aufirst%3DC.%26aulast%3DLangley%26aufirst%3DJ.%26aulast%3DCronise%26aufirst%3DP.%26aulast%3DVaigro-Wolff%26aufirst%3DA.%26aulast%3DGray-Goodrich%26aufirst%3DM.%26aulast%3DCampbell%26aufirst%3DH.%26aulast%3DMayo%26aufirst%3DJ.%26aulast%3DBoyd%26aufirst%3DM.%26atitle%3DFeasibility%2520of%2520a%2520high-flux%2520anticancer%2520drug%2520screen%2520using%2520a%2520diverse%2520panel%2520of%2520cultured%2520human%2520tumor%2520cell%2520lines%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1991%26volume%3D83%26spage%3D757%26epage%3D766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Yamori, T.</span><span> </span><span class="NLM_article-title">Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">S74</span><span class="NLM_x">–</span> <span class="NLM_lpage">S79</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2003&pages=S74-S79&author=T.+Yamori&title=Panel+of+human+cancer+cell+lines+provides+valuable+database+for+drug+discovery+and+bioinformatics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamori%26aufirst%3DT.%26atitle%3DPanel%2520of%2520human%2520cancer%2520cell%2520lines%2520provides%2520valuable%2520database%2520for%2520drug%2520discovery%2520and%2520bioinformatics%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2003%26volume%3D52%26spage%3DS74%26epage%3DS79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Euhus, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudd, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaRegina, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, F. E.</span><span> </span><span class="NLM_article-title">Tumor measurement in the nude mouse</span> <span class="citation_source-journal">J. Surg. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1002%2Fjso.2930310402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=3724177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A280%3ADyaL283lsFGrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1986&pages=229-234&author=D.+M.+Euhusauthor=C.+Huddauthor=M.+C.+LaReginaauthor=F.+E.+Johnson&title=Tumor+measurement+in+the+nude+mouse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor measurement in the nude mouse</span></div><div class="casAuthors">Euhus D M; Hudd C; LaRegina M C; Johnson F E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of surgical oncology</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">229-34</span>
        ISSN:<span class="NLM_cas:issn">0022-4790</span>.
    </div><div class="casAbstract">In this study, the pitfalls of tumor measurement in the nude mouse were evaluated.  Regarding intermethod variation, diameters of subcutaneous tumors in nude mice were expressed as length, area, and volume; tumor weights were also recorded.  These measurements were all compared to a reference standard: water displacement volume.  Estimates of area and volume derived from caliper measurements correlated well with water displacement volume (r = 0.97 and 0.98, respectively).  At necropsy, tumor weight was the most consistent and reproducible reflection of tumor volume (r = 1.0000).  Regarding interobserver variation, mean absolute difference among volumes determined by several investigators who measured the same tumors in living animals was determined.  This averaged 15% of the mean calculated volume.  Regarding intraobserver variation, observers measured four separate masses in nude mice eight times each.  The observers were prevented from realizing that the same animals were being repeatedly evaluated.  Volumes were compared in order to quantify the average variation that occurs when a single investigator repeatedly measures the same mass.  When large masses were measured, this error was 7%; when small masses were measured, the error was 27%.  Recommendations are made for future work employing tumor measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRA4eEHDa7Gl5Pq5LRczm8ffW6udTcc2eagBuqHFeDkW7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL283lsFGrtQ%253D%253D&md5=33e4690abec9f0f531e3b0d569e747ca</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fjso.2930310402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjso.2930310402%26sid%3Dliteratum%253Aachs%26aulast%3DEuhus%26aufirst%3DD.%2BM.%26aulast%3DHudd%26aufirst%3DC.%26aulast%3DLaRegina%26aufirst%3DM.%2BC.%26aulast%3DJohnson%26aufirst%3DF.%2BE.%26atitle%3DTumor%2520measurement%2520in%2520the%2520nude%2520mouse%26jtitle%3DJ.%2520Surg.%2520Oncol.%26date%3D1986%26volume%3D31%26spage%3D229%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Tomayko, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. P.</span><span> </span><span class="NLM_article-title">Determination of subcutaneous tumor size in athymic (nude) mice</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1007%2FBF00300234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=2544306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A280%3ADyaL1M3ovVGjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1989&pages=148-154&author=M.+M.+Tomaykoauthor=C.+P.+Reynolds&title=Determination+of+subcutaneous+tumor+size+in+athymic+%28nude%29+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of subcutaneous tumor size in athymic (nude) mice</span></div><div class="casAuthors">Tomayko M M; Reynolds C P</div><div class="citationInfo"><span class="NLM_cas:title">Cancer chemotherapy and pharmacology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">148-54</span>
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    </div><div class="casAbstract">The athymic (nude) mouse is a useful model for studying the biology and response to therapies of human tumors in vivo.  A survey of recent literature revealed the use of 19 different formulas for determining the size of subcutaneous tumors grown as xenografts in nude mice (2 for determining tumor area, 3 for tumor diameter, and 14 for calculating tumor volume).  We compared the volumes, areas, and diameters predicted by each of the 19 formulas with the actual weights of 50 tumors ranging from 0.46 to 22.0 g established in nude mice as xenografts from human cell lines.  In addition to determining how well each formula predicted relative tumor size, we analyzed how well each formula estimated actual tumor mass.  The ellipsoid volume formulas (pi/6 x L x W x H and 1/2 x L x W x H) were best for estimating tumor mass (r = 0.93), whereas measurements of diameter correlated poorly with tumor mass (r less than 0.66).  Although determination of tumor area correlated well with tumor mass in small tumors (r = 0.89), correlations of area with tumor mass for large tumors were poor (r = 0.41).  We conclude that determination of the ellipsoid volume from measurements of three axes consistently yields the most accurate estimations of both relative and actual tumor mass.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTFNL7A6tb_ZkBuFdjgVNKSfW6udTcc2eagBuqHFeDkW7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M3ovVGjug%253D%253D&md5=af54a5d168f43a4b4d9b52964b05ec65</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1007%2FBF00300234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00300234%26sid%3Dliteratum%253Aachs%26aulast%3DTomayko%26aufirst%3DM.%2BM.%26aulast%3DReynolds%26aufirst%3DC.%2BP.%26atitle%3DDetermination%2520of%2520subcutaneous%2520tumor%2520size%2520in%2520athymic%2520%2528nude%2529%2520mice%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1989%26volume%3D24%26spage%3D148%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="note"><p class="first last">References provided in Supporting Information.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':[]}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 25 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chandrakala  Pidathala</span>, <span class="hlFld-ContribAuthor ">Richard  Amewu</span>, <span class="hlFld-ContribAuthor ">Bénédicte  Pacorel</span>, <span class="hlFld-ContribAuthor ">Gemma L.  Nixon</span>, <span class="hlFld-ContribAuthor ">Peter  Gibbons</span>, <span class="hlFld-ContribAuthor ">W. David  Hong</span>, <span class="hlFld-ContribAuthor ">Suet C.  Leung</span>, <span class="hlFld-ContribAuthor ">Neil G.  Berry</span>, <span class="hlFld-ContribAuthor ">Raman  Sharma</span>, <span class="hlFld-ContribAuthor ">Paul A.  Stocks</span>, <span class="hlFld-ContribAuthor ">Abhishek  Srivastava</span>, <span class="hlFld-ContribAuthor ">Alison E.  Shone</span>, <span class="hlFld-ContribAuthor ">Sitthivut  Charoensutthivarakul</span>, <span class="hlFld-ContribAuthor ">Lee  Taylor</span>, <span class="hlFld-ContribAuthor ">Olivier  Berger</span>, <span class="hlFld-ContribAuthor ">Alison  Mbekeani</span>, <span class="hlFld-ContribAuthor ">Alasdair  Hill</span>, <span class="hlFld-ContribAuthor ">Nicholas E.  Fisher</span>, <span class="hlFld-ContribAuthor ">Ashley J.  Warman</span>, <span class="hlFld-ContribAuthor ">Giancarlo A.  Biagini</span>, <span class="hlFld-ContribAuthor ">Stephen A.  Ward</span>, and <span class="hlFld-ContribAuthor ">Paul M.  O’Neill</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification, Design and Biological Evaluation of Bisaryl Quinolones Targeting Plasmodium falciparum Type II NADH:Quinone Oxidoreductase (PfNDH2). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (5)
                                     , 1831-1843. <a href="https://doi.org/10.1021/jm201179h" title="DOI URL">https://doi.org/10.1021/jm201179h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201179h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201179h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%25252C%252BDesign%252Band%252BBiological%252BEvaluation%252Bof%252BBisaryl%252BQuinolones%252BTargeting%252BPlasmodium%252Bfalciparum%252BType%252BII%252BNADH%25253AQuinone%252BOxidoreductase%252B%252528PfNDH2%252529%26aulast%3DPidathala%26aufirst%3DChandrakala%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D06092011%26date%3D24022012%26date%3D08032012%26volume%3D55%26issue%3D5%26spage%3D1831%26epage%3D1843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Suet C.  Leung</span>, <span class="hlFld-ContribAuthor ">Peter  Gibbons</span>, <span class="hlFld-ContribAuthor ">Richard  Amewu</span>, <span class="hlFld-ContribAuthor ">Gemma L.  Nixon</span>, <span class="hlFld-ContribAuthor ">Chandrakala  Pidathala</span>, <span class="hlFld-ContribAuthor ">W. David  Hong</span>, <span class="hlFld-ContribAuthor ">Bénédicte  Pacorel</span>, <span class="hlFld-ContribAuthor ">Neil G.  Berry</span>, <span class="hlFld-ContribAuthor ">Raman  Sharma</span>, <span class="hlFld-ContribAuthor ">Paul A.  Stocks</span>, <span class="hlFld-ContribAuthor ">Abhishek  Srivastava</span>, <span class="hlFld-ContribAuthor ">Alison E.  Shone</span>, <span class="hlFld-ContribAuthor ">Sitthivut  Charoensutthivarakul</span>, <span class="hlFld-ContribAuthor ">Lee  Taylor</span>, <span class="hlFld-ContribAuthor ">Olivier  Berger</span>, <span class="hlFld-ContribAuthor ">Alison  Mbekeani</span>, <span class="hlFld-ContribAuthor ">Alasdair  Hill</span>, <span class="hlFld-ContribAuthor ">Nicholas E.  Fisher</span>, <span class="hlFld-ContribAuthor ">Ashley J.  Warman</span>, <span class="hlFld-ContribAuthor ">Giancarlo A.  Biagini</span>, <span class="hlFld-ContribAuthor ">Stephen A.  Ward</span>, and <span class="hlFld-ContribAuthor ">Paul M.  O’Neill</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification, Design and Biological Evaluation of Heterocyclic Quinolones Targeting Plasmodium falciparum Type II NADH:Quinone Oxidoreductase (PfNDH2). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (5)
                                     , 1844-1857. <a href="https://doi.org/10.1021/jm201184h" title="DOI URL">https://doi.org/10.1021/jm201184h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201184h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201184h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%25252C%252BDesign%252Band%252BBiological%252BEvaluation%252Bof%252BHeterocyclic%252BQuinolones%252BTargeting%252BPlasmodium%252Bfalciparum%252BType%252BII%252BNADH%25253AQuinone%252BOxidoreductase%252B%252528PfNDH2%252529%26aulast%3DLeung%26aufirst%3DSuet%2BC.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D07092011%26date%3D24022012%26date%3D08032012%26volume%3D55%26issue%3D5%26spage%3D1844%26epage%3D1857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Chen  Chou</span>, <span class="hlFld-ContribAuthor ">Meng-Tung  Tsai</span>, <span class="hlFld-ContribAuthor ">Mei-Hua  Hsu</span>, <span class="hlFld-ContribAuthor ">Sheng-Hung  Wang</span>, <span class="hlFld-ContribAuthor ">Tzong-Der  Way</span>, <span class="hlFld-ContribAuthor ">Chi-Hung  Huang</span>, <span class="hlFld-ContribAuthor ">Hui-Yi  Lin</span>, <span class="hlFld-ContribAuthor ">Keduo  Qian</span>, <span class="hlFld-ContribAuthor ">Yizhou  Dong</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>, <span class="hlFld-ContribAuthor ">Li-Jiau  Huang</span>, and <span class="hlFld-ContribAuthor ">Sheng-Chu  Kuo</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Preclinical Evaluation of New 5,6- (or 6,7-) Disubstituted-2-(fluorophenyl)quinolin-4-one Derivatives as Potent Antitumor Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (22)
                                     , 8047-8058. <a href="https://doi.org/10.1021/jm100780c" title="DOI URL">https://doi.org/10.1021/jm100780c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100780c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100780c%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BPreclinical%252BEvaluation%252Bof%252BNew%252B5%25252C6-%252B%252528or%252B6%25252C7-%252529%252BDisubstituted-2-%252528fluorophenyl%252529quinolin-4-one%252BDerivatives%252Bas%252BPotent%252BAntitumor%252BAgents%26aulast%3DChou%26aufirst%3DLi-Chen%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D24062010%26date%3D25102010%26date%3D25112010%26volume%3D53%26issue%3D22%26spage%3D8047%26epage%3D8058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Ying  Shen</span>, <span class="hlFld-ContribAuthor ">Chun-Peng  Jia</span>, <span class="hlFld-ContribAuthor ">An-Na  Mo</span>, <span class="hlFld-ContribAuthor ">Hong  Liang</span>, <span class="hlFld-ContribAuthor ">Zhen-Feng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Chemodynamic therapy agents Cu(II) complexes of quinoline derivatives induced ER stress and mitochondria-mediated apoptosis in SK-OV-3 cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113636. <a href="https://doi.org/10.1016/j.ejmech.2021.113636" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113636</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113636%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChemodynamic%252Btherapy%252Bagents%252BCu%252528II%252529%252Bcomplexes%252Bof%252Bquinoline%252Bderivatives%252Binduced%252BER%252Bstress%252Band%252Bmitochondria-mediated%252Bapoptosis%252Bin%252BSK-OV-3%2525C2%2525A0cells%26aulast%3DShen%26aufirst%3DWen-Ying%26date%3D2021%26volume%3D223%26spage%3D113636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yohan  Kim</span>, <span class="hlFld-ContribAuthor ">Vijay Vilas  Shinde</span>, <span class="hlFld-ContribAuthor ">Daham  Jeong</span>, <span class="hlFld-ContribAuthor ">Seunho  Jung</span>. </span><span class="cited-content_cbyCitation_article-title">Utilization of Water-Soluble Aminoethylamino–β–Cyclodextrin in the Pfitzinger Reaction—Catalyzed to the Synthesis of Diversely Functionalized Quinaldine. </span><span class="cited-content_cbyCitation_journal-name">Polymers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (2)
                                     , 393. <a href="https://doi.org/10.3390/polym12020393" title="DOI URL">https://doi.org/10.3390/polym12020393</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/polym12020393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpolym12020393%26sid%3Dliteratum%253Aachs%26jtitle%3DPolymers%26atitle%3DUtilization%252Bof%252BWater-Soluble%252BAminoethylamino%2525E2%252580%252593%2525CE%2525B2%2525E2%252580%252593Cyclodextrin%252Bin%252Bthe%252BPfitzinger%252BReaction%2525E2%252580%252594Catalyzed%252Bto%252Bthe%252BSynthesis%252Bof%252BDiversely%252BFunctionalized%252BQuinaldine%26aulast%3DKim%26aufirst%3DYohan%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D2%26spage%3D393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samia S.  Hawas</span>, <span class="hlFld-ContribAuthor ">Nadia S.  El-Gohary</span>, <span class="hlFld-ContribAuthor ">Moustafa T.  Gabr</span>, <span class="hlFld-ContribAuthor ">Mona I.  Shaaban</span>, <span class="hlFld-ContribAuthor ">Mahmoud B.  El-Ashmawy</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, molecular docking, antimicrobial, antiquorum-sensing and antiproliferative activities of new series of pyrazolo[3,4-
              b
              ]pyridine analogs. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2019,</strong> <em>49 </em>
                                    (19)
                                     , 2466-2487. <a href="https://doi.org/10.1080/00397911.2019.1618873" title="DOI URL">https://doi.org/10.1080/00397911.2019.1618873</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2019.1618873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2019.1618873%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DSynthesis%25252C%252Bmolecular%252Bdocking%25252C%252Bantimicrobial%25252C%252Bantiquorum-sensing%252Band%252Bantiproliferative%252Bactivities%252Bof%252Bnew%252Bseries%252Bof%252Bpyrazolo%25255B3%25252C4-%252Bb%252B%25255Dpyridine%252Banalogs%26aulast%3DHawas%26aufirst%3DSamia%2BS.%26date%3D2019%26date%3D2019%26volume%3D49%26issue%3D19%26spage%3D2466%26epage%3D2487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikhil R.  Tasker</span>, <span class="hlFld-ContribAuthor ">Ettore J.  Rastelli</span>, <span class="hlFld-ContribAuthor ">James C.  Burnett</span>, <span class="hlFld-ContribAuthor ">Elizabeth R.  Sharlow</span>, <span class="hlFld-ContribAuthor ">John S.  Lazo</span>, <span class="hlFld-ContribAuthor ">Peter  Wipf</span>. </span><span class="cited-content_cbyCitation_article-title">Tapping the therapeutic potential of protein tyrosine phosphatase 4A with small molecule inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (16)
                                     , 2008-2015. <a href="https://doi.org/10.1016/j.bmcl.2019.06.048" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.06.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.06.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.06.048%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DTapping%252Bthe%252Btherapeutic%252Bpotential%252Bof%252Bprotein%252Btyrosine%252Bphosphatase%252B4A%252Bwith%252Bsmall%252Bmolecule%252Binhibitors%26aulast%3DTasker%26aufirst%3DNikhil%2BR.%26date%3D2019%26volume%3D29%26issue%3D16%26spage%3D2008%26epage%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Priyanka A.  More</span>, <span class="hlFld-ContribAuthor ">Ganapati S.  Shankarling</span>. </span><span class="cited-content_cbyCitation_article-title">Energy efficient Pfitzinger reaction: a novel strategy using a surfactant catalyst. </span><span class="cited-content_cbyCitation_journal-name">New J. Chem.</span><span> <strong>2017,</strong> <em>41 </em>
                                    (21)
                                     , 12380-12383. <a href="https://doi.org/10.1039/C7NJ01937H" title="DOI URL">https://doi.org/10.1039/C7NJ01937H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7NJ01937H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7NJ01937H%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520J.%2520Chem.%26atitle%3DEnergy%252Befficient%252BPfitzinger%252Breaction%25253A%252Ba%252Bnovel%252Bstrategy%252Busing%252Ba%252Bsurfactant%252Bcatalyst%26aulast%3DMore%26aufirst%3DPriyanka%2BA.%26date%3D2017%26date%3D2017%26volume%3D41%26issue%3D21%26spage%3D12380%26epage%3D12383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiancong  Xu</span>, <span class="hlFld-ContribAuthor ">Xuliang  Nie</span>, <span class="hlFld-ContribAuthor ">Yanping  Hong</span>, <span class="hlFld-ContribAuthor ">Yan  Jiang</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Wu</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Yin</span>, <span class="hlFld-ContribAuthor ">Chunrong  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoqiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of water soluble glycosides of pentacyclic dihydroxytriterpene carboxylic acids as inhibitors of α-glucosidase. </span><span class="cited-content_cbyCitation_journal-name">Carbohydrate Research</span><span> <strong>2016,</strong> <em>424 </em>, 42-53. <a href="https://doi.org/10.1016/j.carres.2016.02.009" title="DOI URL">https://doi.org/10.1016/j.carres.2016.02.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.carres.2016.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.carres.2016.02.009%26sid%3Dliteratum%253Aachs%26jtitle%3DCarbohydrate%2520Research%26atitle%3DSynthesis%252Bof%252Bwater%252Bsoluble%252Bglycosides%252Bof%252Bpentacyclic%252Bdihydroxytriterpene%252Bcarboxylic%252Bacids%252Bas%252Binhibitors%252Bof%252B%2525CE%2525B1-glucosidase%26aulast%3DXu%26aufirst%3DJiancong%26date%3D2016%26volume%3D424%26spage%3D42%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiyan  Xiao</span>, <span class="hlFld-ContribAuthor ">Susan L.  Morris-Natschke</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2016,</strong> <em>36 </em>
                                    (1)
                                     , 32-91. <a href="https://doi.org/10.1002/med.21377" title="DOI URL">https://doi.org/10.1002/med.21377</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21377%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DStrategies%252Bfor%252Bthe%252BOptimization%252Bof%252BNatural%252BLeads%252Bto%252BAnticancer%252BDrugs%252Bor%252BDrug%252BCandidates%26aulast%3DXiao%26aufirst%3DZhiyan%26date%3D2016%26date%3D2015%26volume%3D36%26issue%3D1%26spage%3D32%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Soonhyung  Kwon</span>, <span class="hlFld-ContribAuthor ">Dahye  Kang</span>, <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Rh
              I
              -Catalyzed Site-Selective Decarbonylative Alkenylation and Arylation of Quinolones under Chelation Assistance. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>2015 </em>
                                    (17)
                                     , 3671-3678. <a href="https://doi.org/10.1002/ejoc.201500187" title="DOI URL">https://doi.org/10.1002/ejoc.201500187</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201500187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201500187%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRh%252BI%252B-Catalyzed%252BSite-Selective%252BDecarbonylative%252BAlkenylation%252Band%252BArylation%252Bof%252BQuinolones%252Bunder%252BChelation%252BAssistance%26aulast%3DKwon%26aufirst%3DSoonhyung%26date%3D2015%26date%3D2015%26volume%3D2015%26issue%3D17%26spage%3D3671%26epage%3D3678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chin-Yu  Liu</span>, <span class="hlFld-ContribAuthor ">Yung-Yi  Cheng</span>, <span class="hlFld-ContribAuthor ">Ling-Chu  Chang</span>, <span class="hlFld-ContribAuthor ">Li-Jiau  Huang</span>, <span class="hlFld-ContribAuthor ">Li-Chen  Chou</span>, <span class="hlFld-ContribAuthor ">Chi-Hung  Huang</span>, <span class="hlFld-ContribAuthor ">Meng-Tung  Tsai</span>, <span class="hlFld-ContribAuthor ">Chih-Chang  Liao</span>, <span class="hlFld-ContribAuthor ">Mei-Hua  Hsu</span>, <span class="hlFld-ContribAuthor ">Hui-Yi  Lin</span>, <span class="hlFld-ContribAuthor ">Tian-Shung  Wu</span>, <span class="hlFld-ContribAuthor ">Yen-Fang  Wen</span>, <span class="hlFld-ContribAuthor ">Yu  Zhao</span>, <span class="hlFld-ContribAuthor ">Sheng-Chu  Kuo</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of new 2-arylnaphthyridin-4-ones as potent antitumor agents targeting tumorigenic cell lines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>90 </em>, 775-787. <a href="https://doi.org/10.1016/j.ejmech.2014.11.062" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.11.062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.11.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.11.062%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnew%252B2-arylnaphthyridin-4-ones%252Bas%252Bpotent%252Bantitumor%252Bagents%252Btargeting%252Btumorigenic%252Bcell%252Blines%26aulast%3DLiu%26aufirst%3DChin-Yu%26date%3D2015%26volume%3D90%26spage%3D775%26epage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jaideep B.  Bharate</span>, <span class="hlFld-ContribAuthor ">Ram A.  Vishwakarma</span>, <span class="hlFld-ContribAuthor ">Sandip B.  Bharate</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-free domino one-pot protocols for quinoline synthesis. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (52)
                                     , 42020-42053. <a href="https://doi.org/10.1039/C5RA07798B" title="DOI URL">https://doi.org/10.1039/C5RA07798B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA07798B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA07798B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DMetal-free%252Bdomino%252Bone-pot%252Bprotocols%252Bfor%252Bquinoline%252Bsynthesis%26aulast%3DBharate%26aufirst%3DJaideep%2BB.%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D52%26spage%3D42020%26epage%3D42053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pablo  Ríos</span>, <span class="hlFld-ContribAuthor ">Caroline E.  Nunes-Xavier</span>, <span class="hlFld-ContribAuthor ">Lydia  Tabernero</span>, <span class="hlFld-ContribAuthor ">Maja  Köhn</span>, <span class="hlFld-ContribAuthor ">Rafael  Pulido</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-Specificity Phosphatases as Molecular Targets for Inhibition in Human Disease. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants & Redox Signaling</span><span> <strong>2014,</strong> <em>20 </em>
                                    (14)
                                     , 2251-2273. <a href="https://doi.org/10.1089/ars.2013.5709" title="DOI URL">https://doi.org/10.1089/ars.2013.5709</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/ars.2013.5709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fars.2013.5709%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%2520%2526%2520Redox%2520Signaling%26atitle%3DDual-Specificity%252BPhosphatases%252Bas%252BMolecular%252BTargets%252Bfor%252BInhibition%252Bin%252BHuman%252BDisease%26aulast%3DR%25C3%25ADos%26aufirst%3DPablo%26date%3D2014%26volume%3D20%26issue%3D14%26spage%3D2251%26epage%3D2273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth R  Sharlow</span>, <span class="hlFld-ContribAuthor ">Peter  Wipf</span>, <span class="hlFld-ContribAuthor ">Kelley E  McQueeney</span>, <span class="hlFld-ContribAuthor ">Ahmet  Bakan</span>, <span class="hlFld-ContribAuthor ">John S  Lazo</span>. </span><span class="cited-content_cbyCitation_article-title">Investigational inhibitors of PTP4A3 phosphatase as antineoplastic agents. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2014,</strong> <em>23 </em>
                                    (5)
                                     , 661-673. <a href="https://doi.org/10.1517/13543784.2014.892579" title="DOI URL">https://doi.org/10.1517/13543784.2014.892579</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2014.892579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2014.892579%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DInvestigational%252Binhibitors%252Bof%252BPTP4A3%252Bphosphatase%252Bas%252Bantineoplastic%252Bagents%26aulast%3DSharlow%26aufirst%3DElizabeth%2BR%26date%3D2014%26date%3D2014%26volume%3D23%26issue%3D5%26spage%3D661%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew J.  Wiemer</span>, <span class="hlFld-ContribAuthor ">David F.  Wiemer</span>. </span><span class="cited-content_cbyCitation_article-title">Prodrugs of Phosphonates and Phosphates: Crossing the Membrane Barrier. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 115-160. <a href="https://doi.org/10.1007/128_2014_561" title="DOI URL">https://doi.org/10.1007/128_2014_561</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/128_2014_561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F128_2014_561%26sid%3Dliteratum%253Aachs%26atitle%3DProdrugs%252Bof%252BPhosphonates%252Band%252BPhosphates%25253A%252BCrossing%252Bthe%252BMembrane%252BBarrier%26aulast%3DWiemer%26aufirst%3DAndrew%2BJ.%26date%3D2014%26date%3D2014%26spage%3D115%26epage%3D160%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DPhosphorus%252BChemistry%252BI%26aulast%3DMontchamp%26aufirst%3DJean-Luc%26date%3D2015%26volume%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P.R.  Hanson</span>, <span class="hlFld-ContribAuthor ">N.  Asad</span>, <span class="hlFld-ContribAuthor ">Q.  Zang</span>, <span class="hlFld-ContribAuthor ">S.  Jayashinghe</span>, <span class="hlFld-ContribAuthor ">J.  Markley</span>. </span><span class="cited-content_cbyCitation_article-title">6.12 Inorganic Acid Derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 479-554. <a href="https://doi.org/10.1016/B978-0-08-097742-3.00618-2" title="DOI URL">https://doi.org/10.1016/B978-0-08-097742-3.00618-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-097742-3.00618-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-097742-3.00618-2%26sid%3Dliteratum%253Aachs%26atitle%3D6.12%252BInorganic%252BAcid%252BDerivatives%26aulast%3DHanson%26aufirst%3DP.R.%26date%3D2014%26spage%3D479%26epage%3D554%26pub%3DElsevier%26atitle%3DComprehensive%252BOrganic%252BSynthesis%252BII%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li Jun  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian Ling  Yu</span>, <span class="hlFld-ContribAuthor ">Wei Li  Wang</span>, <span class="hlFld-ContribAuthor ">Heng  Li</span>, <span class="hlFld-ContribAuthor ">Dan Dan  Xu</span>, <span class="hlFld-ContribAuthor ">Ya Dong  Bi</span>, <span class="hlFld-ContribAuthor ">Fu De  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Metal modified SSA as a heterogeneous catalyst to promote the cyclocondesation of o-aminobenzonitriles with cycloketones in water. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2014,</strong> <em>55 </em>
                                    (3)
                                     , 710-712. <a href="https://doi.org/10.1016/j.tetlet.2013.12.001" title="DOI URL">https://doi.org/10.1016/j.tetlet.2013.12.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2013.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2013.12.001%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DMetal%252Bmodified%252BSSA%252Bas%252Ba%252Bheterogeneous%252Bcatalyst%252Bto%252Bpromote%252Bthe%252Bcyclocondesation%252Bof%252Bo-aminobenzonitriles%252Bwith%252Bcycloketones%252Bin%252Bwater%26aulast%3DZhang%26aufirst%3DLi%2BJun%26date%3D2014%26volume%3D55%26issue%3D3%26spage%3D710%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yung-Yi  Cheng</span>, <span class="hlFld-ContribAuthor ">Chin-Yu  Liu</span>, <span class="hlFld-ContribAuthor ">Meng-Tung  Tsai</span>, <span class="hlFld-ContribAuthor ">Hui-Yi  Lin</span>, <span class="hlFld-ContribAuthor ">Jai-Sing  Yang</span>, <span class="hlFld-ContribAuthor ">Tian-Shung  Wu</span>, <span class="hlFld-ContribAuthor ">Sheng-Chu  Kuo</span>, <span class="hlFld-ContribAuthor ">Li-Jiau  Huang</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and mechanism of action of 2-(3-hydroxy-5-methoxyphenyl)-6-pyrrolidinylquinolin-4-one as a potent anticancer lead. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (18)
                                     , 5223-5227. <a href="https://doi.org/10.1016/j.bmcl.2013.06.083" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.06.083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.06.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.06.083%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bmechanism%252Bof%252Baction%252Bof%252B2-%2525283-hydroxy-5-methoxyphenyl%252529-6-pyrrolidinylquinolin-4-one%252Bas%252Ba%252Bpotent%252Banticancer%252Blead%26aulast%3DCheng%26aufirst%3DYung-Yi%26date%3D2013%26volume%3D23%26issue%3D18%26spage%3D5223%26epage%3D5227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yung-Yi  Cheng</span>, <span class="hlFld-ContribAuthor ">Chin-Yu  Liu</span>, <span class="hlFld-ContribAuthor ">Li-Jiau  Huang</span>, <span class="hlFld-ContribAuthor ">Chi-Hung  Huang</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>, <span class="hlFld-ContribAuthor ">Cheng-Tung  Lin</span>, <span class="hlFld-ContribAuthor ">Sheng-Chu  Kuo</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic Studies on Regioselective Dephosphorylation of Phosphate Prodrugs during a Facile Synthesis of Antitumor Phosphorylated 2-Phenyl-6,7-methylenedioxy-1H-quinolin-4-one. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2013,</strong> <em>18 </em>
                                    (7)
                                     , 8028-8045. <a href="https://doi.org/10.3390/molecules18078028" title="DOI URL">https://doi.org/10.3390/molecules18078028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules18078028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules18078028%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMechanistic%252BStudies%252Bon%252BRegioselective%252BDephosphorylation%252Bof%252BPhosphate%252BProdrugs%252Bduring%252Ba%252BFacile%252BSynthesis%252Bof%252BAntitumor%252BPhosphorylated%252B2-Phenyl-6%25252C7-methylenedioxy-1H-quinolin-4-one%26aulast%3DCheng%26aufirst%3DYung-Yi%26date%3D2013%26date%3D2013%26volume%3D18%26issue%3D7%26spage%3D8028%26epage%3D8045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">YUNG-YI  CHENG</span>, <span class="hlFld-ContribAuthor ">JAI-SING  YANG</span>, <span class="hlFld-ContribAuthor ">SHIH-CHANG  TSAI</span>, <span class="hlFld-ContribAuthor ">CHIH-CHUANG  LIAW</span>, <span class="hlFld-ContribAuthor ">JING-GUNG  CHUNG</span>, <span class="hlFld-ContribAuthor ">LI-JIAU  HUANG</span>, <span class="hlFld-ContribAuthor ">KUO-HSIUNG  LEE</span>, <span class="hlFld-ContribAuthor ">CHI-CHENG  LU</span>, <span class="hlFld-ContribAuthor ">HSI-CHENG  CHIEN</span>, <span class="hlFld-ContribAuthor ">MINORU  TSUZUKI</span>, <span class="hlFld-ContribAuthor ">SHENG-CHU  KUO</span>. </span><span class="cited-content_cbyCitation_article-title">The newly synthesized 2-(3-hydroxy-5-methoxyphenyl)-6,7-methylenedioxyquinolin-4-one triggers cell apoptosis through induction of oxidative stress and upregulation of the p38 MAPK signaling pathway in HL-60 human leukemia cells. </span><span class="cited-content_cbyCitation_journal-name">Oncology Reports</span><span> <strong>2012,</strong> <em>28 </em>
                                    (4)
                                     , 1482-1490. <a href="https://doi.org/10.3892/or.2012.1923" title="DOI URL">https://doi.org/10.3892/or.2012.1923</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/or.2012.1923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2For.2012.1923%26sid%3Dliteratum%253Aachs%26jtitle%3DOncology%2520Reports%26atitle%3DThe%252Bnewly%252Bsynthesized%252B2-%2525283-hydroxy-5-methoxyphenyl%252529-6%25252C7-methylenedioxyquinolin-4-one%252Btriggers%252Bcell%252Bapoptosis%252Bthrough%252Binduction%252Bof%252Boxidative%252Bstress%252Band%252Bupregulation%252Bof%252Bthe%252Bp38%252BMAPK%252Bsignaling%252Bpathway%252Bin%252BHL-60%252Bhuman%252Bleukemia%252Bcells%26aulast%3DCHENG%26aufirst%3DYUNG-YI%26date%3D2012%26date%3D2012%26volume%3D28%26issue%3D4%26spage%3D1482%26epage%3D1490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chien-Ting  Chen</span>, <span class="hlFld-ContribAuthor ">Mei-Hua  Hsu</span>, <span class="hlFld-ContribAuthor ">Yung-Yi  Cheng</span>, <span class="hlFld-ContribAuthor ">Chin-Yu  Liu</span>, <span class="hlFld-ContribAuthor ">Li-Chen  Chou</span>, <span class="hlFld-ContribAuthor ">Li-Jiau  Huang</span>, <span class="hlFld-ContribAuthor ">Tian-Shung  Wu</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Yang</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>, <span class="hlFld-ContribAuthor ">Sheng-Chu  Kuo</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and in vitro anticancer activity of 6,7-methylenedioxy (or 5-hydroxy-6-methoxy)-2-(substituted selenophenyl)quinolin-4-one analogs. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>46 </em>
                                    (12)
                                     , 6046-6056. <a href="https://doi.org/10.1016/j.ejmech.2011.10.017" title="DOI URL">https://doi.org/10.1016/j.ejmech.2011.10.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2011.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2011.10.017%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bin%2525C2%2525A0vitro%252Banticancer%252Bactivity%252Bof%252B6%25252C7-methylenedioxy%252B%252528or%252B5-hydroxy-6-methoxy%252529-2-%252528substituted%252Bselenophenyl%252529quinolin-4-one%252Banalogs%26aulast%3DChen%26aufirst%3DChien-Ting%26date%3D2011%26volume%3D46%26issue%3D12%26spage%3D6046%26epage%3D6056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jang-Chang  Lee</span>, <span class="hlFld-ContribAuthor ">Li-Chen  Chou</span>, <span class="hlFld-ContribAuthor ">Chi-Hung  Huang</span>, <span class="hlFld-ContribAuthor ">Jing-Gung  Chung</span>, <span class="hlFld-ContribAuthor ">Li-Jiau  Huang</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>, <span class="hlFld-ContribAuthor ">Mien-Chie  Hung</span>, <span class="hlFld-ContribAuthor ">Tzong-Der  Way</span>, <span class="hlFld-ContribAuthor ">Sheng-Chu  Kuo</span>. </span><span class="cited-content_cbyCitation_article-title">CHM-1 induces apoptosis via p38-mediated upregulation of DR5 expression in human ovarian cancer SKOV3 cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2011,</strong> <em>670 </em>
                                    (1)
                                     , 96-104. <a href="https://doi.org/10.1016/j.ejphar.2011.08.006" title="DOI URL">https://doi.org/10.1016/j.ejphar.2011.08.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2011.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2011.08.006%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DCHM-1%252Binduces%252Bapoptosis%252Bvia%252Bp38-mediated%252Bupregulation%252Bof%252BDR5%252Bexpression%252Bin%252Bhuman%252Bovarian%252Bcancer%252BSKOV3%252Bcells%26aulast%3DLee%26aufirst%3DJang-Chang%26date%3D2011%26volume%3D670%26issue%3D1%26spage%3D96%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheng-Ting  Chou</span>, <span class="hlFld-ContribAuthor ">Gorakh S.  Yellol</span>, <span class="hlFld-ContribAuthor ">Wong-Jin  Chang</span>, <span class="hlFld-ContribAuthor ">Mei-Lian  Sun</span>, <span class="hlFld-ContribAuthor ">Chung-Ming  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave assisted straightforward synthetic method for benzimidazole linked quinoxalinones on soluble polymer support. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2011,</strong> <em>67 </em>
                                    (11)
                                     , 2110-2117. <a href="https://doi.org/10.1016/j.tet.2011.01.040" title="DOI URL">https://doi.org/10.1016/j.tet.2011.01.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2011.01.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2011.01.040%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DMicrowave%252Bassisted%252Bstraightforward%252Bsynthetic%252Bmethod%252Bfor%252Bbenzimidazole%252Blinked%252Bquinoxalinones%252Bon%252Bsoluble%252Bpolymer%252Bsupport%26aulast%3DChou%26aufirst%3DCheng-Ting%26date%3D2011%26volume%3D67%26issue%3D11%26spage%3D2110%26epage%3D2117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wentao  Gao</span>, <span class="hlFld-ContribAuthor ">Jia  Liu</span>, <span class="hlFld-ContribAuthor ">Yun  Jiang</span>, <span class="hlFld-ContribAuthor ">Yang  Li</span>. </span><span class="cited-content_cbyCitation_article-title">First synthesis of 2-(benzofuran-2-yl)-6,7-methylene dioxyquinoline-3-carboxylic acid derivatives. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2011,</strong> <em>7 </em>, 210-217. <a href="https://doi.org/10.3762/bjoc.7.28" title="DOI URL">https://doi.org/10.3762/bjoc.7.28</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.7.28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.7.28%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DFirst%252Bsynthesis%252Bof%252B2-%252528benzofuran-2-yl%252529-6%25252C7-methylene%252Bdioxyquinoline-3-carboxylic%252Bacid%252Bderivatives%26aulast%3DGao%26aufirst%3DWentao%26date%3D2011%26date%3D2011%26volume%3D7%26spage%3D210%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/medium/jm-2009-01292j_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901292j&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/medium/jm-2009-01292j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Structures of substituted 2-phenylquinolin-4-ones (2-PQs). (B) Synthesis of sodium 2-(2-fluorophenyl)-6,7-methylenedioxy-quinolin-4-yl hydrogen phosphate (<b>4</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901292j&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/medium/jm-2009-01292j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Differential activity patterns for <b>1</b> against 39 human cancer cell lines. MG-MID: mean of log <i>X</i> values (<i>X</i> = GI<sub>50</sub>, TGI, and LC<sub>50</sub>). Delta: logarithm of the difference between the MG-MID and the log <i>X</i> of the most sensitive cell line. Range: logarithm of the difference between the log <i>X</i> of the most resistant cell line and the log <i>X</i> of the most sensitive cell line. H: High concentration (10<sup>−4</sup> M) (highest concentration of <b>1</b> used during testing); L: Low concentration (10<sup>−8</sup> M) (lowest concentration of <b>1</b> used during testing). H:1 indicates that the number of cell lines tested at the highest concentration is 1. L:0 indicates that the number of cell lines tested at the lowest concentration is 0.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901292j&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/medium/jm-2009-01292j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Mean plasma concentration−time profiles of <b>1</b> and <b>4</b> in male CD-1 (<i>Crl.</i>) mice following a single iv dose of <b>4</b> at 10 mg/kg. (B) Mean plasma concentration−time profiles of <b>1</b> in male CD-1(<i>Crl.</i>) mice following a single iv dose of <b>4</b> and single ip dose of <b>1</b> at 10 mg/kg. (C) Mean plasma concentration−time profile of <b>1</b> and <b>3</b> in male CD-1 (<i>Crl.</i>) mice following a single po dose of <b>4</b> at 10 mg/kg. (D) Mean plasma concentration−time profiles of <b>1</b> in male CD-1 (<i>Crl.</i>) mice following a single po dose of <b>4</b> at 10 mg/kg and single ip dose of <b>1</b> at 10 mg/kg.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901292j&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/medium/jm-2009-01292j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Mean tumor volume−time profiles in SKOV-3 xenograft nude mice (<i>n</i> = 11) following iv dosing of <b>4</b> at 5, 10, and 20 mg/kg five days per week for four consecutive weeks. (B) Mean tumor volume−time profiles in SKOV-3 xenograft nude mice (<i>n</i> = 11) following po dosing of <b>4</b> at 5, 10, and 20 mg/kg five days per week for four consecutive weeks. (C) Mean body weight−time profiles in SKOV-3 xenograft nude mice (<i>n</i> = 11) following iv dosing of <b>4</b> at 5, 10, and 20 mg/kg five days per week for four consecutive weeks. (D) Mean body weight−time profiles in SKOV-3 xenograft nude mice (<i>n</i> = 11) following po dosing of <b>4</b> at 5, 10, and 20 mg/kg five days per week for four consecutive weeks.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901292j&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/medium/jm-2009-01292j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of <b>1</b> on cell growth and cell cycle progression in human ovarian cancer cells. (A) SKOV-3 cells were incubated in the absence or presence of the 10 μM of <b>1</b>, colchicine, doxorubicin, and taxol for 24 h. (B) The time effect of <b>1</b> on cell cycle distribution, cells were treated with 10 μM of <b>1</b> for 6, 12, 24, 36, and 48 h and analyzed for propidium iodide-stained DNA content by flow cytometry. (C) SKOV-3 cells were treated with vehicle (DMSO), <b>1</b> (10 μM) for the indicated time. (D) SKOV-3 cells were treated with the indicated dose <b>1</b> for 24 h. Cells were then harvested and lysed for the detection of cyclin B1, securin, and β-actin protein expression. Western blot data presented are representative of those obtained in at least three separate experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901292j&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/medium/jm-2009-01292j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. BubR1 upregulation was associated with <b>1</b>-induced G2/M cell cycle arrest in human ovarian cancer cells. (A) SKOV-3 cells were treated with vehicle (DMSO), <b>1</b> (10 μM) for the indicated time. (B) SKOV-3 cells were treated with the indicated dose <b>1</b> for 24 h. Whole-cell lysates were resolved by SDS-PAGE and probed with anti-BubR1 mouse mAb. Results are representative of three separate experiments. Blots were probed with anti-β-actin mAb as a loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901292j/production/images/large/jm-2009-01292j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901292j&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i40">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78613" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78613" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 46 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juang, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lednicer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paull, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span> </span><span class="NLM_article-title">Synthesis and cytotoxicity of 1,6,7,8-substituted-2-(4′-substituted phenyl)-4-quinolones and related compounds: identification as antimitotic agents interacting with tubulin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1146</span><span class="NLM_x">–</span> <span class="NLM_lpage">1156</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00061a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=1146-1156&issue=9&author=S.+C.+Kuoauthor=H.+Z.+Leeauthor=J.+P.+Juangauthor=Y.+T.+Linauthor=T.+S.+Wuauthor=J.+J.+Changauthor=D.+Lednicerauthor=K.+D.+Paullauthor=C.+M.+Lin&title=Synthesis+and+cytotoxicity+of+1%2C6%2C7%2C8-substituted-2-%284%E2%80%B2-substituted+phenyl%29-4-quinolones+and+related+compounds%3A+identification+as+antimitotic+agents+interacting+with+tubulin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm00061a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00061a005%26sid%3Dliteratum%253Aachs%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DLee%26aufirst%3DH.%2BZ.%26aulast%3DJuang%26aufirst%3DJ.%2BP.%26aulast%3DLin%26aufirst%3DY.%2BT.%26aulast%3DWu%26aufirst%3DT.%2BS.%26aulast%3DChang%26aufirst%3DJ.%2BJ.%26aulast%3DLednicer%26aufirst%3DD.%26aulast%3DPaull%26aufirst%3DK.%2BD.%26aulast%3DLin%26aufirst%3DC.%2BM.%26atitle%3DSynthesis%2520and%2520cytotoxicity%2520of%25201%252C6%252C7%252C8-substituted-2-%25284%25E2%2580%25B2-substituted%2520phenyl%2529-4-quinolones%2520and%2520related%2520compounds%253A%2520identification%2520as%2520antimitotic%2520agents%2520interacting%2520with%2520tubulin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26issue%3D9%26spage%3D1146%26epage%3D1156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lednicer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents. 150. 2′,3′,4′,5′,5,6,7-Substituted 2-phenyl-4-quinolones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1126</span><span class="NLM_x">–</span> <span class="NLM_lpage">1135</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00034a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1126-1135&issue=8&author=L.+Liauthor=H.+K.+Wangauthor=S.+C.+Kuoauthor=T.+S.+Wuauthor=D.+Lednicerauthor=C.+M.+Linauthor=E.+Hamelauthor=K.+H.+Lee&title=Antitumor+agents.+150.+2%E2%80%B2%2C3%E2%80%B2%2C4%E2%80%B2%2C5%E2%80%B2%2C5%2C6%2C7-Substituted+2-phenyl-4-quinolones+and+related+compounds%3A+their+synthesis%2C+cytotoxicity%2C+and+inhibition+of+tubulin+polymerization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm00034a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00034a010%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%2BK.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DWu%26aufirst%3DT.%2BS.%26aulast%3DLednicer%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents.%2520150.%25202%25E2%2580%25B2%252C3%25E2%2580%25B2%252C4%25E2%2580%25B2%252C5%25E2%2580%25B2%252C5%252C6%252C7-Substituted%25202-phenyl-4-quinolones%2520and%2520related%2520compounds%253A%2520their%2520synthesis%252C%2520cytotoxicity%252C%2520and%2520inhibition%2520of%2520tubulin%2520polymerization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26issue%3D8%26spage%3D1126%26epage%3D1135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents. 155. Synthesis and biological evaluation of 3′,6,7-substituted 2-phenyl-4-quinolones as antimicrotubule agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">3400</span><span class="NLM_x">–</span> <span class="NLM_lpage">3407</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00046a025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=3400-3407&issue=20&author=L.+Liauthor=H.+K.+Wangauthor=S.+C.+Kuoauthor=T.+S.+Wuauthor=A.+Maugerauthor=C.+M.+Linauthor=E.+Hamelauthor=K.+H.+Lee&title=Antitumor+agents.+155.+Synthesis+and+biological+evaluation+of+3%E2%80%B2%2C6%2C7-substituted+2-phenyl-4-quinolones+as+antimicrotubule+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm00046a025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00046a025%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%2BK.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DWu%26aufirst%3DT.%2BS.%26aulast%3DMauger%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents.%2520155.%2520Synthesis%2520and%2520biological%2520evaluation%2520of%25203%25E2%2580%25B2%252C6%252C7-substituted%25202-phenyl-4-quinolones%2520as%2520antimicrotubule%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26issue%3D20%26spage%3D3400%26epage%3D3407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents. 174. 2′,3′,4′,5,6,7-Substituted 2-phenyl-1,8-naphthyridin-4-ones: their synthesis, cytotoxicity, and inhibition of tubulin polymerization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">2266</span><span class="NLM_x">–</span> <span class="NLM_lpage">2275</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm960858s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=2266-2275&issue=14&author=K.+Chenauthor=S.+C.+Kuoauthor=M.+C.+Hsiehauthor=A.+Maugerauthor=C.+M.+Linauthor=E.+Hamelauthor=K.+H.+Lee&title=Antitumor+agents.+174.+2%E2%80%B2%2C3%E2%80%B2%2C4%E2%80%B2%2C5%2C6%2C7-Substituted+2-phenyl-1%2C8-naphthyridin-4-ones%3A+their+synthesis%2C+cytotoxicity%2C+and+inhibition+of+tubulin+polymerization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm960858s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960858s%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DHsieh%26aufirst%3DM.%2BC.%26aulast%3DMauger%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents.%2520174.%25202%25E2%2580%25B2%252C3%25E2%2580%25B2%252C4%25E2%2580%25B2%252C5%252C6%252C7-Substituted%25202-phenyl-1%252C8-naphthyridin-4-ones%253A%2520their%2520synthesis%252C%2520cytotoxicity%252C%2520and%2520inhibition%2520of%2520tubulin%2520polymerization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26issue%3D14%26spage%3D2266%26epage%3D2275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents. 178. Synthesis and biological evaluation of substituted 2-aryl-1,8-naphthyridin-4(1<i>H</i>)-ones as antitumor agents that inhibit tubulin polymerization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">3049</span><span class="NLM_x">–</span> <span class="NLM_lpage">3056</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970146h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=3049-3056&issue=19&author=K.+Chenauthor=S.+C.+Kuoauthor=M.+C.+Hsiehauthor=A.+Maugerauthor=C.+M.+Linauthor=E.+Hamelauthor=K.+H.+Lee&title=Antitumor+agents.+178.+Synthesis+and+biological+evaluation+of+substituted+2-aryl-1%2C8-naphthyridin-4%281H%29-ones+as+antitumor+agents+that+inhibit+tubulin+polymerization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm970146h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970146h%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DHsieh%26aufirst%3DM.%2BC.%26aulast%3DMauger%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents.%2520178.%2520Synthesis%2520and%2520biological%2520evaluation%2520of%2520substituted%25202-aryl-1%252C8-naphthyridin-4%25281H%2529-ones%2520as%2520antitumor%2520agents%2520that%2520inhibit%2520tubulin%2520polymerization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26issue%3D19%26spage%3D3049%26epage%3D3056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tachibana, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents. 181. Synthesis and biological evaluation of 6,7,2′,3′,4′-substituted-1,2,3,4-tetrahydro-2-phenyl-4-quinolones as a new class of antimitotic antitumor agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1155</span><span class="NLM_x">–</span> <span class="NLM_lpage">1162</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9707479" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1155-1162&issue=7&author=Y.+Xiaauthor=Z.+Y.+Yangauthor=P.+Xiaauthor=K.+F.+Bastowauthor=Y.+Tachibanaauthor=S.+C.+Kuoauthor=E.+Hamelauthor=T.+Hacklauthor=K.+H.+Lee&title=Antitumor+agents.+181.+Synthesis+and+biological+evaluation+of+6%2C7%2C2%E2%80%B2%2C3%E2%80%B2%2C4%E2%80%B2-substituted-1%2C2%2C3%2C4-tetrahydro-2-phenyl-4-quinolones+as+a+new+class+of+antimitotic+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm9707479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9707479%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DZ.%2BY.%26aulast%3DXia%26aufirst%3DP.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DTachibana%26aufirst%3DY.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DHackl%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents.%2520181.%2520Synthesis%2520and%2520biological%2520evaluation%2520of%25206%252C7%252C2%25E2%2580%25B2%252C3%25E2%2580%25B2%252C4%25E2%2580%25B2-substituted-1%252C2%252C3%252C4-tetrahydro-2-phenyl-4-quinolones%2520as%2520a%2520new%2520class%2520of%2520antimitotic%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26issue%3D7%26spage%3D1155%26epage%3D1162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Zhang, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tachibana, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents. 196. Substituted 2-thienyl-1,8-naphthyridin-4-ones: their synthesis, cytotoxicity, and inhibition of tubulin polymerization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">4081</span><span class="NLM_x">–</span> <span class="NLM_lpage">4087</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990208z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=4081-4087&issue=20&author=S.+X.+Zhangauthor=K.+F.+Bastowauthor=Y.+Tachibanaauthor=S.+C.+Kuoauthor=E.+Hamelauthor=A.+Maugerauthor=V.+L.+Narayananauthor=K.+H.+Lee&title=Antitumor+agents.+196.+Substituted+2-thienyl-1%2C8-naphthyridin-4-ones%3A+their+synthesis%2C+cytotoxicity%2C+and+inhibition+of+tubulin+polymerization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm990208z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990208z%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%2BX.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DTachibana%26aufirst%3DY.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DMauger%26aufirst%3DA.%26aulast%3DNarayanan%26aufirst%3DV.%2BL.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents.%2520196.%2520Substituted%25202-thienyl-1%252C8-naphthyridin-4-ones%253A%2520their%2520synthesis%252C%2520cytotoxicity%252C%2520and%2520inhibition%2520of%2520tubulin%2520polymerization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26issue%3D20%26spage%3D4081%26epage%3D4087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Zhang, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brossi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tropsha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents. 199. Three-dimensional quantitative structure−activity relationship study of the colchicines binding site ligands using comparative molecular field analysis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990333a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=167-176&issue=2&author=S.+X.+Zhangauthor=J.+Fengauthor=S.+C.+Kuoauthor=A.+Brossiauthor=E.+Hamelauthor=A.+Tropshaauthor=K.+H.+Lee&title=Antitumor+agents.+199.+Three-dimensional+quantitative+structure%E2%88%92activity+relationship+study+of+the+colchicines+binding+site+ligands+using+comparative+molecular+field+analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm990333a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990333a%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%2BX.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DBrossi%26aufirst%3DA.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DTropsha%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents.%2520199.%2520Three-dimensional%2520quantitative%2520structure%25E2%2588%2592activity%2520relationship%2520study%2520of%2520the%2520colchicines%2520binding%2520site%2520ligands%2520using%2520comparative%2520molecular%2520field%2520analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26issue%3D2%26spage%3D167%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Hour, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">6-Alkylamino- and 2,3-dihydro-3′-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicty, and inhibition of tubulin polymerization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">4479</span><span class="NLM_x">–</span> <span class="NLM_lpage">4487</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000151c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4479-4487&issue=23&author=M.+J.+Hourauthor=L.+J.+Huangauthor=S.+C.+Kuoauthor=Y.+Xiaauthor=K.+Bastowauthor=Y.+Nakanishiauthor=E.+Hamelauthor=K.+H.+Lee&title=6-Alkylamino-+and+2%2C3-dihydro-3%E2%80%B2-methoxy-2-phenyl-4-quinazolinones+and+related+compounds%3A+their+synthesis%2C+cytotoxicty%2C+and+inhibition+of+tubulin+polymerization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm000151c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000151c%26sid%3Dliteratum%253Aachs%26aulast%3DHour%26aufirst%3DM.%2BJ.%26aulast%3DHuang%26aufirst%3DL.%2BJ.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DBastow%26aufirst%3DK.%26aulast%3DNakanishi%26aufirst%3DY.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3D6-Alkylamino-%2520and%25202%252C3-dihydro-3%25E2%2580%25B2-methoxy-2-phenyl-4-quinazolinones%2520and%2520related%2520compounds%253A%2520their%2520synthesis%252C%2520cytotoxicty%252C%2520and%2520inhibition%2520of%2520tubulin%2520polymerization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26issue%3D23%26spage%3D4479%26epage%3D4487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents. 211. Fluorinated 2-phenyl-4-quinolone derivatives as antimitotic antitumor agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">3932</span><span class="NLM_x">–</span> <span class="NLM_lpage">3936</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0101085" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3932-3936&issue=23&author=Y.+Xiaauthor=Z.+Y.+Yangauthor=P.+Xiaauthor=T.+Hacklauthor=E.+Hamelauthor=A.+Maugerauthor=J.+H.+Wuauthor=K.+H.+Lee&title=Antitumor+agents.+211.+Fluorinated+2-phenyl-4-quinolone+derivatives+as+antimitotic+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm0101085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0101085%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DZ.%2BY.%26aulast%3DXia%26aufirst%3DP.%26aulast%3DHackl%26aufirst%3DT.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DMauger%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents.%2520211.%2520Fluorinated%25202-phenyl-4-quinolone%2520derivatives%2520as%2520antimitotic%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26issue%3D23%26spage%3D3932%26epage%3D3936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Xia, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hour, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nampoothiri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents. Part 204: Synthesis and biological evaluation of substituted 2-aryl quinazolinones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1193</span><span class="NLM_x">–</span> <span class="NLM_lpage">1196</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=1193-1196&issue=9&author=T.+Xiaauthor=Z.+Y.+Yangauthor=M.+J.+Hourauthor=S.+C.+Kuoauthor=P.+Xiaauthor=K.+F.+Bastowauthor=Y.+Nakanishiauthor=P.+Nampoothiriauthor=T.+Hacklauthor=E.+Hamelauthor=K.+H.+Lee&title=Antitumor+agents.+Part+204%3A+Synthesis+and+biological+evaluation+of+substituted+2-aryl+quinazolinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DZ.%2BY.%26aulast%3DHour%26aufirst%3DM.%2BJ.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DXia%26aufirst%3DP.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DNakanishi%26aufirst%3DY.%26aulast%3DNampoothiri%26aufirst%3DP.%26aulast%3DHackl%26aufirst%3DT.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents.%2520Part%2520204%253A%2520Synthesis%2520and%2520biological%2520evaluation%2520of%2520substituted%25202-aryl%2520quinazolinones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26issue%3D9%26spage%3D1193%26epage%3D1196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Xia, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nampoothiri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brossi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents. Part 226: Synthesis and cytotoxicity of 2-phenyl-4-quinolone acetic acids and their esters</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">2891</span><span class="NLM_x">–</span> <span class="NLM_lpage">2893</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2891-2893&issue=17&author=T.+Xiaauthor=Z.+Y.+Yangauthor=P.+Xiaauthor=K.+F.+Bastowauthor=Y.+Nakanishiauthor=P.+Nampoothiriauthor=E.+Hamelauthor=A.+Brossiauthor=K.+H.+Lee&title=Antitumor+agents.+Part+226%3A+Synthesis+and+cytotoxicity+of+2-phenyl-4-quinolone+acetic+acids+and+their+esters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DZ.%2BY.%26aulast%3DXia%26aufirst%3DP.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DNakanishi%26aufirst%3DY.%26aulast%3DNampoothiri%26aufirst%3DP.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DBrossi%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents.%2520Part%2520226%253A%2520Synthesis%2520and%2520cytotoxicity%2520of%25202-phenyl-4-quinolone%2520acetic%2520acids%2520and%2520their%2520esters%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26issue%3D17%26spage%3D2891%26epage%3D2893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Lai, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span> </span><span class="NLM_article-title">Synthesis and biological relationships of 3′,6-substituted 2-phenyl-4-quinolone-3-carboxylic acid derivatives as antimitotic agents</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=265-275&issue=1&author=Y.+Y.+Laiauthor=L.+J.+Huangauthor=K.+H.+Leeauthor=Z.+Y.+Xiaoauthor=K.+F.+Bastowauthor=T.+Yamoriauthor=S.+C.+Kuo&title=Synthesis+and+biological+relationships+of+3%E2%80%B2%2C6-substituted+2-phenyl-4-quinolone-3-carboxylic+acid+derivatives+as+antimitotic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DY.%2BY.%26aulast%3DHuang%26aufirst%3DL.%2BJ.%26aulast%3DLee%26aufirst%3DK.%2BH.%26aulast%3DXiao%26aufirst%3DZ.%2BY.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DYamori%26aufirst%3DT.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26atitle%3DSynthesis%2520and%2520biological%2520relationships%2520of%25203%25E2%2580%25B2%252C6-substituted%25202-phenyl-4-quinolone-3-carboxylic%2520acid%2520derivatives%2520as%2520antimitotic%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26issue%3D1%26spage%3D265%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Nakamura, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozuka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokuda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuzaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris-Natschke, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Cancer preventive agents, Part 2: Synthesis and evaluation of 2-phenyl-4-quinolone and 9-oxo-9,10-dihydroacridine derivatives as novel antitumor promoters</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">4396</span><span class="NLM_x">–</span> <span class="NLM_lpage">4401</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=4396-4401&issue=14&author=S+Nakamuraauthor=M.+Kozukaauthor=K.+F.+Bastowauthor=H.+Tokudaauthor=H.+Nishinoauthor=M.+Suzukiauthor=J.+Tatsuzakiauthor=S.+L.+Morris-Natschkeauthor=S.+C.+Kuoauthor=K.+H.+Lee&title=Cancer+preventive+agents%2C+Part+2%3A+Synthesis+and+evaluation+of+2-phenyl-4-quinolone+and+9-oxo-9%2C10-dihydroacridine+derivatives+as+novel+antitumor+promoters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DS%26aulast%3DKozuka%26aufirst%3DM.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DTokuda%26aufirst%3DH.%26aulast%3DNishino%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DTatsuzaki%26aufirst%3DJ.%26aulast%3DMorris-Natschke%26aufirst%3DS.%2BL.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DCancer%2520preventive%2520agents%252C%2520Part%25202%253A%2520Synthesis%2520and%2520evaluation%2520of%25202-phenyl-4-quinolone%2520and%25209-oxo-9%252C10-dihydroacridine%2520derivatives%2520as%2520novel%2520antitumor%2520promoters%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26issue%3D14%26spage%3D4396%26epage%3D4401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Wang, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guh, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. Y</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teng, C. M.</span><span> </span><span class="NLM_article-title">CHM-1, a novel synthetic quinolone with potent and selective antimitotic antitumor activity against human hepatocellular carcinoma in vitro and in vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1158%2F1535-7163.MCT-07-2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=18281518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVShsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=350-360&issue=2&author=S.+W.+Wangauthor=S.+L.+Panauthor=Y.+C.+Huangauthor=J.+H.+Guhauthor=P.+C.+Chiangauthor=D.+Y+Huangauthor=S.+C.+Kuoauthor=K.+H.+Leeauthor=C.+M.+Teng&title=CHM-1%2C+a+novel+synthetic+quinolone+with+potent+and+selective+antimitotic+antitumor+activity+against+human+hepatocellular+carcinoma+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">CHM-1, a novel synthetic quinolone with potent and selective antimitotic antitumor activity against human hepatocellular carcinoma in vitro and in vivo</span></div><div class="casAuthors">Wang, Shih-Wei; Pan, Shiow-Lin; Huang, Yu-Chun; Guh, Jih-Hwa; Chiang, Po-Cheng; Huang, Der-Yi; Kuo, Sheng-Chu; Lee, Kuo-Hsiung; Teng, Che-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">350-360</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma is highly chemoresistant to currently available chemotherapeutic agents.  In this study, 2'-fluoro-6,7-methylenedioxy-2-phenyl-4-quinolone (CHM-1), a synthetic 6,7-substituted 2-phenyl-4-quinolone, was identified as a potent and selective antitumor agent in human hepatocellular carcinoma.  CHM-1 induced growth inhibition of HA22T, Hep3B, and HepG2 cells in a concn.-dependent manner but did not obviously impair the viability of normal cells at the IC50 for liver cancer cells.  CHM-1-induced apoptosis was also characterized by immunofluorescence microscopy.  CHM-1 interacted with tubulin at the colchicine-binding site, markedly inhibited tubulin polymn. both in vitro and in vivo, and disrupted microtubule organization.  CHM-1 caused cell cycle arrest at G2-M phase by activating Cdc2/cyclin B1 complex activity.  CHM-1-induced cell death, activation of Cdc2 kinase activity, and elevation of MPM2 phosphoepitopes were profoundly attenuated by roscovitine, a specific cyclin-dependent kinase inhibitor.  CHM-1 did not modulate the caspase cascade, and the pan-caspase-inhibitor z-VAD-fmk did not abolish CHM-1-induced cell death.  However, CHM-1 induced the translocation of apoptosis-inducing factor (AIF) from mitochondria to the nucleus.  Small interfering RNA targeting of AIF substantially attenuated CHM-1-induced AIF translocation.  Importantly, CHM-1 inhibited tumor growth and prolonged the lifespan in mice inoculated with HA22T cells.  In conclusion, we show that CHM-1 exhibits a novel antimitotic antitumor activity against human hepatocellular carcinoma both in vitro and in vivo via a caspase-independent pathway.  CHM-1 is a promising chemotherapeutic agent worthy of further development into a clin. trial candidate for treating cancer, esp. hepatocellular carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorf0i-Lu_cULVg90H21EOLACvtfcHk0lgCBIME_NZPfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVShsr4%253D&md5=e88f1b4fe2236a6ff0a83778b853c504</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-2000%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%2BW.%26aulast%3DPan%26aufirst%3DS.%2BL.%26aulast%3DHuang%26aufirst%3DY.%2BC.%26aulast%3DGuh%26aufirst%3DJ.%2BH.%26aulast%3DChiang%26aufirst%3DP.%2BC.%26aulast%3DHuang%26aufirst%3DD.%2BY%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DLee%26aufirst%3DK.%2BH.%26aulast%3DTeng%26aufirst%3DC.%2BM.%26atitle%3DCHM-1%252C%2520a%2520novel%2520synthetic%2520quinolone%2520with%2520potent%2520and%2520selective%2520antimitotic%2520antitumor%2520activity%2520against%2520human%2520hepatocellular%2520carcinoma%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26issue%3D2%26spage%3D350%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Heimbach, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savolainen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleisher, D.</span><span> </span><span class="NLM_article-title">Absorption rate limit considerations for oral phosphate prodrug</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">848</span><span class="NLM_x">–</span> <span class="NLM_lpage">856</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2003&pages=848-856&issue=6&author=T+Heimbachauthor=D.+M.+Ohauthor=L.+Y.+Liauthor=M.+Forsbergauthor=J.+Savolainenauthor=J.+Lepp%C3%A4nenauthor=Y.+Matsunagaauthor=G.+Flynnauthor=D.+Fleisher&title=Absorption+rate+limit+considerations+for+oral+phosphate+prodrug"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeimbach%26aufirst%3DT%26aulast%3DOh%26aufirst%3DD.%2BM.%26aulast%3DLi%26aufirst%3DL.%2BY.%26aulast%3DForsberg%26aufirst%3DM.%26aulast%3DSavolainen%26aufirst%3DJ.%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DMatsunaga%26aufirst%3DY.%26aulast%3DFlynn%26aufirst%3DG.%26aulast%3DFleisher%26aufirst%3DD.%26atitle%3DAbsorption%2520rate%2520limit%2520considerations%2520for%2520oral%2520phosphate%2520prodrug%26jtitle%3DPharm.%2520Res.%26date%3D2003%26volume%3D20%26issue%3D6%26spage%3D848%26epage%3D856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Jordan, M. A.</span><span> </span><span class="NLM_article-title">Mechanisms of action of antitumor drugs that interact with microtubules and tubulin</span> <span class="citation_source-journal">Curr. Med. Chem. Anticancer Agents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.2174%2F1568011023354290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=12678749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADC%252BD38XislGmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=1-17&author=M.+A.+Jordan&title=Mechanisms+of+action+of+antitumor+drugs+that+interact+with+microtubules+and+tubulin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action of antitumor drugs that interact with microtubules and tubulin</span></div><div class="casAuthors">Jordan, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Anti-Cancer Agents</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-17</span>CODEN:
                <span class="NLM_cas:coden">CMCACI</span>;
        ISSN:<span class="NLM_cas:issn">1568-0118</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Microtubules, major structural components in cells, are the target of a large and diverse group of natural product anticancer drugs.  Given the success of this class of drugs in cancer treatment, it can be argued that microtubules represent the single best cancer target identified to date.  Microtubules are highly dynamic assemblies of the protein tubulin.  They readily polymerize and depolymerize in cells, and they undergo two interesting kinds of dynamics called dynamic instability and treadmilling.  These dynamic behaviors are crucial to mitosis, the process of chromosomal division to form new cells.  Microtubule dynamics are highly regulated during the cell cycle by endogenous cellular regulators.  In addn., many antitumor drugs and natural compds. alter the polymn. dynamics of microtubules, blocking mitosis, and consequently, inducing cell death by apoptosis.  These drugs include several that inhibit microtubule polymn. at high drug concns., namely, the Vinca alkaloids, cryptophycins, halichondrins, estramustine, and colchicine.  Another group of these compds. stimulates microtubule polymn. and stabilizes microtubules at high concns.  These include Taxol, Taxotere, eleutherobins, epothilones, laulimalide, sarcodictyins, and discodermolide.  Importantly, considerable evidence indicates that, at lower concns., these drugs have a common mechanism of action; they suppress the dynamics of microtubules without appreciably changing the mass of microtubules in the cell.  The drugs bind to diverse sites on tubulin and at different positions within the microtubule, and they have diverse effects on microtubule dynamics.  However, by their common mechanism of suppression microtubule dynamics, they all block mitosis at the metaphase/anaphase transition, and induce cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz_AAWMPgVv7Vg90H21EOLACvtfcHk0lgHy-lcFxWPrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XislGmurg%253D&md5=02687ec4acc93772995677ebfa998ce9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F1568011023354290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568011023354290%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DM.%2BA.%26atitle%3DMechanisms%2520of%2520action%2520of%2520antitumor%2520drugs%2520that%2520interact%2520with%2520microtubules%2520and%2520tubulin%26jtitle%3DCurr.%2520Med.%2520Chem.%2520Anticancer%2520Agents%26date%3D2002%26volume%3D2%26spage%3D1%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Casagrande, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miragoli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semeraro, C.</span><span> </span><span class="NLM_article-title">Cardiovascular and renal action of dopaminergic prodrugs</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">S40</span><span class="NLM_x">–</span> <span class="NLM_lpage">S59</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1989&pages=S40-S59&author=C.+Casagrandeauthor=L.+Merloauthor=R.+Ferriniauthor=G.+Miragoliauthor=C.+Semeraro&title=Cardiovascular+and+renal+action+of+dopaminergic+prodrugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCasagrande%26aufirst%3DC.%26aulast%3DMerlo%26aufirst%3DL.%26aulast%3DFerrini%26aufirst%3DR.%26aulast%3DMiragoli%26aufirst%3DG.%26aulast%3DSemeraro%26aufirst%3DC.%26atitle%3DCardiovascular%2520and%2520renal%2520action%2520of%2520dopaminergic%2520prodrugs%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D1989%26volume%3D14%26spage%3DS40%26epage%3DS59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Juntunen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huuskonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laine, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niemi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taipale, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pate, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Järvinen, T.</span><span> </span><span class="NLM_article-title">Anandamide prodrugs 1. Water-soluble phosphate esters of arachidonylethanolamide and R-methanandamide</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1016%2FS0928-0987%2803%2900044-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=12729860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1Ogsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2003&pages=37-43&issue=1&author=J.+Juntunenauthor=J.+Huuskonenauthor=K.+Laineauthor=R.+Niemiauthor=H.+Taipaleauthor=T.+Nevalainenauthor=D.+W.+Pateauthor=T.+J%C3%A4rvinen&title=Anandamide+prodrugs+1.+Water-soluble+phosphate+esters+of+arachidonylethanolamide+and+R-methanandamide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Anandamide prodrugs 1. Water-soluble phosphate esters of arachidonylethanolamide and R-methanandamide</span></div><div class="casAuthors">Juntunen, Juha; Huuskonen, Juhani; Laine, Krista; Niemi, Riku; Taipale, Hannu; Nevalainen, Tapio; Pate, David W.; Jarvinen, Tomi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-43</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Phosphate esters of arachidonylethanolamide (AEA) and R-methanandamide were synthesized and evaluated as water-sol. prodrugs.  Various physicochem. properties (pKa, partition coeff., aq. soly.) were detd. for the synthesized phosphate esters.  The chem. stability of phosphate esters was detd. at pH 7.4.  In vitro enzymic hydrolysis rates were detd. in 10% liver homogenate, and in a pure enzyme-contg. (alk. phosphatase) soln. at pH 7.4.  The intraocular pressure (IOP) lowering properties of R-methanandamide phosphate ester were tested on normotensive rabbits.  The phosphate promoiety increased the aq. soly. of the parent compds. by more than 16 500-fold at pH 7.4.  Phosphate esters were stable in buffer solns., but rapidly hydrolyzed to their parent compds. in alk. phosphatase soln. (t1/2<<15 s) and liver homogenate (t1/2=8-9 min).  The phosphate ester of R-methanandamide reduced IOP in rabbits.  These results indicate that the phosphate esters of AEA and R-methanandamide are useful water-sol. prodrugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorXS1smzJO-LVg90H21EOLACvtfcHk0lgHy-lcFxWPrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1Ogsrg%253D&md5=14dd387434e738be4b43bf083f7a6588</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0928-0987%2803%2900044-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0928-0987%252803%252900044-7%26sid%3Dliteratum%253Aachs%26aulast%3DJuntunen%26aufirst%3DJ.%26aulast%3DHuuskonen%26aufirst%3DJ.%26aulast%3DLaine%26aufirst%3DK.%26aulast%3DNiemi%26aufirst%3DR.%26aulast%3DTaipale%26aufirst%3DH.%26aulast%3DNevalainen%26aufirst%3DT.%26aulast%3DPate%26aufirst%3DD.%2BW.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26atitle%3DAnandamide%2520prodrugs%25201.%2520Water-soluble%2520phosphate%2520esters%2520of%2520arachidonylethanolamide%2520and%2520R-methanandamide%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2003%26volume%3D19%26issue%3D1%26spage%3D37%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Pettit, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grealish, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettit, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapuis, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, J. M.</span><span> </span><span class="NLM_article-title">Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">2534</span><span class="NLM_x">–</span> <span class="NLM_lpage">2542</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010119y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2534-2542&issue=12&author=G.+R.+Pettitauthor=M.+P.+Grealishauthor=M.+K.+Jungauthor=E.+Hamelauthor=R.+K.+Pettitauthor=J.+C.+Chapuisauthor=J.+M.+Schmidt&title=Antineoplastic+agents.+465.+Structural+modification+of+resveratrol%3A+sodium+resverastatin+phosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm010119y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010119y%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DGrealish%26aufirst%3DM.%2BP.%26aulast%3DJung%26aufirst%3DM.%2BK.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DPettit%26aufirst%3DR.%2BK.%26aulast%3DChapuis%26aufirst%3DJ.%2BC.%26aulast%3DSchmidt%26aufirst%3DJ.%2BM.%26atitle%3DAntineoplastic%2520agents.%2520465.%2520Structural%2520modification%2520of%2520resveratrol%253A%2520sodium%2520resverastatin%2520phosphate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26issue%3D12%26spage%3D2534%26epage%3D2542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Perry, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTavish, D.</span><span> </span><span class="NLM_article-title">Estramustine phosphate sodium. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.2165%2F00002512-199507010-00006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=7579781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A280%3ADyaK28%252FovF2guw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1995&pages=49-74&issue=1&author=C.+M.+Perryauthor=D.+McTavish&title=Estramustine+phosphate+sodium.+A+review+of+its+pharmacodynamic+and+pharmacokinetic+properties%2C+and+therapeutic+efficacy+in+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Estramustine phosphate sodium. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer</span></div><div class="casAuthors">Perry C M; McTavish D</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & aging</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-74</span>
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    </div><div class="casAbstract">Estramustine phosphate sodium (estramustine phosphate), a unique antitumour agent, is selectively taken up by prostate cells and exerts antineoplastic effects by interfering with microtubule of dynamics and by reducing plasma levels of testosterone.  In noncomparative studies of estramustine phosphate in patients with hormone-refractory disease, objective response rates ranging from 19 to 69% have been reported.  Preliminary clinical investigations indicate that combining estramustine phosphate with vinblastine, etoposide or paclitaxel improves objective response rates over single-agent treatment, although no survival benefit over single-agent treatment has been demonstrated to date.  In comparative studies, estramustine phosphate produces similar objective response rates to conventional antineoplastic agents in patients with hormone-refractory prostate cancer.  In previously untreated patients with advanced metastatic hormone-responsive prostate cancer, objective responses are achieved in approximately 80% of patients.  Estramustine phosphate appears to be at least as effective as estrogen or flutamide therapy in these patients.  Nausea and vomiting are the most frequently observed adverse effects of treatment with estramustine phosphate.  While these symptoms are usually mild to moderate in nature, they may occasionally be more troublesome to the patient and necessitate withdrawal of treatment.  Cardiovascular complications are a more serious, though less frequently encountered, adverse effect of the drug.  However, these complications may be avoided by careful patient selection and prophylactic treatment measures.  Unlike some other antineoplastic agents, estramustine phosphate is rarely associated with myelosuppression.  In addition to producing similar objective response rates to other established agents, estramustine phosphate improves the subjective status of many patients and has been shown to reduce the intensity of pain and improve the performance status of patients.(ABSTRACT TRUNCATED AT 250 WORDS)</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQwyuB6-rl7DzDnmmyUf5qOfW6udTcc2eZFUCIeZCoRW7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28%252FovF2guw%253D%253D&md5=fbe9637c735c85a6a96e178e99a93a44</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2165%2F00002512-199507010-00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002512-199507010-00006%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DC.%2BM.%26aulast%3DMcTavish%26aufirst%3DD.%26atitle%3DEstramustine%2520phosphate%2520sodium.%2520A%2520review%2520of%2520its%2520pharmacodynamic%2520and%2520pharmacokinetic%2520properties%252C%2520and%2520therapeutic%2520efficacy%2520in%2520prostate%2520cancer%26jtitle%3DDrugs%2520Aging%26date%3D1995%26volume%3D7%26issue%3D1%26spage%3D49%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Witterland, A. H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koks, C. H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beijnen, J. H.</span><span> </span><span class="NLM_article-title">Etoposide phosphate, the water soluble prodrug of etoposide</span> <span class="citation_source-journal">Pharm. World Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1007%2FBF00820727" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=8933576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADyaK28Xnt1KgsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1996&pages=163-170&author=A.+H.+I.+Witterlandauthor=C.+H.+W.+Koksauthor=J.+H.+Beijnen&title=Etoposide+phosphate%2C+the+water+soluble+prodrug+of+etoposide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Etoposide phosphate, the water soluble prodrug of etoposide</span></div><div class="casAuthors">Witterland, A. H. I.; Koks, C. H. W.; Beijnen, J. H.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacy World & Science</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">163-170</span>CODEN:
                <span class="NLM_cas:coden">PWSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-1231</span>.
    
            (<span class="NLM_cas:orgname">Kluwer</span>)
        </div><div class="casAbstract">A review with 38 refs. on the pharmaceutical properties and the current status of etoposide phosphate in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX_cYka0CTw7Vg90H21EOLACvtfcHk0lipgLX4IfsRqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xnt1KgsLo%253D&md5=e53300ce695ea93d67d664c06153dbc8</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2FBF00820727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00820727%26sid%3Dliteratum%253Aachs%26aulast%3DWitterland%26aufirst%3DA.%2BH.%2BI.%26aulast%3DKoks%26aufirst%3DC.%2BH.%2BW.%26aulast%3DBeijnen%26aufirst%3DJ.%2BH.%26atitle%3DEtoposide%2520phosphate%252C%2520the%2520water%2520soluble%2520prodrug%2520of%2520etoposide%26jtitle%3DPharm.%2520World%2520Sci.%26date%3D1996%26volume%3D18%26spage%3D163%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Vincent, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kermani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shido, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bompais-Vincent, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicklin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohlen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafii, S.</span><span> </span><span class="NLM_article-title">Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2992</span><span class="NLM_x">–</span> <span class="NLM_lpage">3006</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2005&pages=2992-3006&issue=11&author=L.+Vincentauthor=P.+Kermaniauthor=L.+M.+Youngauthor=J.+Chengauthor=Z.+Fanauthor=K.+Shidoauthor=G.+Lamauthor=H.+Bompais-Vincentauthor=Z.+Zhuauthor=D.+J.+Hicklinauthor=P.+Bohlenauthor=D.+J.+Chaplinauthor=C.+Mayauthor=S.+Rafii&title=Combretastatin+A4+phosphate+induces+rapid+regression+of+tumor+neovessels+and+growth+through+interference+with+vascular+endothelial-cadherin+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVincent%26aufirst%3DL.%26aulast%3DKermani%26aufirst%3DP.%26aulast%3DYoung%26aufirst%3DL.%2BM.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DZ.%26aulast%3DShido%26aufirst%3DK.%26aulast%3DLam%26aufirst%3DG.%26aulast%3DBompais-Vincent%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DHicklin%26aufirst%3DD.%2BJ.%26aulast%3DBohlen%26aufirst%3DP.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DMay%26aufirst%3DC.%26aulast%3DRafii%26aufirst%3DS.%26atitle%3DCombretastatin%2520A4%2520phosphate%2520induces%2520rapid%2520regression%2520of%2520tumor%2520neovessels%2520and%2520growth%2520through%2520interference%2520with%2520vascular%2520endothelial-cadherin%2520signaling%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2005%26volume%3D115%26issue%3D11%26spage%3D2992%26epage%3D3006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Pettit, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temple, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rener, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansal, N.</span><span> </span><span class="NLM_article-title">Antineoplastic agents 322. Synthesis of combretastatin A-4 prodrugs</span> <span class="citation_source-journal">Anti-Cancer Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=7786396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADyaK2MXms1Wktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1995&pages=299-309&issue=4&author=G.+R.+Pettitauthor=C.+Templeauthor=V.+L.+Narayananauthor=R.+Varmaauthor=M.+J.+Simpsonauthor=M.+R.+Boydauthor=G.+A.+Renerauthor=N.+Bansal&title=Antineoplastic+agents+322.+Synthesis+of+combretastatin+A-4+prodrugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Antineoplastic agents. 322. Synthesis of combretastatin A-4 prodrugs</span></div><div class="casAuthors">Pettit, George R.; Temple, Carroll, Jr.; Narayanan, Ven L.; Varma, Ravi; Simpson, Michael J.; Boyd, Michael R.; Rener, Gregory A.; Bansal, Namita</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drug Design</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">299-309</span>CODEN:
                <span class="NLM_cas:coden">ACDDEA</span>;
        ISSN:<span class="NLM_cas:issn">0266-9536</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Combretastatin A-4 (I, R = H), the principal cancer cell growth-inhibitory constituent of the Zulu medicinal plant (Combretum caffrum, has been undergoing preclin. development.  However, the very limited water soly. of this phenol has complicated drug formation.  Hence, derivs. of the combretastatin A-4 3'-phenol group were prepd. for evaluation as possible water-sol. prodrugs.  As obsd. for combretastatin A-4, the sodium salt (I, R = Na), potassium salt (I, R = K), and hemisuccinic acid ester (I, R = COCH2CH2CO2H) derivs. were essentially insol. in water.  Indeed, these substances regenerated combretastatin A-4 upon reaction with water.  A series of other simple derivs., e.g. I [R = COCH(NH2)CH2CH2CO2H], proved unsatisfactory in terms of water soly. or stability, or both.  The most sol. derivs. evaluated included the ammonium [I, R = P(O)(OH)ONH4], and potassium [I, R = P(O)(OK)2] and sodium [I, R = P(O)(ONa)2] phosphate salts, where the latter two proved most stable and suitable.  Both the potassium and sodium phosphate derivs. of combretastatin A-4 were also found to exhibit the requisite biol. properties necessary for a useful prodrug.  The sodium phosphate salt was selected for drug formulation and further pre-clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCWV9UApN5crVg90H21EOLACvtfcHk0lipgLX4IfsRqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXms1Wktbs%253D&md5=0a16b2b4db491916a9a742c7af69669a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DTemple%26aufirst%3DC.%26aulast%3DNarayanan%26aufirst%3DV.%2BL.%26aulast%3DVarma%26aufirst%3DR.%26aulast%3DSimpson%26aufirst%3DM.%2BJ.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26aulast%3DRener%26aufirst%3DG.%2BA.%26aulast%3DBansal%26aufirst%3DN.%26atitle%3DAntineoplastic%2520agents%2520322.%2520Synthesis%2520of%2520combretastatin%2520A-4%2520prodrugs%26jtitle%3DAnti-Cancer%2520Drug%2520Des.%26date%3D1995%26volume%3D10%26issue%3D4%26spage%3D299%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Edsall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agoston, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClanahan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, M.</span><span> </span><span class="NLM_article-title">Synthesis and in vivo antitumor evaluation of 2-methoxyestradiol 3-phosphate, 17-phosphate, and 3,17-diphosphate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">6700</span><span class="NLM_x">–</span> <span class="NLM_lpage">6705</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070639e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6700-6705&issue=26&author=A.+Edsallauthor=G.+Agostonauthor=A.+Trestonauthor=S.+Plumauthor=R.+McClanahanauthor=T.+Luauthor=W.+Songauthor=M.+Cushman&title=Synthesis+and+in+vivo+antitumor+evaluation+of+2-methoxyestradiol+3-phosphate%2C+17-phosphate%2C+and+3%2C17-diphosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm070639e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070639e%26sid%3Dliteratum%253Aachs%26aulast%3DEdsall%26aufirst%3DA.%26aulast%3DAgoston%26aufirst%3DG.%26aulast%3DTreston%26aufirst%3DA.%26aulast%3DPlum%26aufirst%3DS.%26aulast%3DMcClanahan%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DT.%26aulast%3DSong%26aufirst%3DW.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520in%2520vivo%2520antitumor%2520evaluation%2520of%25202-methoxyestradiol%25203-phosphate%252C%252017-phosphate%252C%2520and%25203%252C17-diphosphate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D26%26spage%3D6700%26epage%3D6705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Ho, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harapanhalli, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahman, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelstein, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassis, A. I.</span><span> </span><span class="NLM_article-title">Synthesis and biologic evaluation of a radioiodinated quinazolinone derivative for enzyme-mediated insolubilization therapy</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc010093p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsV2hs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=357-364&issue=2&author=N.+H.+Hoauthor=R.+S.+Harapanhalliauthor=B.+A.+Dahmanauthor=K.+Chenauthor=K.+Wangauthor=S.+J.+Adelsteinauthor=A.+I.+Kassis&title=Synthesis+and+biologic+evaluation+of+a+radioiodinated+quinazolinone+derivative+for+enzyme-mediated+insolubilization+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biologic Evaluation of a Radioiodinated Quinazolinone Derivative for Enzyme-Mediated Insolubilization Therapy</span></div><div class="casAuthors">Ho, Nanhui; Harapanhalli, Ravi S.; Dahman, Bassam A.; Chen, Kai; Wang, Ketai; Adelstein, S. James; Kassis, Amin I.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">357-364</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have developed a new strategy that aims to conc. therapeutic radionuclides within solid tumors.  This approach, which we have named EMIT (enzyme-mediated insolubilization therapy), is a method for enzyme-dependent, site-specific, in vivo pptn. of a radioactive mol. (from a water-sol. precursor) within the extracellular space of solid tumors.  The prodrug, ammonium 2-(2'-phosphoryloxyphenyl)-6-iodo-4-(3H)-quinazolinone, labeled with iodine-125 (125IPD) and its authentic compd. labeled with iodine-127 (IPD) have been synthesized, purified, and characterized.  The alk. phosphatase (ALP)-mediated conversion of these water-sol. nonfluorescent prodrugs to the water-insol. fluorescent species, iodine-125-labeled 2-(2'-hydroxyphenyl)-6-iodo-4-(3H)-quinazolinone (125ID) and its iodine-127-labeled deriv. (ID), has been demonstrated in vitro.  Biodistribution studies in mice indicate that both 125IPD and 125ID are minimally retained by most tissues and organs.  In addn., following its i.v. injection in mice, 125IPD is localized in ALP-rich regions and converted to 125ID, which remains indefinitely within the tissues where it is produced.  We believe that EMIT is a strategy that will lead to the active and specific concn. and entrapment of therapeutic radionuclides within solid tumors, the consequent protracted irradn. of tumor cells within the range of the emitted particles, and the effective therapy of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs2mEbUpKNQLVg90H21EOLACvtfcHk0lhkReP4V0Z1hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsV2hs7k%253D&md5=4f28d555a5752708f79cd2c6013c8a73</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fbc010093p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc010093p%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DN.%2BH.%26aulast%3DHarapanhalli%26aufirst%3DR.%2BS.%26aulast%3DDahman%26aufirst%3DB.%2BA.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DAdelstein%26aufirst%3DS.%2BJ.%26aulast%3DKassis%26aufirst%3DA.%2BI.%26atitle%3DSynthesis%2520and%2520biologic%2520evaluation%2520of%2520a%2520radioiodinated%2520quinazolinone%2520derivative%2520for%2520enzyme-mediated%2520insolubilization%2520therapy%26jtitle%3DBioconjugate%2520Chem.%26date%3D2002%26volume%3D13%26issue%3D2%26spage%3D357%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Chen, K</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirichian, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al Aowad, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelstein, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassis, A. I.</span><span> </span><span class="NLM_article-title">In silico design, synthesis, and biological evaluation of radioiodinated quinazolinone derivatives for alkaline phosphatase-mediated cancer diagnosis and therapy</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3001</span><span class="NLM_x">–</span> <span class="NLM_lpage">3013</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1158%2F1535-7163.MCT-06-0465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=17172404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlagsb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=3001-3013&issue=12&author=K+Chenauthor=K+Wangauthor=A.+M.+Kirichianauthor=A.+F.+Al+Aowadauthor=L.+K.+Iyerauthor=S.+J.+Adelsteinauthor=A.+I.+Kassis&title=In+silico+design%2C+synthesis%2C+and+biological+evaluation+of+radioiodinated+quinazolinone+derivatives+for+alkaline+phosphatase-mediated+cancer+diagnosis+and+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">In silico design, synthesis, and biological evaluation of radioiodinated quinazolinone derivatives for alkaline phosphatase-mediated cancer diagnosis and therapy</span></div><div class="casAuthors">Chen, Kai; Wang, Ketai; Kirichian, Agop M.; Al Aowad, Ayman F.; Iyer, Lakshmanan K.; Adelstein, S. James; Kassis, Amin I.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3001-3013</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">As part of the development of enzyme-mediated cancer imaging and therapy, a novel technol. to entrap water-insol. radioactive mols. within solid tumors, we show that a water-sol., radioactive quinazolinone prodrug, ammonium 2-(2'-phosphoryloxyphenyl)-6-[125I]iodo-4-(3H)-quinazolinone (125IQ2-P), is hydrolyzed by alk. phosphatase to a water-insol., radiolabeled drug, 2-(2'-hydroxyphenyl)-6-[125I]iodo-4-(3H)-quinazolinone (125IQ2-OH).  Biodistribution data suggest the existence of two isoforms of the prodrug (IQ2-P(I) and IQ2-P), and this has been confirmed by their synthesis and characterization.  Structural differences of the two isoforms have been examd. using in silico mol. modeling techniques and docking methods to describe the interaction/binding between the isoforms and human placental alk. phosphatase (PLAP), a tumor cell, membrane-assocd., hydrolytic enzyme whose structure is known by X-ray crystallog. detn.  Docking data show that IQ2-P, but not IQ2-P(I), fits the active binding site of PLAP favorably and interacts with the catalytic amino acid Ser92, which plays an important role in the hydrolytic process.  The binding free energies (ΔGbinding) of the isoforms to PLAP predict that IQ2-P will be the better substrate for PLAP.  The in vitro incubation of the isoforms with PLAP leads to the rapid hydrolysis of IQ2-P only and confirms the in silico expectations.  Fluorescence microscopy shows that in vitro incubation of IQ2-P with mouse and human tumor cells causes the extracellular, alk. phosphatase-mediated hydrolysis of the mol. and pptn. of fluorescent crystals of IQ2-OH.  No hydrolysis is seen in the presence of normal mouse and human cells.  Furthermore, the intratumoral injection of 125IQ2-P into alk. phosphatase-expressing solid human tumors grown s.c. in nude rats results in efficient hydrolysis of the compd. and retention of ∼70% of the injected radioactivity, whereas similar injection into normal tissues (e.g., muscle) does not produce any measurable hydrolysis (∼1%) or retention of radioactivity at the injected site.  These studies support the enzyme-mediated cancer imaging and therapy technol. and show the potential of such quinazolinone derivs. in the in vivo radio-detection (123I/124I) and therapy (131I) of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF8VRRpStf1bVg90H21EOLACvtfcHk0lhkReP4V0Z1hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlagsb3K&md5=1940df50c83ae3c3cdb933101495ce15</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0465%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK%26aulast%3DWang%26aufirst%3DK%26aulast%3DKirichian%26aufirst%3DA.%2BM.%26aulast%3DAl%2BAowad%26aufirst%3DA.%2BF.%26aulast%3DIyer%26aufirst%3DL.%2BK.%26aulast%3DAdelstein%26aufirst%3DS.%2BJ.%26aulast%3DKassis%26aufirst%3DA.%2BI.%26atitle%3DIn%2520silico%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520radioiodinated%2520quinazolinone%2520derivatives%2520for%2520alkaline%2520phosphatase-mediated%2520cancer%2520diagnosis%2520and%2520therapy%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26issue%3D12%26spage%3D3001%26epage%3D3013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Posoisil, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al Aowad, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelstein, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassis, A. I.</span><span> </span><span class="NLM_article-title">Computational modeling and experimental evaluation of a novel prodrug for targeting the extracellular space of prostate tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">2197</span><span class="NLM_x">–</span> <span class="NLM_lpage">2205</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=2197-2205&author=P.+Posoisilauthor=K.+Wangauthor=A.+F.+Al+Aowadauthor=L.+K.+Iyerauthor=S.+J.+Adelsteinauthor=A.+I.+Kassis&title=Computational+modeling+and+experimental+evaluation+of+a+novel+prodrug+for+targeting+the+extracellular+space+of+prostate+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPosoisil%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DAl%2BAowad%26aufirst%3DA.%2BF.%26aulast%3DIyer%26aufirst%3DL.%2BK.%26aulast%3DAdelstein%26aufirst%3DS.%2BJ.%26aulast%3DKassis%26aufirst%3DA.%2BI.%26atitle%3DComputational%2520modeling%2520and%2520experimental%2520evaluation%2520of%2520a%2520novel%2520prodrug%2520for%2520targeting%2520the%2520extracellular%2520space%2520of%2520prostate%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D2197%26epage%3D2205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirichian, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al Aowad, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelstein, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassis, A. I.</span><span> </span><span class="NLM_article-title">Evaluation of chemical, physical, and biologic properties of tumor-targeting radioiodinated quinazolinone derivative</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">754</span><span class="NLM_x">–</span> <span class="NLM_lpage">764</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc0602937" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVaju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=754-764&author=K.+Wangauthor=A.+M.+Kirichianauthor=A.+F.+Al+Aowadauthor=S.+J.+Adelsteinauthor=A.+I.+Kassis&title=Evaluation+of+chemical%2C+physical%2C+and+biologic+properties+of+tumor-targeting+radioiodinated+quinazolinone+derivative"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of chemical, physical, and biologic properties of tumor-targeting radioiodinated quinazolinone derivative</span></div><div class="casAuthors">Wang, Ketai; Kirichian, Agop M.; Al Aowad, Ayman F.; Adelstein, S. James; Kassis, Amin I.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">754-764</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Our group is developing a novel technol., enzyme-mediated cancer imaging and therapy (EMCIT), that aims to entrap radioiodinated compds. within solid tumors for noninvasive tumor detection and therapy.  In this approach, a water-sol., radioiodinated prodrug is hydrolyzed in vivo to a highly water-insol. compd. by an enzyme overexpressed extracellularly by tumor cells.  We have synthesized and characterized the water-sol. prodrug, 2-(2'-phosphoryloxyphenyl)-6-[125I]iodo-4-(3H)-quinazolinone [125I]5, which is readily hydrolyzed by alk. phosphatase, an enzyme expressed by many tumor cell lines, to a water-insol. drug, 2-(2'-hydroxyphenyl)-6-[125I]iodo-4-(3H)-quinazolinone [125I]1.  In the course of our study, we discovered that ammonium 2-(2'-phosphoryloxyphenyl)-6-tributylstannyl-4-(3H)-quinazolinone, an intermediate in the radioiodination of the prodrug, exists as two isomers (3 and 4) whose radioiodination leads, resp., to [125I]6 and [125I]5.  These prodrugs have different in vitro and in vivo biol. activities.  Compd. 6 is not hydrolyzed by alk. phosphatase (ALP), whereas 5 is highly sol. (mg/mL) in aq. soln. and is rapidly dephosphorylated in the presence of ALP to 1, a water-insol. mol. (ng/mL).  Mouse biodistribution studies indicate that [125I]6 has high uptake in kidney and liver and [125I]5 has very low uptake in all normal organs.  Compds. 3 and 6 are converted, resp., to 4 and 5 after incubation in DMSO.  The stability of 5 in human serum is high.  The min. ALP concn. needed to hydrolyze 5 is much greater than the ALP level in the blood of patients with cancer, and the latter should not affect the pharmacokinetics of the compd.  Incubation of 5 with viable human and mouse tumor-cell lines-but not with normal human cells and mouse tissues-leads to its hydrolysis and the formation of large crystals of 1.  We expect that 5 will also be hydrolyzed in vivo by tumor cells that express phosphatase activity extracellularly and anticipate the specific pptn. of radioiodinated 1 within tumor cell clusters.  This should lead to high tumor-to-normal-tissue ratios and enable imaging (SPECT/PET) and radionuclide therapy of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXYGdIwzwmMrVg90H21EOLACvtfcHk0licP90swJfPrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVaju7s%253D&md5=faf7c8cb5a12c01f126a97ad47aa8988</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fbc0602937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc0602937%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DK.%26aulast%3DKirichian%26aufirst%3DA.%2BM.%26aulast%3DAl%2BAowad%26aufirst%3DA.%2BF.%26aulast%3DAdelstein%26aufirst%3DS.%2BJ.%26aulast%3DKassis%26aufirst%3DA.%2BI.%26atitle%3DEvaluation%2520of%2520chemical%252C%2520physical%252C%2520and%2520biologic%2520properties%2520of%2520tumor-targeting%2520radioiodinated%2520quinazolinone%2520derivative%26jtitle%3DBioconjugate%2520Chem.%26date%3D2007%26volume%3D18%26spage%3D754%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Andrews, K. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atherton, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, A. L.</span><span> </span><span class="NLM_article-title">Hydroxypyridine and hydroxyquinoline phosphates as anti-cholinesterases</span> <span class="citation_source-journal">J. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1954</span><span class="NLM_x">, </span> <span class="NLM_fpage">1638</span><span class="NLM_x">–</span> <span class="NLM_lpage">1640</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1954&pages=1638-1640&author=K.+J.+M.+Andrewsauthor=F.+R.+Athertonauthor=F.+Bergelauthor=A.+L.+Morrison&title=Hydroxypyridine+and+hydroxyquinoline+phosphates+as+anti-cholinesterases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndrews%26aufirst%3DK.%2BJ.%2BM.%26aulast%3DAtherton%26aufirst%3DF.%2BR.%26aulast%3DBergel%26aufirst%3DF.%26aulast%3DMorrison%26aufirst%3DA.%2BL.%26atitle%3DHydroxypyridine%2520and%2520hydroxyquinoline%2520phosphates%2520as%2520anti-cholinesterases%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1954%26spage%3D1638%26epage%3D1640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Horst, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harald, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilmar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhard, S.</span><span> </span><span class="NLM_article-title">New 4-quinolinol- and 5,6,7,8-tetrahydro-4-quinolinol derivatives with biocidal effect</span> <span class="citation_source-journal">Liebigs Ann. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_fpage">1656</span><span class="NLM_x">–</span> <span class="NLM_lpage">1676</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1982&pages=1656-1676&author=G.+Horstauthor=K.+Haraldauthor=M.+Hilmarauthor=S.+Gerhard&title=New+4-quinolinol-+and+5%2C6%2C7%2C8-tetrahydro-4-quinolinol+derivatives+with+biocidal+effect"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHorst%26aufirst%3DG.%26aulast%3DHarald%26aufirst%3DK.%26aulast%3DHilmar%26aufirst%3DM.%26aulast%3DGerhard%26aufirst%3DS.%26atitle%3DNew%25204-quinolinol-%2520and%25205%252C6%252C7%252C8-tetrahydro-4-quinolinol%2520derivatives%2520with%2520biocidal%2520effect%26jtitle%3DLiebigs%2520Ann.%2520Chem.%26date%3D1982%26spage%3D1656%26epage%3D1676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Yamori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishizu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mita, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edatsugi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuba, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takezawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruo, T.</span><span> </span><span class="NLM_article-title">Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">4042</span><span class="NLM_x">–</span> <span class="NLM_lpage">4049</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=4042-4049&author=T.+Yamoriauthor=A.+Matsunagaauthor=S.+Satoauthor=K.+Yamazakiauthor=A.+Komiauthor=K.+Ishizuauthor=I.+Mitaauthor=H.+Edatsugiauthor=Y.+Matsubaauthor=K.+Takezawaauthor=O.+Nakanishiauthor=H.+Kohnoauthor=Y.+Nakajimaauthor=H.+Komatsuauthor=T.+Andohauthor=T.+Tsuruo&title=Potent+antitumor+activity+of+MS-247%2C+a+novel+DNA+minor+groove+binder%2C+evaluated+by+an+in+vitro+and+in+vivo+human+cancer+cell+line+panel"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamori%26aufirst%3DT.%26aulast%3DMatsunaga%26aufirst%3DA.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DK.%26aulast%3DKomi%26aufirst%3DA.%26aulast%3DIshizu%26aufirst%3DK.%26aulast%3DMita%26aufirst%3DI.%26aulast%3DEdatsugi%26aufirst%3DH.%26aulast%3DMatsuba%26aufirst%3DY.%26aulast%3DTakezawa%26aufirst%3DK.%26aulast%3DNakanishi%26aufirst%3DO.%26aulast%3DKohno%26aufirst%3DH.%26aulast%3DNakajima%26aufirst%3DY.%26aulast%3DKomatsu%26aufirst%3DH.%26aulast%3DAndoh%26aufirst%3DT.%26aulast%3DTsuruo%26aufirst%3DT.%26atitle%3DPotent%2520antitumor%2520activity%2520of%2520MS-247%252C%2520a%2520novel%2520DNA%2520minor%2520groove%2520binder%252C%2520evaluated%2520by%2520an%2520in%2520vitro%2520and%2520in%2520vivo%2520human%2520cancer%2520cell%2520line%2520panel%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D4042%26epage%3D4049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Yaguchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koshimizu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirono, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamori, T.</span><span> </span><span class="NLM_article-title">Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1093%2Fjnci%2Fdjj133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=16622124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADC%252BD28XjslOjsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2006&pages=545-556&issue=8&author=S.+Yaguchiauthor=Y.+Fukuiauthor=I.+Koshimizuauthor=H.+Yoshimiauthor=T.+Matsunoauthor=H.+Goudaauthor=S.+Hironoauthor=K.+Yamazakiauthor=T.+Yamori&title=Antitumor+activity+of+ZSTK474%2C+a+new+phosphatidylinositol+3-kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of ZSTK474, a New Phosphatidylinositol 3-Kinase Inhibitor</span></div><div class="casAuthors">Yaguchi, Shin-ichi; Fukui, Yasuhisa; Koshimizu, Ichiro; Yoshimi, Hisashi; Matsuno, Toshiyuki; Gouda, Hiroaki; Hirono, Shuichi; Yamazaki, Kanami; Yamori, Takao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">545-556</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: We previously synthesized a novel s-triazine deriv., ZSTK474 [2-(2-difluoromethylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine], that strongly inhibited the growth of tumor cells.  We identified its mol. target, investigated its effects on cellular signaling pathways, and examd. its antitumor efficacy and toxicity in vivo.  Methods: We used COMPARE anal. of chemosensitivity measurements from 39 human cancer cell lines and identified phosphatidylinositol 3-kinase (PI3K) as a mol. target for ZSTK474.  PI3K was immunopptd. from A549 cell lysates, and its activity was measured by assessing the incorporation of 32P into phosphatidylinositol.  We used the crystal structure of the PI3K-LY294002 complex to model the binding of ZSTK474 to PI3K (where LY294002 is a known PI3K inhibitor).  PI3K downstream activity was analyzed by immunoblotting.  Antitumor activity of ZSTK474 was examd. against A549, PC-3, and WiDr xenografts in nude mice.  Phosphorylation of Akt, a serine/threonine protein kinase and a major signaling component downstream of PI3K, was assessed in vivo by immunohistochem.  Results: PI3K was identified as a mol. target for ZSTK474 by COMPARE anal.  We confirmed that ZSTK474 directly inhibited PI3K activity more efficiently than the PI3K inhibitor LY294002.  At concns. of 1 μM, ZSTK474 and LY2194002 reduced PI3K activity to 4.7% (95% confidence interval [CI] = 3.2% to 6.1%) and 44.6% (95% CI = 38.9% to 50.3%), resp., of the untreated control level.  Mol. modeling of the PI3K-ZSTK474 complex indicated that ZSTK474 could bind to the ATP-binding pocket of PI3K.  ZSTK474 inhibited phosphorylation of signaling components downstream from PI3K, such as Akt and glycogen synthase kinase 3β, and mediated a decrease in cyclin D1 levels.  ZSTK474 administered orally to mice had strong antitumor activity against human cancer xenografts without toxic effects in crit. organs.  Akt phosphorylation was reduced in xenograft tumors after oral administration of ZSTK474.  Conclusion: ZSTK474 is a new PI3K inhibitor with strong antitumor activity against human cancer xenografts without toxic effects in crit. organs.  ZSTK474 merits further investigation as an anticancer drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG0v8LFKdruLVg90H21EOLACvtfcHk0liKM7INicQ9Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjslOjsLw%253D&md5=a2593024975536089ab2ee7e53234ebc</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjj133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjj133%26sid%3Dliteratum%253Aachs%26aulast%3DYaguchi%26aufirst%3DS.%26aulast%3DFukui%26aufirst%3DY.%26aulast%3DKoshimizu%26aufirst%3DI.%26aulast%3DYoshimi%26aufirst%3DH.%26aulast%3DMatsuno%26aufirst%3DT.%26aulast%3DGouda%26aufirst%3DH.%26aulast%3DHirono%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DK.%26aulast%3DYamori%26aufirst%3DT.%26atitle%3DAntitumor%2520activity%2520of%2520ZSTK474%252C%2520a%2520new%2520phosphatidylinositol%25203-kinase%2520inhibitor%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2006%26volume%3D98%26issue%3D8%26spage%3D545%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Radke, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kersting, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiesel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wulfing, P.</span><span> </span><span class="NLM_article-title">Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1038%2Fsj.bjc.6603261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=16832410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnsl2hsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2006&pages=347-354&issue=3&author=I.+Radkeauthor=M.+Gotteauthor=C.+Kerstingauthor=B.+Mattssonauthor=L.+Kieselauthor=P.+Wulfing&title=Expression+and+prognostic+impact+of+the+protein+tyrosine+phosphatases+PRL-1%2C+PRL-2%2C+and+PRL-3+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer</span></div><div class="casAuthors">Radke, I.; Goette, M.; Kersting, C.; Mattsson, B.; Kiesel, L.; Wuelfing, P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-354</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The aim of this study was to investigate the expression of the protein tyrosine phosphatases (PTP) PRL-1, PRL-2, and PRL-3 in human breast cancer and to evaluate its clin. and prognostic significance.  PRL-PTP mRNA expression was examd. in malignant (n=7) and nonmalignant (n=7) cryoconserved breast tissue samples as well as in eight breast cancer cell lines by RT-PCR.  Furthermore, protein expression of PRL-3 was analyzed semiquant. by immunohistochem. in ductal breast carcinoma in situ (n=135) and invasive breast cancer (n=147) by use of tissue microarray technol. (TMA).  In 24 lymph node-pos. patients we selected the corresponding lymph node metastases for anal. of PRL-3 expression, and a validation set (n=99) of invasive breast cancer samples was examd.  Staining results were correlated with clinicopathol. parameters and long-term follow-up.  PRL-3 mRNA expression was significantly higher in malignant compared to benign breast tissue.  For PRL-1 and PRL-2 expression no significant differences were obsd.  Staining of TMAs showed PRL-3 expression in 85.9% ductal carcinoma in situ and 75.5% invasive breast carcinomas.  Anal. of survival parameters revealed a shorter disease-free survival (DFS) in patients with PRL-3-pos. carcinomas, and in particular a significantly shorter DFS in nodal-pos. patients with PRL-3 overexpressing tumors as compared to PRL-3-neg. breast carcinomas (66±7 mo (95% CI, 52-80) vs 97±9 mo (95% CI, 79-115); P=0.032).  Moreover, we found a more frequent expression of PRL-3 in lymph node metastases as compared to the primary tumors (91.7 vs 66.7%; P=0.033).  Our results suggest that PRL-3 might serve as a novel prognostic factor in breast cancer, which may help to predict an adverse disease outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6at4syLymzbVg90H21EOLACvtfcHk0liKM7INicQ9Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnsl2hsrs%253D&md5=04b8400f8b03e01a10c2d4121529a74b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6603261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6603261%26sid%3Dliteratum%253Aachs%26aulast%3DRadke%26aufirst%3DI.%26aulast%3DGotte%26aufirst%3DM.%26aulast%3DKersting%26aufirst%3DC.%26aulast%3DMattsson%26aufirst%3DB.%26aulast%3DKiesel%26aufirst%3DL.%26aulast%3DWulfing%26aufirst%3DP.%26atitle%3DExpression%2520and%2520prognostic%2520impact%2520of%2520the%2520protein%2520tyrosine%2520phosphatases%2520PRL-1%252C%2520PRL-2%252C%2520and%2520PRL-3%2520in%2520breast%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2006%26volume%3D95%26issue%3D3%26spage%3D347%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Rochefort, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glondu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurent, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liaudet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roger, P.</span><span> </span><span class="NLM_article-title">Cathepsin D in breast cancer: mechanisms and clinical application, a 1999 overview</span> <span class="citation_source-journal">Clin. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1016%2FS0009-8981%2899%2900226-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=10675721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtFagurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2000&pages=157-170&issue=2&author=H.+Rochefortauthor=M.+Garciaauthor=M.+Glonduauthor=V.+Laurentauthor=E.+Liaudetauthor=J.-M.+Reyauthor=P.+Roger&title=Cathepsin+D+in+breast+cancer%3A+mechanisms+and+clinical+application%2C+a+1999+overview"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview</span></div><div class="casAuthors">Rochefort, H.; Garcia, M.; Glondu, M.; Laurent, V.; Liaudet, E.; Rey, J.-M.; Roger, P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinica Chimica Acta</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-170</span>CODEN:
                <span class="NLM_cas:coden">CCATAR</span>;
        ISSN:<span class="NLM_cas:issn">0009-8981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 59 refs.  A short review of the literature first confirms the clin. value of cathepsin D as a prognostic marker in breast cancer, when using well standardized assays.  The authors then summarize results of studies, mostly performed in the authors' lab., aimed at understanding the effect of cathepsin D overexpression on metastasis and the mol. mechanisms involved.  Cathepsin D-cDNA transfection increases tumor cell proliferation in vitro and the metastatic potential of 3Y1-Ad12 embryonic rat tumorigenic cells when injected in vivo into nude mice.  The mechanism by which cathepsin D increases the incidence of clin. metastasis involves increased cell growth and decreased contact inhibition rather than escape of cancer cells through the basement membrane.  Different mechanisms are considered to explain this mitogenic activity.  Cathepsin D could act as a protease following its activation at an acidic pH, or as a ligand of different membrane receptors at a more neutral pH.  In this case cathepsin D can displace IGFII from the mannose-6-phosphate/IGFII receptor to the IGFI receptor or activate another membrane receptor to be identified.  The nature of the mechanisms involved in vivo may depend on the micro environment of the tumor cells.  These studies should guide in the development of new therapies aimed at inhibiting the deleterious effect of overexpressed cathepsin D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjO_2Rcg8E3LVg90H21EOLACvtfcHk0liKM7INicQ9Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtFagurw%253D&md5=2f6925755152e3b7f72b08966b4fec77</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FS0009-8981%2899%2900226-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-8981%252899%252900226-0%26sid%3Dliteratum%253Aachs%26aulast%3DRochefort%26aufirst%3DH.%26aulast%3DGarcia%26aufirst%3DM.%26aulast%3DGlondu%26aufirst%3DM.%26aulast%3DLaurent%26aufirst%3DV.%26aulast%3DLiaudet%26aufirst%3DE.%26aulast%3DRey%26aufirst%3DJ.-M.%26aulast%3DRoger%26aufirst%3DP.%26atitle%3DCathepsin%2520D%2520in%2520breast%2520cancer%253A%2520mechanisms%2520and%2520clinical%2520application%252C%2520a%25201999%2520overview%26jtitle%3DClin.%2520Chim.%2520Acta%26date%3D2000%26volume%3D291%26issue%3D2%26spage%3D157%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Liaudet-Coopman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaujouin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derocq, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glondu-Lassis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurent-Matha, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prébois, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochefort, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vignon, F.</span><span> </span><span class="NLM_article-title">Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">237</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1016%2Fj.canlet.2005.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=16046058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADC%252BD28XltF2qsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=2006&pages=167-179&issue=2&author=E.+Liaudet-Coopmanauthor=M.+Beaujouinauthor=D.+Derocqauthor=M.+Garciaauthor=M.+Glondu-Lassisauthor=V.+Laurent-Mathaauthor=C.+Pr%C3%A9boisauthor=H.+Rochefortauthor=F.+Vignon&title=Cathepsin+D%3A+newly+discovered+functions+of+a+long-standing+aspartic+protease+in+cancer+and+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin D: Newly discovered functions of a long-standing aspartic protease in cancer and apoptosis</span></div><div class="casAuthors">Liaudet-Coopman, Emmanuelle; Beaujouin, Melanie; Derocq, Danielle; Garcia, Marcel; Glondu-Lassis, Murielle; Laurent-Matha, Valerie; Prebois, Christine; Rochefort, Henri; Vignon, Francoise</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">237</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-179</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The lysosomal aspartic protease cathepsin D (cath-D) is over-expressed and hyper-secreted by epithelial breast cancer cells.  This protease is an independent marker of poor prognosis in breast cancer being correlated with the incidence of clin. metastasis.  Cath-D over-expression stimulates tumorigenicity and metastasis.  Indeed it plays an essential role in the multiple steps of tumor progression, in stimulating cancer cell proliferation, fibroblast outgrowth and angiogenesis, as well as in inhibiting tumor apoptosis.  A mutated cath-D devoid of catalytic activity still proved mitogenic for cancer, endothelial and fibroblastic cells, suggesting an extra-cellular mode of action of cath-D involving a triggering, either directly or indirectly, of an as yet unidentified cell surface receptor.  Cath-D is also a key mediator of induced-apoptosis and its proteolytic activity has been involved generally in this event.  During apoptosis, mature lysosomal cath-D is translocated to the cytosol.  Since cath-D is one of the lysosomal enzymes which requires a more acidic pH to be proteolytically-active relative to the cysteine lysosomal enzymes, such as cath-B and -L, it is open to question whether cytosolic cath-D might be able to cleave substrate(s) implicated in the apoptotic cascade.  This review summarises our current knowledge on cath-D action in cancer progression and metastasis, as well as its dual function in apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFJdjUCIwta7Vg90H21EOLACvtfcHk0ljePX-qiYLBfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltF2qsbc%253D&md5=eb7be2df7685a6574ca0b161a6c9716d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2005.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2005.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DLiaudet-Coopman%26aufirst%3DE.%26aulast%3DBeaujouin%26aufirst%3DM.%26aulast%3DDerocq%26aufirst%3DD.%26aulast%3DGarcia%26aufirst%3DM.%26aulast%3DGlondu-Lassis%26aufirst%3DM.%26aulast%3DLaurent-Matha%26aufirst%3DV.%26aulast%3DPr%25C3%25A9bois%26aufirst%3DC.%26aulast%3DRochefort%26aufirst%3DH.%26aulast%3DVignon%26aufirst%3DF.%26atitle%3DCathepsin%2520D%253A%2520newly%2520discovered%2520functions%2520of%2520a%2520long-standing%2520aspartic%2520protease%2520in%2520cancer%2520and%2520apoptosis%26jtitle%3DCancer%2520Lett.%26date%3D2006%26volume%3D237%26issue%3D2%26spage%3D167%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Chang, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. Y.</span><span> </span><span class="NLM_article-title">Lysosomal cysteine proteinase cathepsin S as a potential target for anti-cancer therapy</span> <span class="citation_source-journal">J. Cancer Mol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXislyis7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=5-14&author=W.+S.+Changauthor=H.+R.+Wuauthor=C.+T.+Yehauthor=C.+W.+Wuauthor=J.+Y.+Chang&title=Lysosomal+cysteine+proteinase+cathepsin+S+as+a+potential+target+for+anti-cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomal cysteine proteinase cathepsin S as a potential target for anti-cancer therapy</span></div><div class="casAuthors">Chang, Wun-Shaing W.; Wu, Hsin-Ru; Yeh, Chi-Tai; Wu, Cheng-Wen; Chang, Jang-Yang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cancer Molecules</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-14</span>CODEN:
                <span class="NLM_cas:coden">JCMOCF</span>;
        ISSN:<span class="NLM_cas:issn">1816-0735</span>.
    
            (<span class="NLM_cas:orgname">MedUnion Press</span>)
        </div><div class="casAbstract">A review.  In mammalian cells, cysteine proteinases are localized mainly in the cytoplasm and lysosomal compartments.  For lysosomal cysteine proteinases, they are synthesized as inactive zymogens and converted to active forms occurred in the acidic and reducing conditions of late endosomes or lysosomes.  Here we review the roles of active lysosomal cysteine proteinases in particular cathepsin S and its importance to many physiol. or pathol. processes including tumor growth, angiogenesis, and metastasis.  Biochem. and clin. studies have shown significant changes in the levels of mRNA expression and enzyme activity of cathepsin S in various cancer tissues and cell lines.  Immunol., mol. and pharmaceutical approaches to alter the expression and proteolytic activity of cathepsin S all provided strong evidence for a causal role of this proteolytic enzyme in tumor progression and invasion.  Detn. of the x-ray structures of either cathepsin S alone or complexed with inhibitors further offered insights of the active site pocket of cathepsin S, thereby making the rational design of low-mol. wt. synthetic inhibitors feasible for anti-cancer drug development and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKIeGD-mx08LVg90H21EOLACvtfcHk0ljePX-qiYLBfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXislyis7w%253D&md5=2572a030bed10ec8e31fa72fddb466c4</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DW.%2BS.%26aulast%3DWu%26aufirst%3DH.%2BR.%26aulast%3DYeh%26aufirst%3DC.%2BT.%26aulast%3DWu%26aufirst%3DC.%2BW.%26aulast%3DChang%26aufirst%3DJ.%2BY.%26atitle%3DLysosomal%2520cysteine%2520proteinase%2520cathepsin%2520S%2520as%2520a%2520potential%2520target%2520for%2520anti-cancer%2520therapy%26jtitle%3DJ.%2520Cancer%2520Mol.%26date%3D2007%26volume%3D3%26spage%3D5%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Takehara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosokawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohigashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span> </span><span class="NLM_article-title">γ-Aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABA<sub>A</sub> receptor π subunit</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">9704</span><span class="NLM_x">–</span> <span class="NLM_lpage">9712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=9704-9712&author=A.+Takeharaauthor=M.+Hosokawaauthor=H.+Eguchiauthor=H.+Ohigashiauthor=O.+Ishikawaauthor=Y.+Nakamuraauthor=H.+Nakagawa&title=%CE%B3-Aminobutyric+acid+%28GABA%29+stimulates+pancreatic+cancer+growth+through+overexpressing+GABAA+receptor+%CF%80+subunit"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakehara%26aufirst%3DA.%26aulast%3DHosokawa%26aufirst%3DM.%26aulast%3DEguchi%26aufirst%3DH.%26aulast%3DOhigashi%26aufirst%3DH.%26aulast%3DIshikawa%26aufirst%3DO.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DNakagawa%26aufirst%3DH.%26atitle%3D%25CE%25B3-Aminobutyric%2520acid%2520%2528GABA%2529%2520stimulates%2520pancreatic%2520cancer%2520growth%2520through%2520overexpressing%2520GABAA%2520receptor%2520%25CF%2580%2520subunit%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D9704%26epage%3D9712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Wang, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guh, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teng, C. M.</span><span> </span><span class="NLM_article-title">CHM-1 inhibits hepatocyte growth factor-induced invasion of SK-Hep-1 human hepatocellular carcinoma cells by suppressing matrix metalloproteinase-9 expression</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1016%2Fj.canlet.2007.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=17689859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSnt7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=2007&pages=87-96&author=S.+W.+Wangauthor=S.+L.+Panauthor=C.+Y.+Pengauthor=D.+Y.+Huangauthor=A.+C.+Tsaiauthor=Y.+L.+Changauthor=J.+H.+Guhauthor=S.+C.+Kuoauthor=K.+H.+Leeauthor=C.+M.+Teng&title=CHM-1+inhibits+hepatocyte+growth+factor-induced+invasion+of+SK-Hep-1+human+hepatocellular+carcinoma+cells+by+suppressing+matrix+metalloproteinase-9+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">CHM-1 inhibits hepatocyte growth factor-induced invasion of SK-Hep-1 human hepatocellular carcinoma cells by suppressing matrix metalloproteinase-9 expression</span></div><div class="casAuthors">Wang, Shih-Wei; Pan, Shiow-Lin; Peng, Chieh-Yu; Huang, Der-Yi; Tsai, An-Chi; Chang, Ya-Ling; Guh, Jih-Hwa; Kuo, Sheng-Chu; Lee, Kuo-Hsiung; Teng, Che-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">257</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-96</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Clin. observations suggest that hepatocyte growth factor (HGF) can promote invasion and metastasis in hepatocellular carcinoma.  In this study, we found that HGF-stimulated invasion of SK-Hep-1 cells, together with increased expression of matrix metalloproteinase (MMP)-9.  CHM-1 was identified from 2-phenyl-4-quinolone derivs. to potently inhibit HGF-induced cell invasion, proteolytic activity, and expression of MMP-9.  CHM-1 significantly inhibited tyrosine autophosphorylation of c-Met induced by HGF.  CHM-1 also suppressed HGF-induced Akt phosphorylation, and NF-κB activation, the downstream regulators of HGF/c-Met signaling, resulting in the inhibition of MMP-9.  Thus, we suggest that CHM-1 is a potential therapeutic agent against tumor invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtlJme6dRgS7Vg90H21EOLACvtfcHk0ljePX-qiYLBfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSnt7jM&md5=cf714b78ba65bdfffb8d594df27f354c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2007.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2007.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%2BW.%26aulast%3DPan%26aufirst%3DS.%2BL.%26aulast%3DPeng%26aufirst%3DC.%2BY.%26aulast%3DHuang%26aufirst%3DD.%2BY.%26aulast%3DTsai%26aufirst%3DA.%2BC.%26aulast%3DChang%26aufirst%3DY.%2BL.%26aulast%3DGuh%26aufirst%3DJ.%2BH.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DLee%26aufirst%3DK.%2BH.%26aulast%3DTeng%26aufirst%3DC.%2BM.%26atitle%3DCHM-1%2520inhibits%2520hepatocyte%2520growth%2520factor-induced%2520invasion%2520of%2520SK-Hep-1%2520human%2520hepatocellular%2520carcinoma%2520cells%2520by%2520suppressing%2520matrix%2520metalloproteinase-9%2520expression%26jtitle%3DCancer%2520Lett.%26date%3D2007%26volume%3D257%26spage%3D87%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Meraldi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draviam, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorger, P. K.</span><span> </span><span class="NLM_article-title">Timing and checkpoints in the regulation of mitotic progression</span> <span class="citation_source-journal">Dev. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=45-60&author=P.+Meraldiauthor=V.+M.+Draviamauthor=P.+K.+Sorger&title=Timing+and+checkpoints+in+the+regulation+of+mitotic+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeraldi%26aufirst%3DP.%26aulast%3DDraviam%26aufirst%3DV.%2BM.%26aulast%3DSorger%26aufirst%3DP.%2BK.%26atitle%3DTiming%2520and%2520checkpoints%2520in%2520the%2520regulation%2520of%2520mitotic%2520progression%26jtitle%3DDev.%2520Cell%26date%3D2004%26volume%3D7%26spage%3D45%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Paull, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubinstein, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plowman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span> </span><span class="NLM_article-title">Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">1088</span><span class="NLM_x">–</span> <span class="NLM_lpage">1092</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1093%2Fjnci%2F81.14.1088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=2738938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A280%3ADyaL1M3ptlyrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1989&pages=1088-1092&issue=14&author=K.+D.+Paullauthor=R.+H.+Shoemakerauthor=L.+Hodesauthor=A.+Monksauthor=D.+A.+Scudieroauthor=L.+Rubinsteinauthor=J.+Plowmanauthor=M.+R.+Boyd&title=Display+and+analysis+of+patterns+of+differential+activity+of+drugs+against+human+tumor+cell+lines%3A+development+of+mean+graph+and+COMPARE+algorithm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm</span></div><div class="casAuthors">Paull K D; Shoemaker R H; Hodes L; Monks A; Scudiero D A; Rubinstein L; Plowman J; Boyd M R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1088-92</span>
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">The objective of this study was to develop and investigate an approach to optimally detect, rank, display, and analyze patterns of differential growth inhibition among cultured cell lines.  Such patterns of cellular responsiveness are produced by substances tested in vitro against disease-oriented panels of human tumor cell lines in a new anticancer screening model under development by the National Cancer Institute.  In the first phase of the study, we developed a key methodological tool, the mean graph, which allowed the transformation of the numerical cell line response data into graphic patterns.  These patterns were particularly expressive of differential cell growth inhibition and were conveniently amenable to further analyses by an algorithm we devised and implemented in the COMPARE computer program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQUJX57ADL8cwpJitSxOdIlfW6udTcc2ea97cJ1O3hMMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M3ptlyrsw%253D%253D&md5=6612f9f2a7793d1296dfa24224f09545</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F81.14.1088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F81.14.1088%26sid%3Dliteratum%253Aachs%26aulast%3DPaull%26aufirst%3DK.%2BD.%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26aulast%3DHodes%26aufirst%3DL.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DScudiero%26aufirst%3DD.%2BA.%26aulast%3DRubinstein%26aufirst%3DL.%26aulast%3DPlowman%26aufirst%3DJ.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DDisplay%2520and%2520analysis%2520of%2520patterns%2520of%2520differential%2520activity%2520of%2520drugs%2520against%2520human%2520tumor%2520cell%2520lines%253A%2520development%2520of%2520mean%2520graph%2520and%2520COMPARE%2520algorithm%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1989%26volume%3D81%26issue%3D14%26spage%3D1088%26epage%3D1092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skehan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paull, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vistica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hose, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cronise, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaigro-Wolff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray-Goodrich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M.</span><span> </span><span class="NLM_article-title">Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">757</span><span class="NLM_x">–</span> <span class="NLM_lpage">766</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1093%2Fjnci%2F83.11.757" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=2041050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A528%3ADyaK3MXksVWiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1991&pages=757-766&author=A.+Monksauthor=D.+Scudieroauthor=P.+Skehanauthor=R.+Shoemakerauthor=K.+Paullauthor=D.+Visticaauthor=C.+Hoseauthor=J.+Langleyauthor=P.+Croniseauthor=A.+Vaigro-Wolffauthor=M.+Gray-Goodrichauthor=H.+Campbellauthor=J.+Mayoauthor=M.+Boyd&title=Feasibility+of+a+high-flux+anticancer+drug+screen+using+a+diverse+panel+of+cultured+human+tumor+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines</span></div><div class="casAuthors">Monks, Anne; Scudiero, Dominic; Skehan, Philip; Shoemaker, Robert; Paull, Kenneth; Vistica, David; Hose, Curtis; Langley, John; Cronise, Paul; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">757-66</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">The development and implementation of a pilot-scale, in vitro, anticancer drug screen utilizing a panel of 60 human tumor cell lines organized into subpanels representing leukemia, melanoma, and cancers of the lung, colon, kidney, ovary, and central nervous system is described.  The ultimate goal of this disease-oriented screen is to facilitate the discovery of new compds. with potential cell line-specific and/or subpanel-specific antitumor activity.  In the current screening protocol, each cell line is inoculated onto microtiter plates, then preincubated for 24-28 h.  Subsequently, test agents are added in five 10-fold dilns. and the culture is incubated for an addnl. 48 h.  For each test agent, a dose-response profile is generated.  End-point detns. of the cell viability or cell growth are performed by in situ fixation of cells, followed by staining with a protein-binding dye, sulforhodamine B (SRB).  The SRB binds to the basic amino acids of cellular macromols.; the solubilized stain is measured spectrophotometrically to det. relative cell growth or viability in treated and untreated cells.  Following the pilot screening studies, a screening rate of 400 compds. per wk has been consistently achieved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs2v5P80YUP7Vg90H21EOLACvtfcHk0lj5I8zBx3AOaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXksVWiuro%253D&md5=cee33642400d34b01d8f962cb16a9386</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F83.11.757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F83.11.757%26sid%3Dliteratum%253Aachs%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DScudiero%26aufirst%3DD.%26aulast%3DSkehan%26aufirst%3DP.%26aulast%3DShoemaker%26aufirst%3DR.%26aulast%3DPaull%26aufirst%3DK.%26aulast%3DVistica%26aufirst%3DD.%26aulast%3DHose%26aufirst%3DC.%26aulast%3DLangley%26aufirst%3DJ.%26aulast%3DCronise%26aufirst%3DP.%26aulast%3DVaigro-Wolff%26aufirst%3DA.%26aulast%3DGray-Goodrich%26aufirst%3DM.%26aulast%3DCampbell%26aufirst%3DH.%26aulast%3DMayo%26aufirst%3DJ.%26aulast%3DBoyd%26aufirst%3DM.%26atitle%3DFeasibility%2520of%2520a%2520high-flux%2520anticancer%2520drug%2520screen%2520using%2520a%2520diverse%2520panel%2520of%2520cultured%2520human%2520tumor%2520cell%2520lines%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1991%26volume%3D83%26spage%3D757%26epage%3D766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Yamori, T.</span><span> </span><span class="NLM_article-title">Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">S74</span><span class="NLM_x">–</span> <span class="NLM_lpage">S79</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2003&pages=S74-S79&author=T.+Yamori&title=Panel+of+human+cancer+cell+lines+provides+valuable+database+for+drug+discovery+and+bioinformatics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamori%26aufirst%3DT.%26atitle%3DPanel%2520of%2520human%2520cancer%2520cell%2520lines%2520provides%2520valuable%2520database%2520for%2520drug%2520discovery%2520and%2520bioinformatics%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2003%26volume%3D52%26spage%3DS74%26epage%3DS79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Euhus, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudd, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaRegina, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, F. E.</span><span> </span><span class="NLM_article-title">Tumor measurement in the nude mouse</span> <span class="citation_source-journal">J. Surg. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1002%2Fjso.2930310402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=3724177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A280%3ADyaL283lsFGrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1986&pages=229-234&author=D.+M.+Euhusauthor=C.+Huddauthor=M.+C.+LaReginaauthor=F.+E.+Johnson&title=Tumor+measurement+in+the+nude+mouse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor measurement in the nude mouse</span></div><div class="casAuthors">Euhus D M; Hudd C; LaRegina M C; Johnson F E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of surgical oncology</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">229-34</span>
        ISSN:<span class="NLM_cas:issn">0022-4790</span>.
    </div><div class="casAbstract">In this study, the pitfalls of tumor measurement in the nude mouse were evaluated.  Regarding intermethod variation, diameters of subcutaneous tumors in nude mice were expressed as length, area, and volume; tumor weights were also recorded.  These measurements were all compared to a reference standard: water displacement volume.  Estimates of area and volume derived from caliper measurements correlated well with water displacement volume (r = 0.97 and 0.98, respectively).  At necropsy, tumor weight was the most consistent and reproducible reflection of tumor volume (r = 1.0000).  Regarding interobserver variation, mean absolute difference among volumes determined by several investigators who measured the same tumors in living animals was determined.  This averaged 15% of the mean calculated volume.  Regarding intraobserver variation, observers measured four separate masses in nude mice eight times each.  The observers were prevented from realizing that the same animals were being repeatedly evaluated.  Volumes were compared in order to quantify the average variation that occurs when a single investigator repeatedly measures the same mass.  When large masses were measured, this error was 7%; when small masses were measured, the error was 27%.  Recommendations are made for future work employing tumor measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRA4eEHDa7Gl5Pq5LRczm8ffW6udTcc2ea97cJ1O3hMMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL283lsFGrtQ%253D%253D&md5=33e4690abec9f0f531e3b0d569e747ca</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fjso.2930310402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjso.2930310402%26sid%3Dliteratum%253Aachs%26aulast%3DEuhus%26aufirst%3DD.%2BM.%26aulast%3DHudd%26aufirst%3DC.%26aulast%3DLaRegina%26aufirst%3DM.%2BC.%26aulast%3DJohnson%26aufirst%3DF.%2BE.%26atitle%3DTumor%2520measurement%2520in%2520the%2520nude%2520mouse%26jtitle%3DJ.%2520Surg.%2520Oncol.%26date%3D1986%26volume%3D31%26spage%3D229%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Tomayko, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. P.</span><span> </span><span class="NLM_article-title">Determination of subcutaneous tumor size in athymic (nude) mice</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm901292j&amp;key=10.1007%2FBF00300234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm901292j&amp;key=2544306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm901292j&amp;key=1%3ACAS%3A280%3ADyaL1M3ovVGjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1989&pages=148-154&author=M.+M.+Tomaykoauthor=C.+P.+Reynolds&title=Determination+of+subcutaneous+tumor+size+in+athymic+%28nude%29+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of subcutaneous tumor size in athymic (nude) mice</span></div><div class="casAuthors">Tomayko M M; Reynolds C P</div><div class="citationInfo"><span class="NLM_cas:title">Cancer chemotherapy and pharmacology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">148-54</span>
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    </div><div class="casAbstract">The athymic (nude) mouse is a useful model for studying the biology and response to therapies of human tumors in vivo.  A survey of recent literature revealed the use of 19 different formulas for determining the size of subcutaneous tumors grown as xenografts in nude mice (2 for determining tumor area, 3 for tumor diameter, and 14 for calculating tumor volume).  We compared the volumes, areas, and diameters predicted by each of the 19 formulas with the actual weights of 50 tumors ranging from 0.46 to 22.0 g established in nude mice as xenografts from human cell lines.  In addition to determining how well each formula predicted relative tumor size, we analyzed how well each formula estimated actual tumor mass.  The ellipsoid volume formulas (pi/6 x L x W x H and 1/2 x L x W x H) were best for estimating tumor mass (r = 0.93), whereas measurements of diameter correlated poorly with tumor mass (r less than 0.66).  Although determination of tumor area correlated well with tumor mass in small tumors (r = 0.89), correlations of area with tumor mass for large tumors were poor (r = 0.41).  We conclude that determination of the ellipsoid volume from measurements of three axes consistently yields the most accurate estimations of both relative and actual tumor mass.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTFNL7A6tb_ZkBuFdjgVNKSfW6udTcc2ebtx1veGtoE7rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M3ovVGjug%253D%253D&md5=af54a5d168f43a4b4d9b52964b05ec65</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1007%2FBF00300234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00300234%26sid%3Dliteratum%253Aachs%26aulast%3DTomayko%26aufirst%3DM.%2BM.%26aulast%3DReynolds%26aufirst%3DC.%2BP.%26atitle%3DDetermination%2520of%2520subcutaneous%2520tumor%2520size%2520in%2520athymic%2520%2528nude%2529%2520mice%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1989%26volume%3D24%26spage%3D148%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="note"><p class="first last">References provided in Supporting Information.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i39"><a href="/doi/suppl/10.1021/jm901292j">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_23745"></div></div></div></div></div><hr /></hr><p class="last">Literature references for spectrum screen (enzyme and radioligand binding assays); analytical results. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm901292j/suppl_file/jm901292j_si_001.pdf">jm901292j_si_001.pdf (381.67 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm901292j/suppl_file/jm901292j_si_002.pdf">jm901292j_si_002.pdf (13.61 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm901292j&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm901292j%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-4%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm901292j" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799aecb4ba63c34","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
